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Recently, the relationship of anxiety with asthma has been investigated in the
psychological literature, revealing that individuals with asthma are more likely to develop
panic disorder than are individuals without asthma (e.g., Carr, 1998). Two theories
(dyspnedsuffocation fear theory and cognitive theory) have been used to explain how
asthma symptoms are affected by panic attacks or panic disorder. The present study
examines both theories, as well as a hypothesis developed by Carr (1 998) that suggests
that the presence of panic disorder in individuals with asthma may lead to better lung
functioning in response to stressful stimuli than for individuals with asthma alone.
Sixty undergraduate females participated. They were divided into four groups
based on history of asthma and panic disorder (Asthma only, Panic only, Asthma and
Panic, Control). Participants completed questionnaires that assessed depressed mood,
anxiety, anxiety sensitivity, self-focus on bodily sensations, fear of bodily sensations, and
misinterpretation of bodily sensations. Each participant engaged in a 5 min baseline and
three experimental tasks: breathing through a straw, turning one’s head from side to side,

and relaxation. Following each task, spirometry measurements were taken, and
participants completed measures of panic and asthma symptoms, panic attack related
cognitions, and mood.
Women with panic disorder (with or without asthma) reported more depressed
mood, trait anxiety, self-focus on bodily sensations, fear of bodily sensations, and anxiety
sensitivity (on one of two measures of anxiety sensitivity) than women with asthma only
or controls. Women with both asthma and panic disorder reported higher levels of
asthma-related symptoms than women with asthma only. Little support was found for the
application of cognitive theory to asthma alone, however, cognitive theory continued to
explain results for individuals in the panic groups. Likewise, dyspnedsuffocation fear
theory was not supported by the present study, nor was Carr’s hypothesis. Implications
of these results for the two theories and Carr’s hypothesis are discussed. In addition,
suggestions for future research are made.
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Chapter 1
INTRODUCTION
Asthma has long been viewed by both the medical and psychological community
as a chronic respiratory illness that may be provoked or exacerbated by psychological
factors. Knowledge of the relationship of asthma to psychological factors arose from an
accumulation of case studies and anecdotes about the relation between emotional upset or
exposure to benign objects and the exhibition of asthma symptoms (Dekker & Groen,
1956; Dekker, Pelser, & Groen, 1957; French & Alexander, 1941; Rees, 1956). For
example, MacKenzie (I 886) documented the case of a woman with asthma whose
symptoms were precipitated by contact with roses. Interestingly, severe symptoms were
also triggered by contact with an artificial rose. Over time, a variety of events (e.g.,
merely looking at dust, using an elevator, seeing a picture of a horse, or looking at a
goldfish in a bowl) have been reported to lead to asthma symptoms (Dekker & Groen,
1956). Because asthma symptoms appear at times to be evoked or worsened by an
individual’s mental state, or by exposure to objects that should not physiologically lead to
bronchoconstriction, psychological correlates of asthma continue to be widely researched.
In the medical and psychological literature, there are opposing views about
whether or not asthma is indeed caused or exacerbated by psychological factors (e.g.,
Benjamin, 1977; Ibor, 1956; Purcell & Weiss, 1970). In the 1950s, researchers suggested
that emotional factors played a role in the etiology of asthma symptoms (Dekker &
Groen, 1956; Dekker et al., 1957; French & Alexander, 1941). However, at the time, it
was unclear how much emotional factors contributed and how they operated in creating
symptoms (Rees, 1956). Unfortunately, over 40 years later, there has been little progress
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toward a definitive resolution of either of these points. Researchers continue to disagree
about the role played by psychological factors in the experience of asthma.
A variety of contrasting views about the interaction between asthma and
psychological factors have been presented. Psychosomatic models of asthma posit that
the disease may be caused or exacerbated by intense emotions or particular personality
types (e.g., dependent) or characteristics (e.g., emotional lability; Belloch et al., 1994;
French & Alexander, 1941; Henry, Morera, Frugoni, & Gonzalez-Martin, 1993; Lyketsos
et al., 1984). Some theorists suggest that asthma and specific psychological disorders
(e.g., schizophrenia, agoraphobia, depression) are alternate manifestations of each other
(Ibor, 1956; Kelly & Zeller, 1969). In contrast, other researchers propose that asthma is
not caused by psychological phenomena at all, stating that the real task in studying
asthma should be to examine the development of psychopathology as a consequence of
having asthma (Maes & Schlosser, 1987). Conceivably, psychological disorders may
occur as a result of living with a chronic illness, not vice versa (Plutchik, Williams,
Jerrett, Karasu, & Kane, 1978). According to Maes and Schlosser (1987), it may be more
productive to direct research toward questions of psychomaintenance. This area of focus
might include such issues as how particular disorders (e.g., anxiety, depression) or
methods of coping with asthma affect the course and outcome of the disease (Deenen &
Klip, 1993; Janson-Bjerklie, Ferketich, & Benner, 1993; Staudenmayer, Kinsman, &
Jones, 1978). Research about the relation between asthma and psychological factors
leads to conclusions that lie somewhere between these diverse views. Although it would
be inaccurate to state that the etiology of asthma is entirely psychological, it would be a
mistake to discontinue researching the role that psychological factors play in the
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experience of the disease. It is important to continue to investigate antecedent,
concomitant, and consequential psychological phenomena in the hopes of ultimately
reducing the symptoms, suffering, and costs associated with asthma.
Asthma: Relation to Symptoms and Theories of Panic Disorder
Some of the symptoms of asthma are similar to those of panic disorder (e.g.,
shortness of breath, choking sensation, chest pain, fear). This similarity may have
strengthened the view of asthma as an illness with both biological and psychological
causes (Yellowlees & Kalucy, 1990; Zandbergen et al., 1991). In addition, high
comorbidity rates and the applicability of theories of panic disorder to asthma research
have fostered conjoint study of the two disorders.
There is a particularly high rate of comorbidity between asthma and panic
disorder. According to the Diagnostic and Statistical Manual of Mental Disorders-Fourth
Edition (DSM-IV; American Psychological Association [APA], 1994), the 1-year
prevalence rate of panic disorder in the general population is 1% - 2%. For individuals
who have asthma, however, it is estimated to be between 6.5% and 24% (Shavitt, Gentil,
& Mandetta, 1992; Yellowlees, Alpers, Bowden, Bryant, & Ruffin, 1987). This high rate

of comorbidity has led to much speculation about the possibility of common etiological
factors that could lead to both disorders. Because symptoms of asthma are similar to
symptoms of panic disorder, two theories (i.e., dyspnea-suffocation fear theory, cognitive
theory) that have proved useful for understanding panic disorder have been applied to
asthma.
The revised dyspnedsuffocation fear theory addresses the effects of the perception
of difficulty in breathing on the production of panic symptoms (Ley, 1989). Dyspnea
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refers to the sensation that breathing is impaired, whereas suffocation refers to a bodily
condition that may lead to asphyxiation (Ley, 1994; 1998). Suffocation can occur with
little or no discomfort or overt anxiety symptoms. This phenomenon has been observed
in infants who suffer from Ondine’s curse, a disorder wherein an infant temporarily stops
breathing when asleep (Klein, 1993). Oddly, a child with this disorder does not exhibit
symptoms of discomfort or distress when breathing ceases. In contrast, the
dyspnedsuffocation fear theory posits that it is the experience of severe dyspnea in a
context in which an individual believes he or she has little control over the causes of the
sensation (e.g., having one’s head forced under water; an uncued panic attack) that leads
to the experience of panic. The theory’s connection to asthma is reflected in the
experience of dyspnea, which may lead to increased anxiety and further difficulty in
breathing (Dirks, Kinsman, Staudenmayer, & Klieger, 1979; Jones, Kinsman, Dirks, &
Dahlem, 1979; Purcell & Weiss, 1970).
Cognitive theory has been extensively discussed in relation to the understanding
and treatment of panic disorder. Recently, cognitive theory has been applied to the
experience of asthma (e.g., Can, 1998; Carr, Lehrer, & Hochron, 1995; Carr, Lehrer,
Hochron, & Jackson, 1996). According to cognitive theory, panic disorder develops as a
result of the experience of ambiguous sensations that occur in the body. These sensations
are then misinterpreted by an individual as having catastrophic consequences (e.g., “I am
dying”; Clark, 1986). Next, the catastrophic cognitions lead to increased anxiety and
anxiety-related sensations, continuing the cycle (Figure 1.1). In relation to asthma, it has
been hypothesized that misinterpreting or catastrophizing about ambiguous or asthma-

(

Trigger Sti mu Ius
internal or external)

Interpretation of
Sensations as
Catastrophic

Apprehension

I

Sensations

Figure 1.1 Representation of the sequence of events hypothesized to lead to panic attacks
in Clark’s (1986) cognitive theory of panic
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related bodily symptoms may result in increased fear, that in turn may increase the
severity of asthma symptoms (Dorhofer, Sigmon, & Boulard, 1998).
Investigations of the utility of these two theories in explaining asthma symptoms
(as well as the experience of panic) have produced mixed findings. There has been some
support for the dyspnedsuffocation fear theory in relation to asthma (e.g., Carr, Lehrer, &
Hochron, 1992; see Ley, 1994 for criticisms). Support for cognitive theory has been
mixed (e.g., Can- et al., 1995; Carr et al., 1996; Dorhofer et al., 1998; see Carr, 1998 for
opposing viewpoint). The utility of these theories may be in helping researchers better
understand how symptoms of asthma can be triggered or exacerbated by cognitive
interpretations of physiological sensations, or the sensations themselves. In turn, this
understanding could lead to interventions that could possibly reduce asthma symptoms,
suffering, and expense (Klingelhofer & Gershwin, 1988; Lehrer, Sargunaraj, & Hochron,
1992; Rachelefsky, 1987). Thus, it may be important for the two theories to be tested
together in an experimental paradigm in order to assess their applicability to the
experience of asthma. These two theories are further discussed in a later section.
Asthma: General Characteristics
In order to discuss research pertinent to the psychological contributions to asthma
symptoms, it is important to understand the basic characteristics of the disease. The
physiological mechanisms and epidemiology of asthma have been studied for many years.
It is now possible to understand trends in a number of epidemiological studies as well as
the basic physiological changes that underlie an asthma attack.
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Asthma Prevalence and DemoaraDhics
Asthma represents one of three types of chronic obstructive pulmonary disease.
Other types include chronic bronchitis and emphysema (Creer, 1979). Approximately
0.3% - 7.9% of the population of the United States suffers from asthma (Bonner, 1984;
Cookson, 1987; Rees, 1980). Between 1965 and 1983, hospitalization rates for adults
with asthma increased by 50%, whereas in children, the rates increased by 200% (Evans
et al., 1987). This dramatic increase in asthma rates continued in the period between
1980 and 1987, when the prevalence of asthma in the United States increased by 29%
(Expert Panel Report [EPR], 1991). In addition, asthma-related death rates increased by

40% between 1982 and 1991 (Center for Disease Control [CDC], 1995). Researchers
have yet to discover why the mortality rates have steadily increased.
Approximately 63% of individuals with asthma experience symptom onset before
the age of 15. In some studies, males appear to be slightly more prone to asthma (0.6% -

4.7% for men, 0.6 - 1.5% for women; Evans et al., 1987; Rees, 1980). However, other
estimates of gender differences in asthma rates indicate that age may be an important
factor as well. In one community sample, no significant gender differences were found
for individuals younger than age 30 (Dodge & Burrows, 1980). However, for individuals
between 30 and 50, the rates of active asthma for women was nearly double those for men
(although this difference was not statistically significant). Beyond age 50, the rates for
men again exceeded those for women (Pearlman & Bierman, 1988). Asthma is,
therefore, a relatively common disease that is increasing in prevalence. The necessity of
identifying factors that can reduce asthma morbidity and mortality is clear.
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It is particularly important to investigate correlates of asthma in a female
population for several reasons. First, as described above, asthma rates may be higher for
women in certain age groups (Dodge & Burrows, 1980). Second, approximately 75% of
adults hospitalized for asthma are female (Skobeloff et al., 1996). Third, a larger increase
in mortality rates was observed between 1982 and 1991 for women than men (59% for
women, 34% for men; CDC, 1995). These differences in hospitalization and death rates
indicate that there are additional factors beyond prevalence alone that account for gender
differences in asthma severity and use of health care resources.
Asthma remains a costly disorder. In 1976, total cost of asthma in the United
States was estimated to be $1.3 billion dollars, By 1992, that figure, comprising inpatient
hospital services and lost productivity, reached $6.2 billion (Weiss, Gergen, & Hodgson,
1992). With medical costs increasing yearly for the treatment of asthma, the prevention
or curtailing of symptoms and attacks may serve to decrease these overall costs (Dirks &
Kinsman, 1981; Kaptein, 1982).
In summary, asthma rates, deaths due to the disease, and societal costs of the
disorder have been on the rise according to research conducted over the past 30 years.
Because of specific increases in hospitalization and death rates for women, it is important
to examine factors in addition to gender that may lead to differential asthma severity.
These factors include the role of stress and anxiety, which may operate differentially for
males and females.
Physical Alterations During an Asthma Attack
Asthma represents a chronic disorder characterized by three major elements:
airway obstruction that is reversible either spontaneously or in response to treatment,
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airway inflammation, and hyperresponsivity of the airways (American Thoracic Society
[ATS], 1962; 1987; Bailey, Higgins, Richards, & Richards, 1992; EPR, 199 1 ; Pearlman,
1984). Asthma generally occurs in discrete episodes or “attacks,” that are reversible with

or without medical intervention (Hogg, 1984). The severity and pattern of asthma attacks
varies greatly from individual to individual (Purcell & Weiss, 1970). Some individuals
with asthma may only need to utilize occasional medication in the presence of a specific
trigger, whereas others may not need to use medication at all (Alexander, 198 1). More
severe asthma may not be completely reversible or controllable through use of regular
medication (Creer, 1982; Matts, 1984). In this case, the individual is never completely
without some asthma-related symptoms (American Medical Association [AMA], 1996).
When asthma symptoms are triggered by a particular stimulus (e.g., exercise,
overbreathing, airway cooling, allergic irritation, emotional factors), a variety of
physiological changes occur in the respiratory system (Matts, 1984). These changes
include constriction of the smooth muscles in the airways and swelling or contraction of
the bronchial walls, mucosal edema and secretion of thick mucus, and infiltration of the
inflammatory cells (Creer, Reynolds, & Kotses, 1991; Hogg, 1984; Scanlon, 1984).
When lung obstruction increases, the sternocleidomastoid muscles maximize chest
expansion, leading to breathing at a level near total lung capacity (EPR, 199 1).
Infiltration of the inflammatory cells involves the release of chemicals (e.g.,
histamine, prostaglandins) by mast cells into the mucosal, submucosal, and smooth
muscle layers (McFadden, 1980a). This infiltration results in increased permeability of
the capillaries, leading to inflammation. The inflammatory response results in the
secretion of substances (e.g., mucus, proteins) that may occlude the smaller airways
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(ATS, 1987; Cross, 1994). In addition, the mucus secreted becomes more viscous, and
during an asthma attack, the speed at which it is cleared from the airways decreases
(McFadden, 1980b). During a severe attack, mucus plugs may form in the airways,
further reducing an individual’s ability to breathe (Nadel& Barnes, 1984).
Although individuals’ symptom patterns may differ, the three major symptoms of
hyperresponsivity, airway obstruction, and inflammation are generally observed across
individuals with asthma. When symptoms are triggered, bronchial muscles constrict, the
lungs may hyperinflate, and thick mucus may be secreted. Each of these physiological
changes contributes to difficulty in breathing.
Measures of Respiration
Several different measures of bronchial change have been used in asthma
research. To some extent, each of these measures is related to the effort exerted by an
individual. When asthma symptoms are present, the narrowing of the bronchial tubes
leads to the reduction of vital capacity, expiratory flow rate, and maximal voluntary
ventilation, as well as increased airway resistance (ATS, 1962; see Table 1.1). These
symptoms are measurable via apparatus designed for the monitoring of lung function.
Frequently, a spirometer or a peak flow meter is used. This process involves having an
individual take a deep inhalation and then exhale as rapidly and completely as possible
into the apparatus (Hyatt, Scanlon, & Nakamura, 1997). Less frequently, the more
invasive procedure of forced oscillation pneumography is used.
Spirometry
Spirometry assesses several different aspects of lung function, including forced
vital capacity (FVC), forced expiratory volume, measurements during the middle of the
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Table 1.1
Measures of lung h c t i o n ; increase vs. decrease during an asthma attack

Measures that Increase
~

Measures that Decrease

~~

Total lung capacity

Vital capacity

Functional residual capacity

Forced vital capacity

Residual volume

Forced expiratory volume at 1 second

Total respiratory resistance

Maximal voluntary ventilation

Peak expiratory flow rate

Forced expiratory volume at 1 second
Forced vital capacity
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exhalation, and total respiratory resistance. The overall purpose is to measure changes in
the rate at which the lungs change volume during forced exhalations (Hyatt et al., 1997).
As measured by a spirometer, FVC reflects the total amount of air exhaled
forcefully after a complete inhalation. Vital capacity positively correlates with the level
of lung hyperinflation that occurs during an asthma attack (EPR, 1991). However,
disagreement exists about the sensitivity of FVC as a measure. Some researchers report
that FVC is very sensitive to narrowing of the airways during an asthma attack (Hyatt et
al., 1997), whereas others contend that this measure alone may not be reliably affected by
asthmatic symptoms (Carr et al., 1992). In addition, FVC is effort-dependent and may
not be sensitive to changes in total respiration (Miller & Kotses, 1995).
Forced expiratory volume at 1 sec (FEVl) represents the amount of air expelled in
the first second after the start of exhalation. An estimation of the change in function of
the large airways that narrow during an asthma attack is provided by this measure. FEVl
is sensitive to the level of airway obstruction (which reduces the speed at which air is
exhaled), as well as disease severity (Hyatt et al., 1997; Laszlo, 1994). A decrease greater
than or equal to 20% is considered clinically significant (Isenberg, Lehrer, & Hochron,
1992b).
These two measures (i.e., FEVl and FVC) are frequently combined in a ratio
format (FEVI/FVC) to provide an index of the percent of an individual’s full lung
capacity expired after the first second. Generally, a normal adult is able to exhale
between 75% - 85% of their total lung capacity after 1 sec, 94% after 2 sec, and 97% after

3 sec (Creer, 1979). This ratio is important for two reasons. First, it provides the
interpreter with the ability to identify individuals who have airway obstruction as well as
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reduced FVC, indicated by a low ratio (Hyatt et al., 1997; Laszlo, 1994). Second, the
ratio assists in the identification of the cause of low FEVI. If FEVl is low, but the ratio is
normal, this finding may indicate that restriction is occurring. Alternatively, a decreased
overall ratio indicates that obstruction is likely (Carr et al., 1992).
Forced expiratory flow at 50% vital capacity (FEFso)represents the rates of air
flow in the middle airways. It is much less effort dependent than FEVI. However, a
larger range of values are considered to be normal, leading to difficulty in interpretation
(Asmundson & Stein, 1994; Carr et al., 1992; Hyatt et al., 1997). FEF25-75 reflects the
average rate of air flow during the middle half of the exhalation. This rate represents the
state of both large and small airways. Generally, values are greater than 150 L/min for
men and 100 L/min for women (Creer, 1979).
Total respiratory resistance (R,) is a measure of the air flow resistance of the
airways, lung tissue, and chest wall. When an individual experiences an asthma attack,
constriction of the bronchioles leads to an increase in the measure of air flow resistance
(Miller & Kotses, 1995). However, increased airway resistance may or may not be
related to asthma symptoms. Normal individuals often exhibit temporary (less than 1 min
in duration) responses to bronchoconstrictive suggestion (Isenberg, Lehrer, & Hochron,
1992a).
In summary, the use of spirometry in asthma research is reflected in several
commonly used measures. Of these measures (e.g., FVC, FEVI, FEFso,Rt), the most
frequently used and most informative appear to be FEVl and the ratio of FEVl/FVC (e.g.,
Aitken, Zealley, & Rosenthal, 1969; Carr et al., 1992; Carr, Lehrer, Rausch, & Hochron,
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1994; Isenberg et al., 1992b). In the present study, these two measures will be utilized as
an index of respiratory change in response to experimental tasks.
Peak Air Flow
Peak flow is measured by a simple apparatus that measures liters of air expelled
per min, or an individual’s peak expiratory flow rate (PEFR). Many peak flow meters are
made of plastic, with a spring device that bumps a marker up to the appropriate number
(Chiaramonte & Prabhu, 1982). Peak air flow reflects a relatively rough estimate, and is
quite effort-dependent (Hyatt et al., 1997). This measure is less sensitive to small airways
obstruction, but does correlate strongly with measures obtained via spirometry (Creer,
1979). PEFR also correlates with the level of lung hyperinflation (EPR, 1991). Overall,
peak flow represents a simple measure of lung function, but it is highly effort-dependent,
limiting its usefulness.
Forced Oscillation Pnewnonraphy
Forced oscillation pnewnography assesses the degree to which obstruction due to
bronchoconstriction is occurring. Alternating multiple-frequency pressure oscillations are
applied to the airways via a mouthpiece. This procedure results in a measure of total
respiratory impedance (Rz;
Franetzki, Prestele, & Korn, 1979; Lehrer et al., 1996).
Measurement of lung function via the forced oscillation method is not effort-dependent,
and does not require maximum exertion on the part of the participant. However, this
equipment is not easily available to non-medically trained researchers (Sirota, 1982).
Conclusions about Measurement
Each of the above measures has documented strengths and weaknesses.
Unfortunately, there has been no standardization of measurement within the asthma
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literature. This lack of a common measurement standard, particularly in older articles,
makes it difficult to compare results across studies. More recent studies examining the
relationship between asthma and panic disorder have consistently utilized FVC, FEVl,
FEFso, and the FEVl/FVC ratio (e.g., Carr et al., 1992; Carr et al., 1994; Isenberg et al.,
1992b). The consistent use of these measures in future asthma research should facilitate
building a knowledge base and enhance communication among researchers in the field.
Psychological Approaches to Asthma
A large proportion of the published research in the psychological literature
relating to asthma focuses on examining how, why, and when psychological events
influence the elicitation of asthma symptoms. One line of research considers how airway
changes may occur due to psychological manipulations. A second line of research
involves measuring the respiratory effects of exposing an individual with asthma to a
particular type of imaginal or real aversive stimuli (e.g., mental arithmetic, imagination of
aversive scenes, viewing a graphic movie). A third line examines how suggestion can
lead to bronchoconstriction or bronchodilation. These three areas are discussed next.
Physiological Mechanisms
If psychological stimuli produce airway changes in individuals with asthma, it is
important to consider how these changes might occur physiologically (Masuda, Notske, &
Holmes, 1966). The autonomic nervous system regulates and controls alterations in lung
function, and an increase in arousal may lead to a large change in airway smooth muscle
tone (Erskine-Milliss & Schonell, 1981; McFadden, 1980a). Indeed, some researchers
have conceptualized asthma as a malfunction of the autonomic nervous system
(Holtzman, Sheller, Dimeo, Nadel, & Boushey, 1980; Nadel & Barnes, 1984). The
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sympathetic and parasympathetic nervous systems appear to control different portions and
functions of the airways. The sympathetic system controls the lower or small airways,
whereas the parasympathetic system controls the upper or large airways (Nadel& Barnes,
1984). Similarly, sympathetic nervous system activation leads to bronchodilation,
whereas the parasympathetic nervous system produces bronchoconstriction (ErskineMilliss & Schonell, 1981).
The vagus nerve is one of the 12 cranial nerves, and represents a key component
of the parasympathetic nervous system (Scanlon, 1984). Connecting the brain with the
lungs, the vagus nerve may represent the specific pathway by which emotion may lead to
asthma symptoms (Erskine-Milliss & Schonell, 1981). When this nerve is directly
stimulated, airway constriction results (Nadel, Cabezas, & Austin, 1971; Widdicombe,
1975). Constriction occurs due to the release of acetylcholine at the end of the vagus
nerve, near the lungs (McFadden, 1980a). The released acetylcholine is then received by
receptors in the bronchial smooth muscle tissue, forming cyclic guanosine
monophosphate. When an overabundance of guanosine monophosphate occurs, an
imbalance with cyclic adenosine monophosphate results. It is this imbalance that leads to
airway smooth muscle constriction (Scanlon, 1984). Release of acetylcholine from
postganglionic cholinergic fibers of the vagus nerve may also trigger contraction of
bronchial smooth muscle as well as mucus secretion (Harries, Parkes, & Lessof, 1981;
Nadel & Barnes, 1984). Further evidence for the involvement of vagal activity is found
in the cessation of bronchoconstriction by administration of substances that block the
vagal efferent pathway (Mussel1 & Hartley, 1988; Widdicombe, 1975). Similarly, in
animal research, cutting the vagus nerve results in bronchodilation (McFadden, 1980b).
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Increases in vagal activity lead to more severe constriction of the upper airways
than the lower airways (Nadel et al., 1971). Not all individuals with asthma exhibit
alterations in lung function in response to psychological stimuli. Therefore, it has been
suggested that those who do respond tend to experience more upper airway constriction
(thus further implicating the parasympathetic nervous system; Lehrer, Isenberg, &
Hochron, 1993).
Evidence for parasympathetic system involvement in bronchoconstriction has
been found in a variety of studies investigating the effects of stress and relaxation on
bronchoconstriction. In a typical study, peak air flow is measured in controls who have
been conditioned to tense or relax their facial muscles in response to a particular cue
(Glaus & Kotses, 1983). As the face and throat muscles constrict (measured via
electromyography), airway constriction results, leading to a decrease in peak air flow.
Alternatively, when participants are asked to relax their facial muscles, bronchodilation
results. Interestingly, other types of muscular tension and relaxation (e.g., limb muscle)
do not produce alterations in lung function. One explanation for these findings is that
sensory information from the facial muscles affects the vagus nerve via trigeminal
pathways (Kotses & Miller, 1987). However, it is possible that the role of the facial
muscles in producing bronchoconstriction is a facet of the more general diving reflex.
This reflex occurs in humans and other animals when the face is immersed in cold water,
or cold pressure is applied to the forehead. As a result, the body conserves oxygen by
slowing heart rate and limiting blood flow to all parts except the brain. In addition,
bronchoconstriction occurs.

~
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Further evidence implicating the vagus nerve in bronchoconstriction has been
found in a study that used placebo bronchoconstrictor methodology. In this type of study,
individuals with asthma are told that they will be inhaling a substance that provokes
bronchoconstiction. In actuality, the substance is inert and should have no effect on lung
hnction. Before the suggestion was given in this particular study, one group of
participants was administered a substance known to block parasympathetic nervous
system activity. By eliminating the action of the vagus nerve, the measurable effects of
bronchoconstrictive suggestion were not observed (McFadden, Luparello, Lyons, &
Bleecker, 1969). From these studies, evidence has accumulated suggesting that the vagus
nerve and parasympathetic nervous system processes affect lung function.
Parasympathetic nervous system involvement, specifically through stimulation of
the vagus nerve, appears to be the conduit by which psychological stimuli lead to airways
changes (e.g., Isenberg et al., 1992a, Lehrer et al., 1993). Increased arousal, possibly
reflected in increased face and throat muscular tension, stimulates the vagus nerve. In
turn, the vagus nerve sends chemicals to the lungs, which increase bronchoconstriction of
the upper airways. Therefore, psychological stimuli appear to be capable of affecting the
physiological mechanisms underlying asthma symptoms. Research exploring different
psychological stimuli that have been utilized to produce asthma symptoms is summarized
next.
Imagined and In-Vivo Stressful Tasks
The role of imaginal or in-vivo exposure to aversive or stressful events in the
production of bronchoconstriction is well documented (e.g., Isenberg et al., 1992a; Kotses
et al., 1987). Individuals with asthma may exhibit increased air flow resistance when
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imagining symptoms of asthma, imagining the experience of a cough, or imagining
emotions such as fear and anger (e.g., Creer et al., 1991). Similarly, the performance of
particular types of aversive tasks in a laboratory setting have been shown to lead to
increased air flow resistance in individuals with or without asthma (Isenberg et al.,
1992a).
In a typical experimental paradigm, individuals with or without asthma would
view three films that varied in emotional content (i.e., children with asthma in the
hospital, an industrial accident, and a mother deciding whether or not to put her infant up
for adoption). In comparison to controls, individuals with asthma tend to respond to each
of the three films with increased Rt, particularly during extremely emotional scenes
(Levenson, 1979). More recently, Dorhofer, Sigmon, and Boulard (1 997) found that
women with asthma who listened to scenes depicting the experience of asthma and
negative asthma-related situations (e.g., “You decide to go out with a friend. You go to a
local bar, where most people are smoking. You feel your lungs tighten as you breathe in
the smoky air.”) exhibited decreased peak air flow and higher levels of anxiety in
comparison to controls. These studies demonstrate that exposing individuals with asthma
to emotional or asthma-related stimuli consistently reduces lung function compared to
controls.
Other types of aversive cognitive tasks have been utilized in asthma research. In
one study, male college controls were assigned to perform either an easy or difficult
arithmetic task (Kotses, Westlund, & Creer, 1987). The group that performed the
difficult calculations exhibited significantly higher Rt. It should be noted that controls
exhibit transient increased lung resistance as well when engaging in arithmetic tasks.

Therefore, it appears that physiological responses of individuals with asthma are not
qualitatively different from that of individuals without asthma. This pattern of lung
resistance effects indicates that asthma studies that do not include controls may simply be
measuring normal human responses, not a particular response caused by the pathology of
asthma (Kotses, Hindi-Alexander, & Creer, 1989). Individuals who have asthma do,
however, exhibit greater and more consistent increases in Rt in response to a variety of
stimuli than controls. According to some researchers, a quantitative (i.e., occurring along
a continuum), rather than qualitative, difference in response may occur (Isenberg et al.,
1992a).
The type of aversive task used may result in different types of lung response. In a
study of individuals with and without asthma (Lehrer et al., 1996), the effects on lung
function, measured via forced oscillation, of active (e.g., mental arithmetic and reaction
time tasks) versus passive (e.g., watching 2 gory films) tasks were compared.
Interestingly, when both groups engaged in active tasks, Rzdecreased (resulting in better
lung function) in comparison to the passive tasks. According to the researchers, active
tasks may activate the sympathetic nervous system, which is responsible for the “fight or
flight” response. Activation of this system may balance or override the effects of the
parasympathetic system, leading to overall bronchodilation. In contrast, passive tasks
may lead to increased parasympathetic activation that results in bronchoconstriction.
Thus, the observed alterations in lung function may depend on the nature of the task
utilized as a stressor.
In general, it appears that a wide variety of aversive tasks lead to alterations in
lung function. In many cases, these procedures lead to decreases in lung function, but in
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some cases, an increase may be noted. Further research would be helpful in order to
make more definitive statements about the conditions under which bronchoconstriction
versus bronchodilation will occur.
Placebo Bronchoconstrictor Studies
The role that placebos (neutral substances that an individual believes will have a
real effect) may play in the development of bronchoconstriction has been widely studied.
It is well known in both the medical and psychological literature that placebos are
frequently capable of creating measurable psychological or physical alterations in an
individual (e.g., Edmeads, 1984). In the study of asthma, a specific type of research has
evolved wherein bronchoconstriction is induced in response to a placebo. In a typical
research protocol, participants inhale a substance that is presented as either a neutral
substance (control condition) or as a strong bronchoconstrictor (e.g., Kotses et al., 1989;
Luparello, Lyons, Bleecker, & McFadden, 1968; McFadden et al., 1969; Miller & Kotses,

1990; Wigal, Kotses, Rawson, & Creer, 1988). In reality, the inhaled substance is inert
(e.g., saline solution, distilled water, room air) in both conditions. At baseline and after
the inhalation(s), airway function is measured via spirometry or peak flow. One early
report indicated that full-blown asthma attacks were both induceable and reversible with
the use of this methodology (Luparello et al., 1968). In this type of study, researchers
hypothesize that the physiological mechanism responsible for the airway response is the
vagus nerve, as the body responds to heightened arousal (Spector, Luparello, Kopetzky,
Souhrada, & Kinsman, 1976).
Subsequent studies, however, have not reported the occurrence of full-blown
asthma attacks. More frequently, less severe but measurable alterations in lung function
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occur. For example, a group of 29 individuals with asthma inhaled a saline solution on
five occasions (Janson-Bjerklie, Boushey, Carrieri, & Lindsey, 1986). During the first
(control) trial, participants were informed that they were inhaling an inert substance.
During the second through fifth (suggestion) trials, participants were informed that they
were inhaling a chemical in progressively increasing doses that would cause chest
tightness and wheezing. Although no full-blown asthma attacks were noted, 34% of the
participants responded to the suggestion with a clinically significant increase in airway
resistance (i.e., greater than 20% above baseline).
Similar studies have been conducted using variants of this basic methodology.
Alterations in the focus of the experiments have led to the use of different types of inert
substances (e.g., distilled water, saline) and different orders of control versus suggestion
trials. Reviewing the use of saline as an inert substance, Isenberg et al. (1992a) calculated
that approximately 48% of participants responded to the suggestion trial with a clinically
significant deterioration in lung function (20% decrease, e.g., Luparello et al., 1968;
Luparello, Leist, Louie, & Sweet, 1970; McFadden et al., 1969; Philipp, Wilde, & Day,
1972). In comparison, only 17% responded to the control condition.
A large number of placebo bronchoconstrictor studies have been reported in the
asthma literature. Most studies report that a proportion of the participants exhibit some
bronchoconstriction in comparison to baseline (e.g., Butler & Steptoe, 1986; JansonBjerklie et al., 1986; McFadden et al., 1969). According to a review of studies that used
bronchoconstrictive suggestion, approximately 30 to 40% of participants exhibit
temporary decreases in lung function in response to the suggestion (Isenberg et al.,
1992a). However, these authors have suggested a more conservative average of 20%
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participant response, taking into account serious methodological problems. This low rate

of responsiveness to the experimental manipulation greatly reduces the value of data
obtained with this type of methodology for drawing conclusions about the contribution of
psychological factors to asthma.

A related methodology involves using a substance that will cause actual
bronchoconstriction or bronchodilation. These substances are inhaled with either
suggestion of bronchoconstriction or bronchodilation (e.g., receive bronchoconstrictor but
told it is a bronchodilator; Luparello et al., 1970; Strupp et al., 1974). One experiment of
this type involved participants inhaling methacholine, a known bronchoconstrictor, during
two trials. During the first trial, participants were told that they were inhaling either a
bronchodilator or a bronchoconstrictor. During the second trial, participants were given
the opposite suggestion. For example, one participant was given methacholine during
two trials (Pastorello et al., 1987). During the first trial, he or she was told that the
inhaled substance would produce difficulty in breathing. During the second trial, the
participant was told that the inhaled substance would lead to easier breathing. Thus,
individuals were given the same substance but were given two different suggestions about
its possible effect. Airway responses to the trials were mixed. In comparison to baseline
lung function, statistically significant changes did not occur after the trials. Normally, it
would be expected that an individual would experience significant bronchoconstriction
when inhaling methacholine. According to the authors, the absence of significant
changes indicates that the suggestion prevents the expected bronchoconstriction. On the
other hand, the lack of significant changes could be due to inconsistent physiological
responses or heterogeneity within the sample.
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Many studies that utilize bronchoconstrictive suggestion use small samples and
have other serious methodological flaws that reduce the impact of the manipulation. For
example, individuals with asthma have hyperreactive airways that are irritated by a wide
variety of stimuli. The effects of a particular methodology may not be directly
attributable to the experimental manipulation. In addition, simply taking a deep breath
before exhaling into a spirometer or other apparatus can cause transient air flow
obstruction in some individuals (Gayrard, Orehek, Grimaud, & Charpin, 1975; Gayrard,
Orehek, Grimaud, & Charpin, 1979; Orehek, Gayrard, Grimaud, & Charpin, 1975).
Therefore, it is important to consider the effects of these flaws or confounds on the results
presented in this literature.
Confounds from the type of substance inhaled are frequently observed in placebo
bronchoconstrictor studies. The use of nebulized saline as a control substance raises
particular difficulties. Inhalation of saline causes bronchoconstriction for some
participants, confounding the results (Lewis, Lewis, & Tattersfield, 1983). In some cases,
participants respond with bronchoconstriction to both control and suggestion conditions
as a result of warm saline's effects on the lungs. Unfortunately, response to the control
substance in some cases eliminates any measurable placebo effect (Pastorello et al.,
1987). Indeed, particular concentrations of saline have been suggested for use as a
challenge task for measurement of airway hyperreactivity in individuals with asthma
(Boulet, Legris, Thibault, & Turcotte, 1987; Schoeffel, Anderson, & Altounyan, 1981).
Cooling of the airways has also been shown to cause bronchoconstriction (Deal,
McFadden, Ingram, Breslin, & Jaeger, 1980; Spector & Farr, 1974). Room temperature
saline (20" C) and warm saline at 37" C produces different results. Bronchoconstriction
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as a result of suggestion only occurs when saline is cool, not when it is at room
temperature (Lewis et al., 1983). Thus, when the type of substance inhaled in a control
condition causes bronchoconstriction, the level of airway change due to the experimental
manipulation is difficult to estimate.
Another flaw commonly found in placebo bronchoconstrictor studies reflects the
lack of estimates of the clinical significance of the reduction in airway function. A
reduction of approximately 20% of peak air flow is considered to be indicative of
impairment, and a reduction of 50% or more is likely to require emergency medical
intervention (Isenberg et al., 1992a). However, few studies use these guidelines in
assessing the degree to which participants responded.
Control groups are rarely used in placebo bronchoconstrictor studies (e.g., Butler
& Steptoe, 1986; Horton, Suda, Kinsman, Souhrada, & Spector, 1978; Janson-Bjerklie et

al., 1986; Neild & Cameron, 1985; Pastorello et al. 1987). This methodological oversight
restricts the conclusions that can be drawn about responses of individuals with asthma
versus individuals without asthma. Further research has shown that responses to
suggestion occur in a similar manner in individuals without asthma (as described above),
throwing further doubt on the utility of the placebo bronchoconstrictor methodology
(Wigal et al., 1988).
In summary, although widely used, the placebo bronchoconstrictorl
bronchodilator studies suffer from a lack of methodological soundness. Although a
moderate percentage of individuals with asthma do appear to respond to these
a

manipulations, the extent to which these findings are valid and generalizable is
questionable. Thus, the results of this type of study must be interpreted cautiously.
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Currently, due to the variety of problems that commonly occur in placebo
bronchoconstrictor studies, asthma researchers have been less likely to utilize this
methodology. Rather, less intrusive stimuli (e.g., listening to aversive scenes, mental
arithmetic) have been advocated when a task that affects lung function is to be studied
(Dorhofer & Sigmon, in press). These stimuli may be more ecologically valid, similar to
types of events that trigger asthma symptoms in everyday life.
Emotional States and Asthma Symptoms
Positive and negative emotional states may accompany or lead to symptoms of
asthma. The relation between naturally occurring mood states (i.e., measured several
times during the course of the day) and peak expiratory air flow has been investigated in
several studies. Mood states and peak air flow are often measured at the same time
during an individual’s usual daily activities. However, studies of this nature are generally
correlational in nature.
Frequently, individuals record their observations several times per day. In one
study, boys in a treatment facility wore FM radio transmitters for 4 hours per day
(Miklich, Chai, Purcell, Weiss, & Bradley, 1974). Approximately every 20 minutes, each
boy was instructed via a transmitter to measure and record peak flow, as well as note
mood. For 38% of the boys, significant negative correlations between emotional intensity
and peak flow were found.
More recent studies have generally corroborated the finding that peak flow and
naturally occurring negative mood states are significantly correlated for some individuals
with asthma (e.g., Hyland, 1990; Steptoe & Holmes, 1985). However, not all participants
exhibit a negative correlation between mood state intensity and peak flow (as the mood
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becomes more intense, peak flow decreases). In addition, the type of mood state (e.g.,
anger, sadness, joy) accompanied by decreased peak flow may vary from individual to
individual. For example, some individuals may exhibit decreased air flow while
experiencing anger, whereas other individuals may exhibit decreased air flow while sad,
happy, or during other emotional states (Steptoe & Holmes, 1985). A review of studies
that induce emotional states in participants in the laboratory identified a subgroup of
individuals with asthma (40%) who respond to emotional stimuli (e.g., induction of
anger, fear, anxiety) with increased airway resistance (Isenberg et al., 1992a). The
authors, however, did not hypothesize why only a subset of individuals with asthma
exhibit lung function that correlates with negative mood states.
An additional difficulty in interpreting the results of studies examining the moodpeak flow relation reflects the cyclical nature of this relation (ie., mood-peak flow
relationship is stronger in the evening; Hyland, 1990). Studies of circadian rhythms in
asthma have shown that for some individuals, asthma symptoms occur more frequently at
night, with increased severity (Barnes, 1985; Clark, 1985; Hetzel, 1981; Hetzel & Clark,
1980). Thus, it is possible that time of day should be carefully considered in studies
examining the relations between mood, suggestion, and bronchoconstriction.
Overall, some evidence has been found for a negative correlation between a few
types of positive and negative mood states and lung function. However, this research
needs to be replicated and extended before stronger conclusions can be made. The
heterogeneity of mood states correlated with reduced lung function warrants further
investigation. Possibly, mood state may be another avenue by which facial muscle
tension or general arousal affects the vagus nerve, leading to bronchoconstriction. One
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mood state in particular (e.g., anxiety) has been studied extensively in individuals with
asthma.
The Role of Anxiety in Asthma
Asthma-Related Panic-Fear
In individuals with asthma, panic-fear is hypothesized to be an anxious state
experienced in response to asthma symptoms. The first type, illness-specific panic-fear,
refers to the anxiety experienced in response to asthma symptoms (Kinsman, Dirks,
Dahlem, & Heller, 1980). It is measured by a subscale of the Asthma Symptom Checklist
(ASC; Kinsman, Dahlem, Spector, & Staudenmayer, 1977; Kinsman, Luparello,
O’Banion & Spector, 1973). The second type, generalized panic-fear, is more stable and
trait-like, and is measured by a subscale of the Minnesota Multiphasic Personality
Inventory (MMPI; Carr et al., 1995; Dirks, Jones, & Kinsman, 1977). According to Dirks
et al. (1 977), the panic-fear trait scale identifies individuals with asthma who are
sensitive, emotionally labile, and either unable or unwilling to persist during stressful life
events.
For individuals with asthma, scores on the illness-specific panic-fear scale have
been found to be positively correlated with a diagnosis of panic disorder and the tendency
to report symptoms of panic in response to asthma symptoms, whereas scores on the trait
scale are not (Carr et al., 1995). In addition, the illness-specific scale is related to
measures of catastrophic cognitions (e.g., the Agoraphobic Cognitions Questionnaire and
the Anxiety Sensitivity Index; Chambless, Caputo, Bright, & Gallagher 1984; Reiss,
Peterson, Gursky, & McNally, 1986; Carr et al., 1995). Although both measures have
been widely used in the asthma literature, the illness-specific scale appears to be the more
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valid, reliable measure. Therefore, discussion of the panic-fear construct below will refer
only to findings relevant to this scale.
Research on the panic-fear construct has revealed that high panic-fear levels are
related to several negative outcomes for individuals with asthma. Panic-fear levels are
positively correlated with the intractability of asthma, increased steroid medication needs
for maintenance and overuse of as-needed medication (Carr et al., 1995; Dirks, Fross, &
Evans, 1977; Dirks, Jones et al., 1977). Prescription decisions by physicians tend to be
influenced by the distress or anxiety level of the patient, not actual respiratory hnction
(Hyland, Kenyon, Taylor, & Morice, 1993). In addition, requests for as-needed
medications are more frequent for inpatients with high panic-fear as compared to those
with low panic-fear (Dahlem, Kinsman, & Horton, 1979). These requests were
independent of lung function for those with high panic-fear (Dahlem, Kinsman, &
Horton, 1977).
Although it may be maladaptive to have a high level of panic-fear, it may be just
as maladaptive to have low panic-fear. Individuals with low panic-fear levels are often
discharged from the hospital earlier than individuals with moderate or high levels (Dirks,
Kinsman, Horton, Fross, & Jones, 1978). However, individuals with either very high or
very low panic-fear levels are more likely to be rehospitalized than are individuals with
moderate levels of panic-fear (Dirks, Kleiger, & Evans, 1978; Kaptein, 1982).
Rehospitalization rates have been found to be independent of objective asthma severity
(Dirks, Fross, & Paley, 1978). To explain these rates, one hypothesis posits that
individuals with high levels of panic-fear tend to overreact to symptoms of asthma and
overmedicate themselves during the attack (Dahlem et al., 1977). After the attack has
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subsided, these individuals then sharply decrease their medication in order to reduce the
medication’s side effects. According to these authors, undermedication may lead to the
development of symptom recurrence leading to hospitalization or rehospitalization.
In contrast, low levels of panic-fear in individuals with asthma may lead to
discounting or minimization of symptoms until they are severe enough to require
hospitalization (Dirks, Kinsman et al., 1978). Once individuals with low panic-fear are
hospitalized, they may be anxious to be discharged and hurry their recovery. However,
they may be discharged too early, leading to the necessity for rehospitalization (Carret
al., 1995). Thus, both high and low levels of panic-fear may lead to behaviors that can be
detrimental to an individual’s health.
One conceptualization of the panic-fear construct posits that it represents selffocused attention to breathing difficulties. The more attention paid to respiratory
symptoms, the higher the resultant level of panic-fear (Jones et al., 1979). Two recent
studies found that for individuals with asthma, anxiety sensitivity levels predicted the
experience of panic-fear (Cam et al., 1995; Dorhofer et al., 1998). It is likely that these
two constructs are related aspects of attention to bodily sensations, and may be important
in further understanding how psychological factors affect asthma.
Anxiety Sensitivity
Anxiety sensitivity, the fear of bodily sensations related to the experience of fear
(Reiss et al., 1986), represents an important construct in both anxiety and asthma
research. High levels of anxiety sensitivity are positively related to anxiety disorders in
general, but particularly to the experience of panic attacks. According to expectancy
theory (Reiss, 1991), there are three fundamental fears: fear of injury, fear of anxiety, and
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fear of negative evaluation. Anxiety sensitivity relates to fear of anxiety. More
specifically, fear of anxiety refers to the belief that experiencing anxiety-related
sensations may lead to harmful bodily, social, or psychological consequences (Taylor &
Cox, 1998). Individuals with high levels of anxiety sensitivity report increased levels of
fear of anxiety symptoms, whereas individuals with low anxiety sensitivity levels do not
fear the experience of anxiety (Shostak & Peterson, 1990).
Explanations of anxiety sensitivity have changed over the years. When the fear of
anxiety or “fear of fear” concept was first developed, it was posited that fear of anxiety
symptoms resulted from interoceptive conditioning related to the experience of panic
attacks (Goldstein & Chambless, 1978). Some researchers posit that this hypothesis is
unlikely given that some individuals who have never experienced a panic attack report
high levels of anxiety sensitivity (Maller & Reiss, 1992). Anxiety sensitivity may thus
function as an antecedent, rather than a consequence, of panic attacks. Further research
indicates that anxiety sensitivity may develop as a result of childhood learning
experiences. A recent study of undergraduates revealed that if an individual’s parents
reinforced his or her sick-role behavior, the individual was more likely to have a high
level of anxiety sensitivity (Watt, Stewart, & Cox, 1998). Thus, learning to catastrophize
about general types of bodily sensations may lead to anxiety sensitivity levels that are
higher than normal. Increased anxiety sensitivity may also result from environmental
stressors such as trauma or relationship problems (Maller & Reiss, 1992).
Anxiety sensitivity appears to function as a risk factor that is necessary but not
sufficient for the development of panic attacks (Maller & Reiss, 1992). High levels of
anxiety sensitivity may facilitate conditioning of anxious responses due to a vicious cycle
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of amplification and interpretation of anxiety symptoms (Taylor, Koch, & McNally,
1992). The experience of panic attacks increases anxiety sensitivity further, resulting in
an escalation of panic due to sensitivity to body sensations (Reiss, 1987). Indeed, anxiety
sensitivity levels have been found to predict the development of panic attacks over a
three-year period (Maller & Reiss, 1992). A more recent line of research has investigated
the effects of differing levels of anxiety sensitivity on participants’ responses to
experimental tasks. Both individuals with and without asthma have been studied utilizing
this methodology.
Anxiety sensitivity levels have been found to predict responses to a variety of
stressful tasks in individuals without asthma. After engaging in a hyperventilation task,
undergraduates with high anxiety sensitivity levels reported experiencing more bodily
sensations and more anxiety than participants with low anxiety sensitivity (Holloway &
McNally, 1987). A second study (Donne11 & McNally, 1989) compared responses to a
hyperventilation task in individuals with or without panic, who differed in anxiety
sensitivity levels. Regardless of history of panic, high anxiety sensitivity participants
reported more anxiety and more bodily sensations in response to hyperventilation than
individuals with low anxiety sensitivity. Highest levels of bodily sensations were found
in individuals who were high in anxiety sensitivity and had experienced at least one panic
attack. It is important to note that individuals with a history of panic and low anxiety
sensitivity responded similarly to individuals with low anxiety sensitivity and no history
of panic. Thus, it appears that anxiety sensitivity levels, not history of panic attacks,
influences anxiety and reports of bodily sensations in response to hyperventilation.
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Less intrusive stressful tasks (e.g., mental arithmetic) employed with individuals
varying in levels of anxiety sensitivity have led to mixed results. Anxiety sensitivity does
not account for physiological arousal level after an arithmetic task, but does relate to selfreported anxiety after the task (Shostak & Peterson, 1990). Individuals with high anxiety
sensitivity levels reported experiencing more anxiety symptoms and a greater level of
cognitively experienced anxiety after engaging in mental arithmetic. These results
indicate that although actual physiological changes may not occur during a stressful task,
individuals with high anxiety sensitivity may erroneously perceive that threatening
physiological changes have occurred. A second study examined physiological (EMG,
heart rate, skin temperature, epidermal activity) reactions and self-reports of cognitions in
response to relaxation and a mental arithmetic task (Borden & Lister, 1994) in individuals
varying in anxiety sensitivity levels and history of panic versus no panic. Results
indicated that only panic attack history, not anxiety sensitivity level, predicted reactions
to physiological changes in response to the stressful task. The authors concluded that
physiological and cognitive/subjective responses in individuals with high anxiety
sensitivity are in some cases desynchronous. It is also possible that in this case, the
stressful task did not activate sufficient arousal to activate fearful cognitions in
participants.
The relation between anxiety sensitivity and asthma is just beginning to be
explored. Dorhofer and Sigmon (in press) found that women with asthma alone, with a
history of panic attacks, or with asthma and panic attacks had similar levels of anxiety
sensitivity. The anxiety sensitivity scores of the asthma alone and asthma and panic
history groups were significantly higher than those of controls. In addition, researchers
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have hypothesized that observed differences in anxiety sensitivity levels may be a partial
cause of increased rates of panic disorder among individuals with asthma. The presence
of panic disorder in individuals with asthma is not thought to be due to dyspnea or other
asthma-related symptoms (Carr, 1998). Moreover, panic disorder in individuals with
asthma appears to be influenced by catastrophic misinterpretation of bodily sensations,
similar to individuals who do not have asthma but do have panic disorder (Carr et al.,
1994). According to proponents of the cognitive theory of panic disorder, without
catastrophic misinterpretation, panic disorder does not occur (e.g., Clark, 1986).
Overall, a rapidly growing body of literature has provided general support for the
existence of anxiety sensitivity as an independent, valid construct. In addition to its key
role in panic disorder research, recent studies have shown the importance of anxiety
sensitivity in individuals’ responses to stressful tasks. Currently, the promising relation
between anxiety sensitivity and the experience of asthma may, with further research,
assist in the development of new theories about the relation between psychological
variables and asthma symptoms. Because of the relation between anxiety sensitivity and
both asthma and the development of panic disorder, it is important to further explore the
nature of the relation between asthma and panic disorder.
Panic Disorder
Panic attacks involve a sudden sensation of intense fear or discomfort with a
variety of accompanying symptoms (e.g., increased heart rate, sweating, shortness of
breath, dizziness, nausea, numbness or tingling, and fear of losing control, going crazy, or
dying; APA, 1994). Estimates of the lifetime prevalence of panic disorder in the general
population range from 1.5% - 3.5%, with one-year prevalence rates of 1% - 2% (APA,
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1994). For women, the rate of panic disorder is approximately twice that of men (APA,
1994; McNally, 1990). Interestingly, the experience of panic attack symptoms can
closely resemble symptoms of asthma. Indeed, asthma and panic disorder frequently
coexist and may be exacerbated by one another (Shavitt et al., 1992; van PeskiOosterbaan, Spinhoven, van der Does, Willems, & Sterk, 1996). Current models of panic
disorder are currently being applied to conceptualizations of asthma in the hope of
identifying common factors and points of intervention.
Panic disorder has been the focus of an explosion of research interest since the
publication of the 3‘d version of the DSM, which clearly delineated panic disorder as an
independent diagnosis (APA, 1980; Barlow et al., 1985). Previous to DSM-111, panic
attacks generally were of little interest except as a manifestation of other disorders (Rapee
& Barlow, 1993). Since that time, disagreement has arisen concerning the possibility of

truly “spontaneous” panic attacks (Margraf, Ehlers, & Roth, 1986a). Panic attacks with
all their accompanying symptoms are now reproducible in the clinical or laboratory
setting, indicating that perhaps panic attacks are not solely spontaneous as was once
thought. A number of different panic challenge tasks have been developed that can elicit
panic symptoms for the purpose of research and treatment.
Although individuals who experience panic attacks may report that their attacks
have no cue, findings suggest that there may be external precipitants to the occurrence of
an attack (e.g., stress, exposure to a feared situation, Hibbert, 1984). In addition, internal
events (e.g., the experience of bodily sensations) followed by catastrophic cognitions
have been shown to be a frequent precursor of panic attacks (Clark, 1986; Ley, 1985).
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Because panic attacks frequently have an identifiable and replicable precursor, it is
possible to create symptoms similar to those of panic attacks in the laboratory.
Panic challenge tasks. Many types of biological challenges have been utilized in
order to study panic attacks in the laboratory setting or as aids in treatment studies. This
type of study has investigated the effects of inducing panic-related physiological
sensations in individuals with high anxiety sensitivity, panic attacks, panic disorder, and
controls. These challenges typically involve an activity that produces bodily sensations
similar to those experienced in a panic attack. In a typical challenge task, an individual is
infused with sodium lactate, norepinephrine, or isoproterenol, given an oral dose of
yohimbine or caffeine, or asked to inhale a mixture of carbon dioxide and oxygen
(McNally, 1990). Each of these substances has led to self-reports of panic attack
symptoms and/or attacks in most individuals with either a history of panic attacks or a
diagnosis of panic disorder. However, other activities that do not involve ingestion of a
chemical or other substance have been utilized in research on and treatment of panic
disorder (e.g., voluntary hyperventilation, spinning in a chair).
In the treatment of panic disorder, one common component includes exposure to
panic sensations (e.g., Barlow & Craske, 1994; Hecker & Thorpe, 1992). Producing
these sensations in a therapy setting is accomplished via such activities as voluntary
hyperventilation, shaking the head from side to side, spinning in a chair, and breathing
through a straw (Clark, 1993; Hecker & Thorpe, 1992). For example, turning one’s head
from side to side produces sensations that often accompany a panic attack such as
dizziness and nausea, whereas breathing through a straw can produce feelings of
restricted air flow or dyspnea (Barlow & Craske, 1994).
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Individuals who have never experienced a panic attack generally do not respond
with panic or increased anxiety symptoms to panic challenge tasks (e.g., Balon, Yergani,
Pohl, Muench, & Berchou, 1990; Donne11 & McNally, 1989; Fyer et al., 1987; van den
Hout, van der Molen, Griez, Lousberg, & Nansen, 1987). Interestingly, individuals
without panic report the same bodily sensations as those with panic, but they do not
report the accompanying anxiety (Gaffney, Fenton, Lane, & Lake, 1988; Margraf, Ehlers,
& Roth, 1986b). According to some researchers, it is a fearful response to the induced

bodily sensations that leads to a panic attack (e.g., Clark, 1986; McNally, 1990).
However, other researchers posit that although catastrophic cognitions in some cases can
result in a panic attack, cognitions do not invariably accompany or lead to the experience
of a panic attack (Rachman, Lopatka, & Levitt, 1988; Westling & Ost, 1993). Panic may
occur in the reported absence of these thoughts in approximately 27% of attacks
(Rachman et al., 1988). An additional study found that nearly all of the full-blown panic
attacks (9 1%) were accompanied by catastrophic cognitions, with only 57% of the limited
symptom attacks characterized by this type of thinking (Westling & Ost, 1993). Thus, the
evidence for catastrophic cognitions as causal agents in panic disorder has been mixed
and warrants further investigation.
Comorbiditv of Asthma and Panic Disorder. A number of studies have examined
comorbidity rates of asthma and panic disorder. Including estimates for asthma as well as
other types of chronic obstructive pulmonary disease, these rates yield a conservative
median of estimates of 9.7% (van Peski-Oosterbaan et al., 1996). Rates of panic attack
history are higher, with approximately 45% of individuals with asthma experiencing at
least one unexpected panic attack (Perna, Bertani, Politi, Colombo, & Bellodi, 1997).
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The presence of panic disorder in individuals with asthma is not thought to be related to
the degree of pulmonary impairment experienced (Carret al., 1994). That is, more severe
asthma is not necessarily accompanied by higher rates of panic disorder. However, panic
attacks are more common for individuals with asthma if they have high levels of anxiety
sensitivity. Among a sample of individuals with asthma who reported high anxiety
sensitivity, 35.3% were diagnosed with panic disorder (Carret al., 1994).
It has been argued that these high comorbidity rates may be in part due to
selection bias (van Peski-Oosterbaan et al., 1996). Individuals who experience both a
chronic illness and panic disorder are more likely to seek treatment for either or both
conditions. In turn, these treatment-seeking individuals are often recruited for study
participation. The method by which the diagnosis is obtained also may have an effect on
comorbidity rates. Different interview schedules have resulted in greatly discrepant
estimates (van Peski-Oosterbaan et al., 1996). Therefore, it is important to consider
carefully the type of measure used to diagnose panic disorder when estimating the
prevalence of panic in asthma. However, even the lowest estimate of panic disorder
found in individuals with asthma is much higher than the rate in the general population.
This high rate of comorbidity suggests that there is a particular connection between
asthma and panic disorder that merits further examination.
Hypothesized Effects of Comorbidity. When individuals with asthma sense that
they may be starting to have an asthma attack, they may experience sensations of fear or
panic. This increased anxiety may make asthma symptoms worse through an increase in
parasympathetic nervous system activation (Rumbak, Kelso, Arheart, & Self, 1993).
However, for individuals with asthma, it has also been hypothesized that having
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symptoms of panic disorder may actually be adaptive, rather than maladaptive (Carr,
1998). To test this hypothesis, individuals with asthma, panic disorder, or both
conditions engaged in stressful tasks (ie., arithmetic task, reaction time task, viewing
gory films; Carr et al., 1996). In response to these tasks, individuals with either asthma or
panic disorder exhibited decreased airway resistance. In addition, individuals with panic
disorder, with or without asthma, exhibited lower airway impedance at baseline than
those with asthma only at baseline. Surprisingly, individuals with asthma

panic

disorder exhibited lower airway impedance at baseline than individuals with asthma.
After the tasks, no significant results were found for the interaction between asthma,
panic, and task. However, at baseline, individuals with asthma were found to have
significantly higher airway impedance (more difficulty breathing) in comparison with
those with asthma and panic disorder.
A nonsignificant trend for better lung function for the asthma and panic disorder
group was noted following the film tasks. This contrast between the lung function of the
asthma and asthma and panic disorder groups suggests that having both disorders may
make it easier to breathe. At present, it is unclear what role psychological or
physiological processes play in this phenomenon. Because only one published study
reported this facilitation, replication is necessary. According to the researchers, these
results are congruent with previous research indicating that low levels of panic-fear in
asthma result in higher levels of asthma-related mortality. These deaths are thought to be
a result of decreased sensitivity to bodily symptoms that can be fatal if ignored (Cam et
al., 1996).
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Individuals with asthma may suffer from several different types of anxiety,
including illness-specific panic-fear, high anxiety sensitivity, panic attacks, and panic
disorder. Some researchers hypothesize that excessive or insufficient panic-fear levels
are detrimental to an individual’s ability to accurately assess their asthma symptoms,
leading to increased medication intake or hospitalization (Carret al., 1995). Possibly,
panic-fear resembles anxiety sensitivity in that both constructs describe attention to and
fear of bodily sensations. In addition, individuals who have asthma and high levels of
anxiety sensitivity may be more vulnerable to the development of panic disorder.
Preliminary research indicates that having both disorders may actually facilitate breathing
during stressful tasks rather than impeding it (Carret al., 1996). Therefore, it is important
to explore the practical and theoretical implications of the comorbidity of panic and
asthma.
Relevance of Psychological Theories to Asthma
Psychosomatic Theories of Asthma
Historically, an influential literature review on psychogenic factors in asthma
(French & Alexander, 1941) strengthened the view of asthma as psychosomatic in nature.
Using data from case studies, French and Alexander concluded that allergic and
psychological factors worked in concert to produce asthma symptoms. In addition, they
cited evidence of the efficacy of hypnosis in preventing asthma attacks in response to

known allergens. According to psychoanalytic theory, individuals with asthma may be
experiencing separation anxiety (expressed as a suppressed cry) that may lead to an attack
(Purcell & Weiss, 1970; Turnbull, 1962). According to this view, treatment based on
psychoanalytic theory could assist individuals with asthma in working through their
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unconscious conflicts, resulting in reduced numbers of asthma attacks (French &
Alexander, 1941). However, empirical studies have failed to confirm the tenets of the
psychosomatic theory of asthma (Creer, 1982).
Over time, this view has been generally superseded by a biopsychosocial view
which emphasizes genetic and biological components that may be responsible for the
initial development of asthma (e.g., Matts, 1984; Rees, 1980). However, as discussed
above, psychological and social stimuli may also have an effect on the severity of
symptoms and the manner in which treatment is conducted. Two psychological models,
dyspnedsuffocation fear theory and cognitive theory, have been extended to the
conceptualization of asthma severity and frequency.
DyspnedSuffocation Fear Theory
Ley (1 989) proposed the dyspnedsuffocation fear theory to explain the occurrence
of panic attacks. In later articles, three types of panic attacks were described in order to
account for individual differences in panic symptoms (Ley, 1992a; 1992b). Currently, the
dyspnedsuffocation fear theory is most applicable to one of the three types of panic
attacks, or hyperventilatory panic attacks (Ley, 1998). Because of the similarity of
symptom experience between panic attacks and asthma, this theory has since been
extended to asthma.
Dyspnea is a commonly reported sensation during a panic attack (de Ruiter,
Garssen, Rijken, & Kraaimaat, 1992; Ley, 1989). According to the dyspnedsuffocation
fear theory, the fear that accompanies a panic attack results from severe dyspnea that is
induced by hyperventilation. The panic attack itself occurs when an individual feels that
he or she has little or no control over the dyspnea (Ley, 1998).
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Further evidence for the role of dyspnea in panic comes from observations of the
frenzied activity that can occur during a panic attack (Ley, 1989). Ley hypothesizes that
this activity may serve to increase metabolic C02 levels, thus reducing the sensation of
dyspnea. However, recent studies involving panic challenge tasks have utilized C02enriched air to provoke panic-related sensations. Conversely, during relaxation,
metabolic C02 levels are known to decrease. This decrease may account for the
experience of panic cued by relaxation or those occurring during sleep (Ley, 1988a;
1988b). Although these findings appear contradictory, Ley describes how CO;! inhalation
may produce both panic-related sensations

pleasant sensations (Ley, 1989). For

approximately 1 minute after inhaling C02-enriched air, participants generally report
experiencing the sensation that breathing is uncontrollable, leading to acute anxiety.
During this time, heart rate increases, dissipating the C02. After the first minute, when
C02 levels decrease, participants may report a pleasant relaxation state. Excluding
catastrophic cognitions, dyspnea and any resultant experience of fear are posited to be the
sole triggers for hyperventilatory panic attacks. According to Ley (1989), common
cognitions reported during panic (that are of central importance in the cognitive theory of
panic) may actually be due to cerebral hypoxia that occurs as a result of hyperventilation.
In contrast, other researchers argue that dyspnea, hyperventilation, and tachycardia
(frequently observed in response to hyperventilation) are produced by cooling or water
loss that occurs during overbreathing (de Ruiter et al., 1992). De Ruiter et al. suggest that
it is just as likely that dyspnea leads to hyperventilation as vice versa. Regardless of
which explanation is correct, individuals who experience panic attacks report that they
notice dyspnea and/or other physiological symptoms before experiencing fear (Ley,
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1985). According to the dyspnedsuffocation fear theory, the proposed sequence of
events in a panic attack is as follows: Hyperventilation

+ fear + sensations +

catastrophic cognitions.
To test the tenets of the dyspnedsuffocation fear theory, Carr et al. (1992)
investigated dyspnea in individuals with panic disorder, asthma, and controls. The
researchers hypothesized that the high rate of concordance of panic disorder in
individuals who have respiratory disorders may be due to the experience of dyspnea.
Tests of pulmonary function and self-reports of mood during and after a relaxation task
revealed that compared to controls, individuals with asthma and individuals with panic
disorder exhibited similar levels of dyspnea and similar levels of psychopathology.
Results indicated that although individuals with asthma or panic disorder report
comparable levels of dyspnea, panic symptoms are accounted for by different factors. A
significant amount of variance in panic symptoms in individuals with asthma is explained
by dyspnea, but not for individuals with panic disorder. In other words, panic symptoms
in asthma may be due to dyspnea, but in panic disorder, they are not due to dyspnea
levels. This difference in the contribution of dyspnea to the experience of panic
symptoms suggests that the dyspnedsuffocation fear theory (rather than explaining panic
attacks) may be better utilized to more fully understand dyspnea and its relation to
asthma.
According to Ley (1994), however, individuals in the above study were selected
according to DSM-111-R criteria for panic disorder, not for their experience of
hyperventilatory panic attacks. Thus, Ley argues, the lack of support for the
dyspnedsuffocation fear theory in relation to panic disorder is due to this methodological
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flaw. In rebuttal, Carr and Lehrer (1 994) point out that Ley’s (1 992a; 1992b) subtypes of
panic attacks have yet to be empirically validated. Furthermore, Carr and Lehrer (1994)
argue that individuals in both the panic disorder and asthma groups reported a level of
dyspnea that was significantly greater than controls. Thus, individuals in the panic
disorder group did indeed experience a high level of dyspnea. It is possible, however,
that this sample was generally composed of individuals experiencing hyperventilatory
panic attacks. Overall, the results of these studies must be replicated and extended in
order to determine the specific role of dyspnedsuffocation fear in asthma and/or panic
disorder.
Cognitive Theory
The cognitive theory of panic proposes that catastrophic misinterpretation of
benign bodily sensations results in the experience of a panic attack (Clark, 1986).
Extending this theory to asthma, it is possible that individuals with asthma and a tendency
to misinterpret symptoms may experience more frequent and more severe asthmatic
episodes. Mislabeling non-asthma related bodily sensations as symptoms of asthma may
have serious consequences. In studies of asthma inpatients, 19% - 27% consistently
mislabeled relatively benign bodily symptoms (e.g., fatigue, worry, irritability, anxiety) as
an asthma attack. Those individuals who exhibited this tendency to mislabel symptoms
were more likely to be rehospitalized for asthma at a 6-month follow-up. Forty to 84% of
the mislabelers were rehospitalized by 6 months, whereas only 29% - 40% of the nonmislabelers were rehospitalized. There was no measured difference between symptom
mislabelers and non-mislabelers in lung function (Dirks & Schraa, 1983). In individuals
with asthma, the consequences of symptom misinterpretation may be due to the anxiety-
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producing effects of the catastrophic interpretation of benign sensations that may lead to
increased bronchoconstriction.
According to Clark (1993), there are three criteria that must be fulfilled in order to
demonstrate cognitive mediation of panic attacks induced by biological challenge tasks:
1) panic disorder patients have a stronger tendency to misinterpret certain bodily
sensations than controls;

2 ) that thoughts based on the misinterpretation of bodily sensations accompany
challenge induced panic attacks; and
3) that experimental manipulations of cognitive variables have an influence on
whether or not an individual panics during a biological challenge test (Clark,
1993, p. 76).
Clark (1 993) provides evidence that these three criteria have been fulfilled in the
research on panic disorder. Thus, strong support for cognitive mediation of panic attacks
during biological challenge tests has been reported in the panic literature.
Criterion One. Criterion One has been confirmed through research utilizing the
modified Interpretations Questionnaire (Butler & Matthews, 1983). This questionnaire
assesses the extent to which individuals interpret ambiguous internal and external stimuli
as threatening. Individuals with panic disorder tend to mistakenly interpret bodily
sensations as symptoms of an approaching physical or mental catastrophe more than
individuals with other types of anxiety disorders or controls (Clark, 1993). Research with
expanded versions of the Interpretations Questionnaire revealed that individuals with
panic disorder are less likely to be able to reinterpret stimuli as nonthreatening once they
have made an anxiety-related response (e.g., Kamieniecki, Wade, & Tsourtos, 1997).
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Criterion Two. The second criterion (thoughts based on the misinterpretation of
bodily sensations are present during challenge induced panic attacks) has also been
supported. Individuals with panic disorder were exposed to feared situations (e.g.,
walking alone into a supermarket). Participants completed measures of their level of fear,
a checklist of bodily sensations, and a checklist of fearful cognitions after each trial.
Approximately 73% of the panic attacks experienced by the participants were
accompanied by self-reports of fearful cognitions (Rachman et al., 1988). Significantly
more fearful cognitions were reported on the trials that led to panic than those that did
not, indicating that panic is generally accompanied by these types of catastrophic
cognitions.
Criterion Three. The third criterion (manipulating cognitions either leads to or
prevents panic attacks in experimental settings) is perhaps the most important of the three
criteria. Yet, this hypothesis has been more difficult to unambiguously support. Many
studies have revealed that the manipulation of cognitive variables can affect the
likelihood of panic symptoms or attacks during challenge tests (Margraf, 1993;
Salkovskis & Clark, 1990; van der Molen, van den Hout, Vroemen, Lousberg, & Griez,

1986). To test this hypothesis, studies alter the information participants are given before
a challenge task begins.
Instructing two groups of controls that the sensations of hyperventilation are either
symptoms of impending fainting or signs of a higher state of consciousness produces very
different results (van der Molen et al., 1986). Although the same bodily sensations and
changes in heart rate and pCO2 were produced in both groups, these sensations were rated
as either pleasant or unpleasant, depending entirely on the instructions given (Salkovskis
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& Clark, 1990). A similar study examined the effects of instructions on self-reported

mood in response to sodium lactate infusion. Two groups of controls were informed that
they would either experience anxious tension or pleasant excitement in response to the
infusion. As was expected, the group that received the anxious tension suggestion
reported significantly higher levels of negative, anxious mood.
Expectations about what symptoms a C02/02 challenge task will produce also
alter the likelihood of experiencing a panic attack. Individuals with either panic disorder
or social phobia were given one of two different explanations of the symptoms they
would experience as a result of C02/02 inhalation (e.g., Rapee, Mattick, & Murell, 1986).
The first explanation gave the individual no expectation about what he or she would
experience, whereas the second explanation listed symptoms that are commonly reported
during a panic attack. After the inhalation trial, participants were given a list of 10
neutral and panic related cognitions and were asked to indicate what went through their
mind when they began to feel the bodily sensations associated with the gas. Individuals
in both conditions reported similar levels and types of bodily sensations. However, many
more of the individuals who were in the “no explanation” condition experienced a panic
attack. The cognitions reported by this group were significantly more likely to be
catastrophic in nature (Rapee et al., 1986). The results of this study provide strong
evidence that an individual’s fearful cognitions in an ambiguous situation can lead to
panic symptoms. Conversely, if an individual can attribute ambiguous bodily sensations
to a known cause, then he or she may be less likely to have a panic attack.
Cognitions about situational control may also alter the anxiety responses of
individuals with panic disorder. In one study, participants were allowed to “turn down”
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the level of C02 they were receiving if a light turned on (for half the participants, the light
never turned on; for the others, the light was turned on during the entire procedure;
Sanderson, Rapee, & Barlow, 1989). In actuality, the dial did not alter the C02 level in
any way. However, participants who believed they had control over the gas reported
fewer and less severe symptoms of panic, less resemblance to panic sensations, and fewer
occurrences of actual panic attacks (Sanderson et al., 1989). Studies of this type provide
support for the role that cognitions play in the production andor reduction of panic
symptoms and attacks.
In addition, anticipating the negative effect of C02 inhalation can produce
increased self-reports of physiological responses that indicate increasing levels of anxiety.
In comparison, when neutral expectations are fostered for participants with panic
disorder, hyperventilation does not result in strong physiological responses (Margraf,
1993). Thus, it appears that it is negative interpretations of bodily sensations that lead to
the experience of panic. The symptoms of hyperventilation or any other experience alone
do not result in a panic attack.
summary
The relationship of asthma with psychological factors has been studied for many
years (e.g., French & Alexander, 1941; MacKenzie 1886). A variety of methodologies,
including exposure to real or imagined aversive events (Creer et al., 1991; Dorhofer et al.,
1997), suggestion of bronchoconstriction (Kotses et al., 1989; Luparello et al., 1968;
Janson-Bjerklie et al., 1986), and naturalistic observation of mood states (Hyland, 1990;
Miklich et al., 1974; Steptoe & Holmes, 1985), have been used to identify factors that are
related to alterations in lung fbnction. These factors include type of task (active versus
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passive) and mood (positive versus negative). Classical conditioning and stress
provocation have both been suggested as possible causal factors in alterations in lung
function (Dekker et al., 1956; Miller & Kotses, 1995).
Recently, the relationship of anxiety with asthma has been investigated in the
psychological literature (e.g., Carr, 1998). High panic-fear levels have been linked to
negative outcomes (e.g, medication overuse, rehospitalization) for individuals with
asthma (Carr et al., 1995; Dahlem et al., 1979; Dirks, Fross et al., 1977; Dirks, Jones et
al., 1977; Hyland et al., 1993). High anxiety sensitivity levels also appear to be related to
asthma, and may pose an additional risk factor in the development of panic disorder
(Dorhofer et al., 1997). In addition, it is well established that individuals with asthma are
more likely to develop panic disorder than are individuals without asthma (Carr et al.,
1994; van Peski-Oosterbaan et al., 1996). Further, the mechanisms and consequences
surrounding the frequent comorbidity of asthma and panic disorder have been of interest
to researchers (e.g., Carr et al., 1996; van Peski-Oosterbaan et al., 1996). Specifically, the
presence of both panic disorder and asthma may lead to better lung functioning in
response to stressful stimuli than for individuals with asthma alone (Carr, 1998). At
present, it remains unclear what role psychological or physiological processes play in this
phenomenon.
Because of the similarity and frequent comorbidity of asthma and panic disorder,
two theories (dyspnedsuffocation fear theory and cognitive theory) have been used to
explain how asthma symptoms are affected by psychological factors. New studies
examining these theories in relation to asthma have resulted in some support for each
(Carr et al., 1992; Carr, 1998; Dorhofer et al., 1997). At the present time, no published
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research has examined both theories within the same study. These theories may
contribute to further understanding the mechanisms underlying the comorbidity and
experience of asthma and panic disorder.
Statement of Purpose
The present research project was designed to investigate dyspnedsuffocation fear
theory and cognitive theory in relation to asthma. In addition, Carr’s hypothesis
regarding the possible beneficial effects of comorbid panic disorder and asthma on lung
function was tested. Using experimental challenge tasks that produce asthma and/or
panic-like sensations, tenets of these theories and C a d s hypothesis were investigated in
women with asthma. Lung function and self-reports of cognitions, bodily sensations, and
dyspnea levels were assessed. For individuals with asthma, the presence of panic
disorder may actually assist breathing efforts (Can et al., 1996). Therefore, it may be
important to identify what elements of the panic experience are associated with increased
lung function (e.g., changes in level of catastrophic cognitions, perception of dyspnea).
In the present study, comparison groups will include individuals with asthma,
asthma and panic disorder, panic disorder alone, and controls. The utilization of these
four groups allowed comparisons of individuals who may 1) experience aversive bodily
sensations and anxiety on a regular basis and 2) may be able to pinpoint or explain the
source of the bodily sensations (e.g., individuals with asthma). In addition, comparison
of these groups allowed for replication and extension of dyspnealsuffocation fear theory,
cognitive theory, and Carr’s hypothesis in relation to asthma.
The dyspnedsuffocation fear theory was tested in a manner similar to that of a
previous study that used a passive relaxation condition (Carr et al., 1992). In a replication
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of previous research, individuals relaxed as deeply as possible with their eyes closed for 5
minutes. In an extension of dyspnedsuffocation fear theory, changes in dyspnea level
were assessed before and after engaging in breathing through a straw and head turning.
Breathing through a straw and turning one’s head from side to side are active tasks
designed to induce sensations that are dyspneic (affect perception of lung function) and
panic-related (dizziness), respectively (Barlow & Craske, 1994; Hecker & Thorpe, 1992).
According to dyspnedsuffocation fear theory, it was expected that individuals with
asthma and/or panic disorder would report greater changes in dyspnea levels than controls
after a passive task. Similarly, after the head turning task, individuals with asthma and/or
panic disorder were expected to report greater changes in dyspnea levels than controls. In
contrast, greater changes in dyspnea levels were expected for controls after the straw task,
as this group may not have experience with shortness of breath.

To test C a d s hypothesis that having both asthma and panic disorder is adaptive
for lung function, an active task was utilized. According to Carr, producing panic-like
sensations led to an increase in lung function observed for the comorbid group in
previous research. To replicate and extend this hypothesis, individuals with and without
asthma and panic disorder engaged in the head turning task (producing panic-like
sensations) as well as Carr’s relaxation task.

An adaptation of Clark’s cognitive model of panic (extended to asthma) and the
criteria for evidence of a cognitive component to panic disorder were used to investigate
differences in cognitions experienced after the tasks for individuals with or without
asthma and panic disorder (Clark, 1986). In addition, changes in panic-related cognitions
were assessed after each task.

Extending Clark’s model to asthma included the following hypotheses:

1) compared to controls, individuals who have asthma fear and misinterpret
certain bodily sensations more;

2) thoughts based on the misinterpretation of bodily sensations accompany
challenge induced asthma symptoms or attacks; and

3) experimental manipulations of cognitive variables have an influence on
whether or not an individual has asthma symptoms, increased air flow resistance, or an
asthma attack during a challenge task.
Unlike the panic disorder literature, the asthma literature is less clear on whether
or not these hypotheses have been supported. Hypothesis one, that individuals with

asthma fear and misinterpret bodily sensations more than controls, has not yet been
investigated. However, previous research (Dorhofer & Sigmon, in press) indicates that as
a group, individuals with asthma report higher levels of anxiety sensitivity or fear of
anxiety sensations. The present study investigated this hypothesis by having participants
complete questionnaires that assessed an individual’s tendency to fear, focus on, and
misinterpret ambiguous situations or sensations.
Hypothesis two, that thoughts based on the misinterpretation of sensations
accompany induced asthma symptoms, has not been investigated in the asthma literature.
The present study examined this hypothesis by assessing panic-related cognitions after the
experimental tasks.
Hypothesis three, that experimental manipulations of cognitive variables have an
influence on whether or not an individual has asthma symptoms, increased air flow
resistance, or an asthma attack during a biological challenge test, has been supported
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through use of placebo bronchoconstrictor methodology. As discussed previously, this
type of study generally produces alterations in lung function depending on the suggestion
given (e.g., Isenberg et al., 1992a). For individuals with asthma, it appears that specific
cognitions (e.g., expecting that lung function will decrease) do indeed affect the
likelihood of changes in airway function.
Hypotheses
Hypothesis One
Compared to baseline, individuals with asthma, panic disorder, and asthma and
panic will experience a greater decrease in dyspnea level after the relaxation task and
head turning task than controls. After the straw task, controls are expected to experience
a greater decrease in dyspnea level than the other three groups.
Hmothesis Two
After the relaxation task, the panic and asthma and panic groups will report a
greater increase in panic-related symptoms from baseline than the asthma group. In turn,
the asthma group will report a greater increase in these symptoms than the control group.
After the head turning task, the panic and asthma and panic groups are expected to
experience a greater increase in panic sensations than the asthma and control groups.
Panic-related symptoms will be equivalent for all groups after the straw task.
Hypothesis Three
Individuals in the asthqa and panic group will experience an increase in lung
function after the relaxation and head turning tasks in comparison to baseline. In
contrast, the control group will exhibit no change in lung function. The asthma and panic
groups will exhibit a decrease in lung function after these tasks. Following the straw
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task, it is expected that the asthma and asthma and panic groups will both show an
increase in lung function. No change is expected for the control group, and a decrease is
expected for the panic group.
Hypothesis Four
After the relaxation and head turning tasks, individuals with panic disorder and
asthma and panic will report an increase in panic-related cognitions in comparison to the
asthma and control groups. After the straw task, the asthma and asthma and panic
groups will report a greater increase in panic-related cognitions than the panic group, with
the control group reporting no increase.
Hmothesis Five
Individuals in the asthma, panic, and asthma and panic groups are expected to
report more self-focus on bodily sensations than the control group.
Hwothesis Six
Individuals in the asthma, panic, and asthma and panic groups will report more
misinterpretation of bodily sensations than the control group.
Hypothesis Seven
Individuals in the panic and asthma and panic groups are expected to report more
fear of anxiety sensations than the asthma group. In turn,the asthma group will report a
higher level than the control group. Panic-fear levels will be higher for the asthma and
panic group than the asthma group, and the panic group’s level will be higher than that of
the control group.
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Chapter 2
METHOD
Participants
Sixty female participants over the age of 18 were recruited on the University of
Maine campus and in the community. The sample included four groups of 15 participants
who were diagnosed with asthma, panic disorder, asthma and comorbid panic disorder, or
had no diagnosis (control group). A power analysis (based on an effect size calculated
utilizing group means from previous research; Carr et al., 1996; see Appendix A)
revealed that 15 participants per group would result in a power of .94.
Participants were recruited through psychology classes and through flyers posted
at the University of Maine and at stores in Bangor, Maine. For undergraduates in
psychology classes, extra course credit was offered. Other participants were offered
payment for their participation. All participants read and signed an informed consent
form (Appendix B). At the conclusion of the experiment, they were debriefed and
received a referral list for psychological treatment.
Participants with asthma and panic disorder were selected based on criteria similar
to that used by Carr et al. (1995). An attempt to verify that participants had been
diagnosed with asthma was made via contact with the participant’s physician.
Participants signed a release of information form (Appendix C ) that was sent to their
physician. The physician completed the form, indicating the individual’s diagnosis and
age at diagnosis, asthma severity, and any medications that may have been prescribed.
Participants had to indicate during the diagnostic interview that their panic symptoms and
their asthma symptoms occurred independently (e.g., panic has occurred at times when an
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individual’s asthma was well controlled). The panic disorder section of a structured
diagnostic interview (Anxiety Disorders Interview Schedule for DSM-IV [ADIS-IV];
Brown, Di Nardo, & Barlow, 1994) was utilized to diagnose the presence of panic
disorder according to DSM-IV criteria.
Experimenters
The experiment was primarily conducted by the principal investigator and another
advanced graduate student in clinical psychology. Interrater reliability for the ADIS-IV
interviews was established by a second rater (an advanced graduate student in clinical
psychology). This individual was blind to the experimental conditions. He or she
listened to audiotapes of the diagnostic interviews and provided a second rating for each
participant. The second rater was trained by the principal investigator in ADIS-IV
scoring procedures.
Dependent Measures
The Anxiety Disorders Interview for DSM-IV. The Anxiety Disorders Interview
for DSM-IV (ADIS-IV; Brown et al., 1994) was utilized to establish a diagnosis of panic
disorder. Reliability and validity information on the ADIS-IV is not yet available,
however, these data are available for the previous versions, the ADIS (Di Nardo, O’Brien,
Barlow, Waddell, & Blanchard, 1983), based on DSM-111 criteria (APA, 1980), and the
ADIS-R (Di Nardo & Barlow, 1988), which was based on DSM-111-R criteria (APA,
1987). Interrater reliability for the ADIS has been examined in several studies. Two
outpatient samples resulted in a kappa value of .68 for anxiety disorders in general and
kappas for specific disorders ranged between .56 and .90 (Di Nardo et al., 1983). A third
study comparing independent diagnoses made by psychiatrists and lay interviewers
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utilizing the ADIS led to somewhat lower kappa values (range = .47 - .67). The interrater
reliability of the ADIS-R is generally acceptable; kappas range from .57 to .82 (Di Nardo,
Moras, Barlow, Rapee, & Brown, 1993).
Anxiety Sensitivity Index. The Anxiety Sensitivity Index (ASI; Reiss et al., 1986;
Appendix D) is a 16-item self-report measure that assesses the fear of experiencing
anxiety symptoms. Items on the AS1 take the form of statements about the possible
negative consequences of anxiety symptoms (e.g., “When I notice that my heart is beating
rapidly, I worry that I might have a heart attack”). Each item is rated on a 5-point Likert
scale (O=very little; 4=very much), and scores range from 0 to 64. High scores on the AS1
are highly correlated with agoraphobia, panic disorder, or other anxiety disorders
(Peterson & Reiss, 1992). The AS1 has acceptable reliability (test-retest at two weeks:
.75; at three years:

= .71; coefficient alpha = .88; Maller

=

& Reiss, 1992; Peterson &

Reiss, 1992). Validity studies indicate that the AS1 is positively related to the Taylor
Manifest Anxiety Scale (Taylor, 1953) and the Anxiety Frequency Checklist (Reiss et al.,
1986). However, the AS1 accounts for a significant portion of variance in Fear Survey
Schedule-I1 (Geer, 1965) scores above and beyond the other two measures (Reiss et al.,
1986). In addition, the AS1 predicts anxiety levels after hyperventilation, whereas
measures of trait anxiety do not (McNally, 1989). Thus, it appears that anxiety sensitivity
assesses a component of anxiety not tapped by trait anxiety measures.
Scores on the AS1 reliably differentiate between individuals diagnosed with
agoraphobia or panic disorder and those with other types of anxiety disorders. In
addition, AS1 scores discriminate between controls and individuals with anxiety disorders
(Peterson & Heilbronner, 1987; Reiss et al., 1986). Thus, it appears that the AS1 has

58
clinical utility for differentiation of individuals with anxiety disorders. This measure is
particularly relevant for panic disorder.
Several studies of the factor structure of the AS1 have led to the identification of at
least three factors. These factors include fear of somatic sensations, fear of cognitive
dyscontrol, and fear of publicly observable symptoms. Recently, a new instrument, the
Anxiety Sensitivity Profile (see below) has been developed to further explore these
factors (Taylor & Cox, 1998). In this study, the AS1 was utilized as a measure of group
differences in level of fear of anxiety sensations and resulted in a coefficient alpha of .9 1.
Anxiety Sensitivity Profile. The Anxiety Sensitivity Profile (ASP; Taylor & Cox,
1998; Appendix E) is a 60-item self-report measure that was developed in response to
criticisms of the ASI’s factor structure. The ASP includes 60 items that question 6
domains of anxiety symptoms and their perceived dangerousness: cardiovascular,
respiratory, gastrointestinal, publicly observable anxiety reactions, dissociative and
neurological symptoms, and cognitive dyscontrol. Each item is rated with regard to the
likelihood that the sensation would lead to a negative outcome for the individual on a 1
(not at all likely) to 7 (extremely likely) Likert scale.
Coefficient alpha for the six subscales of the ASP range from .88 to .94. The ASP
subscales correlate significantly with both the AS1 (IS between .41 and .66) and the Trait
version of the State-Trait Anxiety Inventory (gs between .11 and .29; Spielberger,
Gorsuch, Lushene, Vagg, & Jacobs, 1982; Taylor & Cox, 1998). Further reliability and
validity studies on the ASP have yet to be published. In the present study, only the
respiratory subscale of the ASP was utilized as a measure of the perceived dangerousness
of respiratory symptoms.
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Asthma Symptom Checklist. The Asthma Symptom Checklist (ASC; Kinsman et
al., 1977; Kinsman et al., 1973; Appendix F) is a 36-item list of somatic and mood
symptoms that are related to asthma. Each item is rated on frequency of occurrence
during asthma attacks (1

= never;

5 = always). The ASC is composed of five factors:

Panic-fear, irritability, fatigue, hyperventilation-hypocapnia,and bronchoconstriction.
The ASC provides an index of the specific symptoms an individual experiences during an
attack, and may be related to measures of bother, anxiety, and depression. Cluster
internal consistency reliabilities for the subscales range from .78 to .92 (Kinsman et al.,
1977).
The panic-fear subscale (ASC-PF) has been extensively used to estimate an
individual’s level of anxiety in response to asthma symptoms. This subscale is
hypothesized to measure illness-specific panic-fear (Carr et al., 1995). ASC-PF scores
are not related to pulmonary function, indicating that an individual’s level of anxiety
about their symptoms is not related to the severity of their asthma. However, scores are
positively correlated with level of prescribed steroids, excessive use of as-needed
medications, and more frequent hospitalizations and rehospitalizations (Dirks, Fross et
al., 1977). The ASC was used in two ways. First, it was used to assess the general level
of symptoms typically experienced by individuals with asthma during an attack. Second,
it was used with all four groups as a state measure after each task to assess the current
level of asthma-related symptoms.
Body Vigilance Scale. The Body Vigilance Scale (BVS; Schmidt, Lerew, &
Trakowski, 1997; Appendix G) is an 18-item measure that assesses the degree to which
individuals focus conscious attention on internal bodily sensations. Each item is rated on
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a 1-10 Likert scale (1 = No attention paid to this sensation, 10 = Extreme amount of
attention paid to this sensation). Test-retest reliability over a 5-week period is .58 in a
sample of individuals with panic disorder. Internal consistency of the BVS is high, with
Cronbach’s alpha = .82 for both a sample of undergraduates and a sample of individuals
with panic disorder (Schmidt et al., 1997). In a sample of individuals diagnosed with
social phobia, Cronbach’s alpha was slightly lower (.74; Schmidt et al., 1997). In the
present study, Cronbach’s alpha was 3 2 . Body vigilance is significantly correlated with
anxiety sensitivity as well as anxiety measured by the Beck Anxiety Inventory, but not
STAI Trait anxiety or depression symptoms (Schmidt et al., 1997). In this study, the BVS
provided a measure of participants’ focus on their bodily sensations.
Born Category Scale. The Borg Category Scale (Borg, 1982; Appendix H) is a
visual analog scale that assesses an individual’s level of dyspnea. This measure ranges
from 0 (nothing at all) to 10 (maximal) ratings of difficulty breathing. The Borg Scale
was utilized between tasks to assess participants’ level of dyspnea. This provided a selfreport measure of the level of breathing difficulty participants perceive that they are
experiencing.
Brief Body Sensations Interpretation Ouestionnaire. The Brief Body Sensations
Interpretation Questionnaire (BBSIQ; Clark et al., 1997; Appendix I) is a 14-item
measure based on the Interpretation Questionnaire (McNally and Foa, 1987). The BBSIQ
includes two categories of ambiguous events: panic body sensations and external events.
There are several steps to completing the BBSIQ. Participants first read each item and
then write down “why” the event occurred. Next, they turn the page and are given three
explanations (negative, positive, or neutral) to rank-order. Finally, participants return to
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the beginning of the measure and rate how much they would believe each explanation if
they were in that situation. The ratings range from 0 (not at all likely to be true) to 8
(extremely likely to be true). Clark et al. (1997) note that the written “why” responses are
very time consuming to score and do not provide additional information above and
beyond the ranking information. Indeed, in the second study in the Clark et al. (1 997)
article, the “why” responses are not scored at all. Following this convention, these
responses were not scored for the purposes of this study.
Internal consistency is satisfactory (Cronbach’s alpha = .86 for ranking of panic
body sensations, .90 for ratings of panic body sensations, .74 for ranking of external
events, and .SO for external event belief ratings). For individuals diagnosed with panic
disorder, the BBSIQ panic body sensation items correlate significantly with the ACQ
Physical Concerns factor, but not with the ACQ Social-Behavioral Consequences factor
or the STAI. BBSIQ external event items correlate with the ACQ Social-Behavioral
Consequences factor and STAI Trait anxiety, but not with the ACQ Physical Concerns
factor. Test-retest reliability has not yet been examined for the BBSIQ. In this study, the
BBSIQ provided a measure of the degree to which participants tend to interpret
ambiguous situations in a threatening way.
General Histow. The General History (GH; Appendix J) questionnaire was
constructed specifically for the purpose of this study. It assesses use of prescription
medications, known triggers of asthma symptoms, involvement in sports or other types of
physical exercise, and cigarette smoke exposure. The GH provided information about
environmental stimuli that the individual is exposed to on a daily basis.
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Panic Attack Cognitions Questionnaire. The Panic Attack Cognitions
Questionnaire (PACQ; C l m , Broyles, Borden, & Watkins, 1990; Appendix K) is a 35item self-report checklist that assesses negative cognitions associated with panic attacks.
The PACQ was utilized as a state measure of catastrophic, panic-related cognitions
between tasks. The degree of preoccupation with each cognition during a panic attack is
rated on a 1 (not at all) to 4 (totally dominated) Likert scale.
The PACQ has been found to reliably differentiate between individuals who
experience panic attacks versus individuals diagnosed with other anxiety disorders (Clum
et al., 1990). Cronbach’s alpha for the PACQ was .88. In addition, the PACQ was found
to contribute uniquely to the differentiation between individuals with and without panic
attacks (depression, state and trait anxiety measures were also included; Clum et al.,
1990).
Profile of Mood States. The Profile of Mood States (POMS; McNair, Lorr, &
Droppleman, 1971; Appendix L) is a 63-item self-report questionnaire that assesses
transient mood states. It was utilized throughout the experiment to detect alterations in
mood due to the experimental tasks. The POMS is composed of 6 subscales: DepressionDejection, Tension-Anxiety, Anger-Hostility, Fatigue-Inertia, Vigor-Activity, and
Confusion-Bewilderment. Each item is rated with regard to how much an individual is
currently experiencing that emotion on a 0 (not at all) to 4 (extremely) Likert scale. For
this study, only the Tension-Anxiety subscale was used. This subscale assess somatic
tension. Internal consistency for this scale is .90, and a high degrees of test-retest
reliability in a sample of outpatients has been found (I = .70; McNair et al., 1971).
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State-Trait Anxiety Inventory. The State-Trait Anxiety Inventory (STAI;
Spielberger et al., 1982, Appendix M) is a 40-item self-report measure that assesses two
aspects of anxiety. Twenty items measure an individual’s general or “trait” level of
anxiety, and 20 items assess an individual’s current or “state” level of anxiety. For the
State version, items are rated according to how the individual feels at the moment, from 0
(not at all) to 4 (very much so). The items on the Trait version are rated according to how
the individual generally feels (0 = almost never, 4 = almost always). The test-retest
reliability for the state version in college students (.16 to .54) is lower than that of the trait
version (.73 to .86), as may be expected (Spielberger et al., 1982). In this study, the STAI
provided measures of the general and current levels of anxious mood that participants
experience. Coefficient alpha in the present study was .80 for the state version and .74
for the trait version.
Symptom Checklist. Because no single measure of both asthma and panic
symptoms exists in the published literature, a new measure was devised as a state
measure of both types of symptoms. The Symptom Checklist (Appendix N) comprises
all the items of the ASC (five subscales) plus a sixth subscale comprised of 14 items from
the Panic Attack Symptoms Questionnaire (PASQ; Clum et al., 1990). PASQ items were
selected that did not overlap with items already on the ASC. The PASQ itself is a 36item checklist of symptoms frequently experienced during a panic attack. It reliably
differentiates between individuals with panic attacks and individuals diagnosed with other
anxiety disorders (Clum et al., 1990). In addition, the PASQ contributes uniquely to the
differentiation between individuals with and without panic attacks (depression, state, and
trait anxiety measures were also included; Clum et al., 1990).
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Visual Analog Scales. A 7-point Likert scale (Appendix 0)was utilized between
tasks to assess the similarity of sensations experienced during the task to those
experienced during a panic attack. The scale ranges from 0 (not at all similar) to 7
(extremely similar). Because the sensations that individuals with panic disorder
experience differ from individual to individual (Barlow & Craske, 1994), some challenge
tasks may not be as salient as others. This visual analog scale provided a measure of how
similar sensations during the tasks were to those experienced during panic attacks.

A second 7-point Likert scale (Appendix P) assessed how stressful the task was
for the participant. The scale ranges from 0 (not at all stressful) to 7 (extremely stressful).
Because some researchers have proposed that stress reactivity causes increased air flow
resistance (Kotses et al., 1989), it is important to measure the participant’s perception of
stress level.
A third 7-point Likert scale (Appendix Q) assessed how similar the sensations
produced during the tasks were to an asthma attack. The nature of symptoms experienced
by individuals with asthma varies from individual to individual (Purcell & Weiss, 1970).
Therefore, it was important to utilize a self-report measure of how similar the sensations
experienced during the tasks were to an asthma attack.
Participants completed a fourth 7-point Likert scale (Appendix R) that assessed
how much control they believed they had over the sensations experienced during each
task. According to Ley (1998), dyspnea produces panic sensations when the individual
believes he or she has little or no control over the dyspnea.
Measurement of Lung Function. Pulmonary function was assessed via
spirometry, using methodology similar to previous studies (e.g., Carr et al., 1992; Carr et
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al., 1994; Isenberg et al., 1992b). At each assessment, participants exhaled forcefully 3
times at maximal lung capacity, or until at least 2 equivalent readings (+/- 5%) are
obtained. No more than 5 exhalations were attempted at any assessment. A nose clip
was utilized to reduce air escaping through the nasal passages. Measures examined
included FEVl and the ratio of FEVl to FVC (FEVlRVC). Because the level of expected
lung capacity differs based on an individual’s body height, age, weight, and gender, FEVl
was analyzed as percent predicted based on the participant’s characteristics, calculated by
the spirometer.
Procedure
Participant Selection. Students in numerous Psychology courses completed
screening questionnaires that assessed presence or absence of asthma and history of panic
attacks. Approximately 1,500 women were screened over a 1.5 year period. Interested
participants who met the initial screening criteria for one of the groups were contacted by
telephone and asked a series of short questions relating to their medical and psychiatric
history. If the responses to these questions indicated that the individual continued to meet
criteria, the individual was asked to take part in the structured interview (ADIS-IV).
Those who did not meet the inclusion criteria were provided with a brief explanation of
why they were not be able to take part in the study (e.g., “We are looking for people who
did not experience the onset of both panic and asthma within a year’s time.”) and thanked
for their interest in the experiment. Women who met initial inclusion criteria were
scheduled for the experiment during the first 7 days of their menstrual cycle in order to
control for hormonal levels that may affect lung function (e.g., Chandler, Shuldheisz,
Phillips, & Muse, 1997; Cross, 1994; Settipane & Simon, 1989).
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Upon arrival at the laboratory, the experimenter verbally explained the
information in the consent form, and participants were asked to read and sign the consent
form. Individuals were informed that they would be engaging in tasks not expected to be
more stressful than those encountered in daily living, and that they could discontinue
participation in the experiment at any time without penalty. After signing the informed
consent form, each participant was interviewed utilizing the panic disorder section of the
ADIS-IV .
Exclusionary Conditions. In addition to assessment for panic disorder,
participants were screened for history of schizophrenia or psychotic episode(s), and
alcohol and drug abuse or dependence within the past year. Medical conditions that
resulted in exclusion included vestibular disorders and other chronic diseases (i.e.,
diabetes, hypo or hyperthyroidism, etc.).
Following the structured interview, those who met criteria for participation
immediately began the experimental session. Individuals who did not meet criteria were
debriefed, thanked for their participation, paid or given course credit, and given a list of
treatment referral information.
Questionnaire Assessment. During the experimental session, participants
completed the packet of questionnaires and engaged in the experimental tasks.
Questionnaires included the ACQ, ASI, respiratory subscale, ASC, BBSIQ, BVS, GH,
and STAI, and were presented in random order to minimize the possibility of order
effects. Participants were asked to read the instructions for each questionnaire carefully
before completing it.
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Tasks. Once the questionnaire packet was completed, participants engaged in the
three experimental tasks: turning head from side to side, breathing through a straw, and
relaxation. To control for order effects, the tasks were counterbalanced. A 5-minute
baseline preceded each task. During each baseline, participants sat in a comfortable chair
and were told:
“Now we are going to take a short, 5-minute break. During this time, simply sit
back and rest. After 5 minutes, we will measure your lung function and you will have a
short set of questionnaires to complete.”
After each baseline and after each task, spirometry measures were taken, and each
participant completed the anxiety subscale of the POMS, PACQ, PASQ, ASC, Borg
Scale, and the visual analog scales.
Head Turning, Task. The head turning task involved the participant turning her
head from side to side while seated in a chair for 2 minutes. This task was designed to
cause symptoms reminiscent of a panic attack (i.e., dizziness), without affecting lung
finction or increasing heart rate (Barlow & Craske, 1994). It is particularly important to
avoid activity that affects heart rate, because heart rate is related to respiratory rate
(Lehrer, Hochron, Rausch, & Can, 1994a). If heart rate is inadvertently increased, then
respiratory rate also increases.
Participants were seated in a chair and told:
“During this task, please turn your head from side to side (experimenter
demonstrates). This task will last 2 minutes. Your task is to focus on your thoughts,
feelings, and the sensations you experience while turning your head. After the minute is
up, I will measure your lung function, and have you will complete the short questionnaire
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packet again. If it becomes absolutely necessary for you to stop this activity before the 2
minutes are up, that is okay, but please do your best to continue for as long as you can.”

To avoid the loss of participants due to possible inability to complete 2 full
minutes of the head turning task, the length of time the participant continued was
recorded. Data for participants completing at least 30 seconds of the task was retained.
Straw Task. Breathing though a straw lasted 2 minutes. This task was designed
to mimic the sensations of dyspnea experienced during an asthma attack (Barlow &
Craske, 1994).
Participants were seated in a comfortable chair and a nose clip was placed on their
nose. They were told:
“In this task, you will be breathing through this straw for 2 minutes. Your task is
to focus on your thoughts, feelings, and the sensations you experience while breathing
through the straw. Again, after this task, I will measure your lung function and ask you to
complete the short questionnaire packet. If it becomes absolutely necessary for you to
stop this activity before the 2 minutes are up, that is okay, but please do your best to
continue for as long as you can.”
Again, to reduce participant attrition, the length of time participants continued
was recorded. Data for participants who continued the straw task for at least 30 seconds
was retained.
Relaxation Task. Relaxation was 5 minutes in length. This task served as a
comparison and also replicated the findings of Carr et al. (1992).
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Participants were seated in a comfortable chair and told:
“During this task, please relax as completely as possible with your eyes closed.
You will have 5 minutes to simply sit back and relax. After the task, I will measure your
lung function and have you complete the short questionnaire packet.”
Spirometry Procedure. Instructions for the participants regarding how their lung
function was measured were modeled after American Thoracic Society guidelines (ATS,
1995). Participants were shown the equipment and the disposable mouthpiece they
exhaled into. The following instructions were provided:
“This is a spirometer. It is a machine that measures how well your lungs are
working. You will be exhaling into this mouthpiece (show mouthpiece). I am going to
put this nose clip on your nose in order to prevent air from escaping. It is very important
that you inhale completely before you put the mouthpiece in your mouth. If you inhale
into the mouthpiece, this will alter the readings. When you put the mouthpiece in, make
sure you have made a good seal with your lips to prevent air from escaping on the sides
(experimenter demonstrates with another mouthpiece). When you exhale, it is important
that you blast the air from your lungs and then continue exhaling as fully as possible
(experimenter demonstrates). We will be doing at least 3 exhalations after each task. Do
you have any questions?”
The experimenter demonstrated the procedure and, as the participant exhaled,
encourage her to exhale as fully as possible. At least 3 acceptable (<0.2 L variation;
ATS, 1995) maneuvers were necessary. No more than 5 total maneuvers were attempted
at any task interval.
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Debriefing. After the completion of the series of tasks, lung function assessments,
and questionnaire measures, participants were thanked for their participation and
debriefed. Participants not receiving experimental credit were paid $10.00 to assist in
defiaying travel costs associated with their participation in the study.
Modifications to Procedure. Because of the difficulty in obtaining participants,
two of the constraints that had originally been placed on participation had to be
abandoned. It was hoped that women would be able to be scheduled during the first week
of their menstrual cycle in order to hold hormonal factors constant. It is well-established
that hormone fluctuations during the menstrual cycle may lead to exacerbations for some
women during the premenstrual phase (e.g., Chandler et al., 1997; Cross, 1994; Settipane
& Simon, 1989). Furthermore, the menstrual cycle appears to impact frequency and

severity of panic attacks (e.g., Cameron, Kuttesch, McPhee, & Curtis, 1988; Cook et al.,
1990; Kaspi, Otto, Pollack, Eppinger, & Rosenbaum, 1994; Sigmon et al., 2000).
However, potential participants were less likely to follow through with scheduled
assessments when planned dates were more than a few weeks away. Instead, women
indicated which phase of the menstrual cycle they were in and that information was
recorded as part of data collection.
Several women in each of the groups smoked cigarettes on a regular basis.
Previous research in the asthma and panic area has excluded individuals who smoke in
order to rule out reasons for lung dysfunction other than asthma (e.g., Carr et al., 1992;
Carr et al., 1996). If the study had been conducted with a larger sample size, it is possible
that a more homogeneous sample without confounds (i.e., smoking status, menstrual
cycle phase) might have been obtained.
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Chapter 3
RESULTS
In this section, participant characteristics, interrater reliability statistics for
diagnostic interviews using the panic section of the Anxiety Disorders Interview for
DSM-IV (ADIS-IV; Brown et al., 1994), and results for each hypothesis are presented.
Additional related findings are included in the results for each hypothesis as well as at the
end of the Results section. All data analyses were conducted with SPSS version 10.0
software for Windows. Where possible, power and effect size (eta2) were calculated for
each analysis. According to Cohen (1988), effect sizes o f . 10, .25, and .40 are considered
to be small, medium, and large, respectively. Post hoc comparisons were conducted
using Tukey’s HSD test with alpha set at .05.
Sample Characteristics
Demographic Information
Female participants were 93% Caucasian, 3% Hispanic, and 3% Native American.
All but one participant was an undergraduate at the University of Maine (99%). The four
groups of participants (Asthma only, Panic only, Asthma and Panic, Control) did not
significantly differ in age, F(3,55) = .43, G.The mean age of participants by group was
as follows: Asthma only, M = 19.47,
9.24; Panic, M = 20.93,

=

1.81; Asthma and Panic,

= 22.80, SD =

= 3.08; Control, M = 21.07, SD = 4.67.

Asthma Groups
Women in the Asthma only and Asthma and Panic groups were compared on
several variables that related to their asthma condition. Women in the Asthma only group
were first diagnosed with the disease at a mean age of 11.38 years (SD = 5.84), whereas
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women in the Asthma and Panic group were diagnosed at a mean age of 16.83 years
=

(a

12.59). However, these means were not significantly different F(1,23) = .56, m.

Women in the two asthma groups did not significantly differ with regard to the number of
medications taken. Women in the Asthma group reported taking an average of 1.8
medications, and women in the Asthma and Panic group reported taking 3.33
medications,

c(1,28) = 2.48, m.Types of medications taken by both groups were similar,

most frequently beta agonists (60% of Asthma group, 47% of Asthma and Panic group),
followed by corticosteroids (13% of Asthma group, 13% of Asthma and Panic group) and
allergy medications (13% of Asthma group, 20% of Asthma and Panic group). Similarly,
there was no significant difference in length of time from last asthma attack in weeks
between the Asthma (M= 46.38, SD = 71.53) and Asthma and Panic groups (M= 32.87,
SD = 83.66), F( 1,26) = .OO, 3.

Several t tests were performed on the subscales of the Asthma Symptom Checklist
(ASC) comparing the responses of women in the Asthma only and Asthma and Panic
groups (see Table 3.1). Women in the Asthma and Panic group reported higher levels of
asthma symptoms than the Asthma only group on total scale score, I( 1,28) = -2.67, p <
.01, the Panic Fearf(1,28) = -2.96, p < .006, Irritability, 1(1,28) = -2.41, p < .02, and

Fatigue t( 1,28) = -2.17, p < .03 subscales. Means for the Hyperventilation i( 1,28) = -.58,

ns, and Bronchoconstriction1(1,28) = -1.74, ns, subscales were not significantly different
between the Asthma only and Asthma and Panic groups.
Panic Groups
Women in the Asthma and Panic and Panic only groups were compared on panicrelated variables assessed on the Anxiety Disorders Interview Schedule for DSM-IV

73
Table 3.1
Means and Standard Deviations for Asthma Symptom Checklist Subscales

Asthma

Asthma & Panic

Total Score

98.26 (27.57)

122.78 (18.95)

-2.67*

Panic Fear

19.06 (8.08)

27.20 (6.87)

-2.96**

Irritability

14.00 (5.50)

19.00 (5.85)

-2.41*

Fatigue

11.53 (4.89)

15.28 (4.32)

-2.17*

Hyperventilation

20.60 (6.25)

21.73 (4.25)

-.58

Bronchoconstriction

33.06 (8.97)

38.00 (7.43)

-1.74

* p < .05. ** p < .01.
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(Brown et al., 1994). Both groups reported having experienced panic attacks for a similar
length of time (Asthma only: M = 78.93 months, SD = 54.43; Asthma and Panic: M =
68.40 months, SJ = 65.00), F(l,27) = .538, ns. Women in the Panic only group reported
an average of 7.33 panic attacks (SJ = 9.63) over the past month, and 36.73 attacks (B
= 59.84) over the

past 6 months. These values were not significantly different from those

reported by the Asthma and Panic group, who reported an average of 7.93 attacks (SJ =
7.90) in the past month, F(l,28) = .001, IS- and 39.00 attacks

(m= 43.09) over the past 6

months, F(l,28) = .32, ns. When asked to rate the amount they worried about having
another panic attack during the past month on a 0 (no worry/apprehension) to 8
(constantly worriedextreme apprehension) Likert scale, the average response of the
women in the Panic only group was 4.60 (SJ = 2.56), whereas women in the Asthma and
Panic group reported less worry, 3.73 (SJ

= 2.60).

These means, however, were not

significantly different, F( 1,28) = . 0 0 1 , ~ Similarly,
.
no significant differences were
found between the Panic only and Asthma and Panic groups on measures of panic attack
life interference and distress, F( 1,28) = 2.89, ns, and F( 1,28) = .89, ns, respectively.

An advanced clinical graduate student reviewed audiotapes of the ADIS-IV
interviews and rated which group criteria the participant met. These ratings were
compared with the principal investigator. Unfortunately, 13 out of 60 interviews were not
recorded due to equipment failure. On the remaining 47 participant interviews, the
principal investigator and the advanced clinical graduate student agreed 100% that
women in the Panic only and Asthma and Panic groups met DSM-IV criteria for Panic
Disorder and that women in the Asthma and Control groups did not meet criteria for
Panic Disorder.
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Ouestionnaire Measures
Oneway ANOVAs were performed on total scores for the following questionnaire
measures. Means and standard deviations for these measures appear in Table 3.2.
On the State version of the State-Trait Anxiety Inventory (STAI; Spielberger et al., 1983),
no significant differences between groups were found, €33,56)

=

1 . 6 8 , s . On the Trait

version, however, a significant effect for group was found, F(3,56) = 9.71, p < .0001 (see
Figure 3.1). Women in the Panic only group reported significantly more trait anxiety than
women in the Asthma only and Control groups, and women in the Asthma and Panic
group reported more trait anxiety than the Asthma only group. Mean scores for the
Asthma only and Control groups did not significantly differ, nor did the Asthma and
Panic and Panic only groups.
Profile of Mood States
A oneway ANOVA was conducted on baseline Profile of Mood States (POMS;
McNair et al., 1971) Tension-Anxiety subscale scores to identify group differences,
F(3,56) = 5.41, p < .002 (see Table 3.3). Post hoc analyses revealed that the Panic only

group reported significantly more anxiety at baseline than the Asthma only and Control
groups. The Asthma and Panic group did not differ from any other group, and the
Asthma only group did not differ from the Control group. To calculate POMS scores for
each task taking into account baseline differences, change scores were derived for each
task from baseline. A MANOVA on POMS change scores from all three tasks revealed a
significant overall effect for group, Wilks’ lambda F(9,129) = 2.58, p < .009, power =
.85, eta2 = .12. Followup oneway ANOVAs and post hoc tests indicated that on the head
turning task, F(3,55) = 5.67, p < .002, women in the Asthma and Panic group reported

Table 3.2
Means and Standard Deviations for Questionnaires
~~

Asthma (a)

Asthma & Panic (b)

Panic (c)

Control (d)

State Anxiety

48.60 (4.13)

52.66 (8.53)

53.20 (8.94)

49.26 (4.05)

Trait Anxiety

47.60b,, (3.73)

55.26, (6.78)

57.06,d (5.90)

50.93, (4.21)

Note: Groups are significantly different from means subscripted.

***

< .0001.

.18
9.71***
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Table 3.3
Means and Standard Deviations for Profile of Mood States Tension-Anxiety Scores

Asthma (a)

Asthma & Panic (b)

Panic (c)

Control (d)

Baseline

5.26, (3.41)

9.73 (7.73)

14.46,d (10.90)

4.93, (5.70)

F(3,56) = 5.41**

Head Turning

6.26b (4.74)

17.13%,,d(9.53)

17.06b (1 1.48)

5.8Ob (5.26)

F(3,55) = 5.67**

-1.oo

-7.40

-2.60

-37

7.46 (6.73)

16.86d (9.01)

17.93 (11.91)

5.86b (5.04)

-2.20

-7.13

-3.47

-.93

11.66 (10.93)

3.21 (4.67)

+2.80

+1.72

Change
Straw
Change
Relaxation
Change

3.33 (3.15)
+1.93

6.06 (5.50)
+3.67

F(3,55) = 2.62

l33,55) = .31

Note. Negative change scores reflect intensification of anxiety relative to baseline; positive change scores reflect decrease in anxious
mood relative to baseline. Groups are significantly different from means subscripted.
** p < .01.
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more anxiety compared to baseline than the other three groups (see Figure 3.2). Women
in the Asthma only group did not score differently from women in the Panic only or
Control groups, and the Panic only and Control groups did not differ on their self-report
of anxious mood. On the straw task, F(3,55) = 2.62, p < .06, a trend toward significance
was identified. The Asthma and Panic group exhibited a larger increase in anxiety during
the straw task than the other three groups, although this was not statistically significant.
Finally, no significant mood changes were identified for the relaxation task, F(3,55) =

.31,m.
Results for Hypotheses
Hypothesis One
According to Hypothesis One, in comparison to baseline scores, individuals in the
Asthma only, Panic only, and Asthma and Panic groups would experience a greater
increase in dyspnea level after the relaxation and head turning tasks than the Control
group. Controls were expected to experience greater dyspnea after the straw task.
Baseline Borg Dyspnea Scale (BDS; Borg, 1982) scores were compared via a oneway
ANOVA (see Table 3.4). No baseline group differences were found, F(3,56) = 2.03, ns,
In order to compare BDS scores after each task to baseline, change scores were calculated
for each task. BDS scores from the head turning, straw, and relaxation tasks were
subtracted from baseline scores. A oneway ANOVA revealed no significant differences
between groups on BDS change scores following the straw, F(3,56) = 1.66, gs,or
relaxation tasks, F(3,56) = . 4 4 , ~ Group
.
differences on the head turning task, however,
approached significance, F(3,56) = 2.57, p < .06. Post hoc analyses, however, did not
identify significant differences between any pairs of groups. During the head turning
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Table 3.4
Means and Standard Deviations for Borg Dyspnea Scale Scores
~

Asthma (a)

Asthma & Panic (b)

Panic (c)

Control (d)

Baseline

1.67 (1.23)

1.87 (1.67)

1.53 (1.25)

.SO (1 -26)

2.03

Head Turning

1.87 (1.19)

2.80 (1.37)

2.27 (1.75)

.47 (S2)

2.57

Change
Straw
Change
Relaxation
Change

-.20

-.93

-.74

-.33

2.53 (1.19)

4.00 (1.13)

3.40 (2.56)

2.13 (1.64)

-.86

-2.13

-1.87

-1.33

1.13 (1.19)

1.13 (1.19)

-.54

-.74

.87 (1.19)

.14 (.36)

+.66

+.66

1.66

.44

Note. Negative change scores reflect intensification of dyspnea relative to baseline; positive change scores reflect decrease in dyspnea
relative to baseline. Groups are significantly different from means subscripted.
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task, women in the Asthma and Panic and Panic only groups reported more anxiety than
women in the Asthma and Control groups.
Hypothesis Two
According to Hypothesis Two, after the relaxation task, the Panic only and
Asthma and Panic groups would report a greater increase in panic-related symptoms from
baseline than the Asthma only group. In turn, the Asthma only group was expected to
report a greater increase in these symptoms than the Control group. After the head
turning task, the Panic only and Asthma and Panic groups were expected to report a
greater increase in panic sensations than the Asthma only and Control groups. After the
straw task, panic-related symptoms were expected to be equivalent for all groups.
Baseline scores from the six subscales of the Symptom Checklist (five subscales
of the ASC, plus panic specific symptoms) were analyzed via ANOVA. Five out of the
six subscales resulted in a significant oneway ANOVA and significant group differences
with post hoc testing (see Table 3.5). On the Panic-Fear, F(3,56) = 4.09, p < .01,
Fatigue F(3,56) = 4.38, p < .008, and Hyperventilation subscales, F(3,56) = 4.77, p <
9 -

.005, an identical pattern of scores was identified. For these three subscales, women in
the Panic only group scored higher than women in the Asthma only and Control groups.
The Asthma and Panic group did not significantly differ from any other group. On the
Irritability subscale, F(3,56) = 4.65, p < .006, women in the Panic only group scored
significantly higher than women in the Asthma only group. No differences were found
for the Asthma and Panic or Control groups. On the Bronchoconstriction subscale,
F(3,56) =

1.92, ns, no significant group differences were identified. Finally, on the Panic-

Specific subscale, women in the Panic only group scored higher than women in the

Table 3.5
Means and Standard Deviations for Baseline Symptom Checklist Subscales

Asthma (a)

Panic-Fear

.73, (1.09)

Asthma & Panic (b)

Panic (c)

Control (d)

3.53 (5.15)

5.53,d (6.10)

1.27, (4.54)

4.09**

Irritability

1.06, (.79)

3.60 (2.94)

5.20, (5.14)

2.06 (2.52)

4.65**

Fatigue

2.26, (3.01)

3.26 (3.63)

5.80,d (4.58)

1.33, (2.71)

4.38**

Hyperventilation

1.73, (2.12)

1.86 (2.94)

4.53qd (4.08)

.SO, (1.56)

4.77**

Bronchoconstriction

6.00 (5.27)

5.13 (5.89)

7.06 (6.70)

2.40 (4.11)

1.92

Panic Symptoms

2.26 (1.75)

5.60 (7.51)

7.40d (7.5 1)

2.00, (2.07)

3.45*

Note: Groups are significantly different from means subscripted.

* p < .05. ** p < .01.
00

w
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Control group. No significant differences were identified for the Asthma and Panic or
Asthma only groups.
In order to compare Symptom Checklist subscale scores while taking into account
baseline differences, change scores for each task were calculated (see Table 3.6). For the
head turning task, a MANOVA on the six subscale scores did not reveal any significant
group differences, Wilks’ lambda E( 18,144) = 1.39, ns, power = 3 2 , effect size = .13.
Likewise, the overall MANOVA on the relaxation task was nonsignificant, Wilks’
lambda F( 18,144) = 1.81, ns, power = .93, effect size = .17. No followup ANOVAs were
conducted for these two tasks. On the straw task, however, a significant Wilks’ lambda
was revealed, E( 18,144) = 2.76, p < .0001, power = .99, effect size = .24. Followup
oneway ANOVAs were significant for two of the six subscales, Hyperventilation, F(3,56)
= 5.26, p

< .003, and Bronchoconstriction, F(3,56) = 3.17, p < .03. Post hoc testing for

the Hyperventilation subscale revealed that the Panic only group scored significantly
higher than the Asthma only and Control groups. The Asthma and Panic group did not
differ from any other group. On the Bronchoconstriction subscale, women in the Asthma
and Panic group scored higher than the Asthma only group. No significant differences
were found for the Panic only or Control groups. Post hoc tests on the remaining
subscale scores, Panic-Fear, F(3,56) = 1.07, ns, Irritability, F(3,56) = 1.58, ns, Fatigue,
F(3,56) = .87, ns, and Panic Specific, F(3,56) = 2.10, ns, revealed no significant findings.

Hwothesis Three
According to Hypothesis Three, individuals in the Asthma and Panic group were
expected to experience an increase in lung function after the relaxation and head turning
tasks in comparison to baseline. In contrast, the Control group was expected to exhibit no

Table 3.6
Means and Standard Deviations for Task Symptom Checklist Subscales

Asthma (a)

Asthma & Panic (b)

Panic (c)

Control (d)

7.93 (7.88)

.40 (.91)

+.86

-.66

6.80 (6.23)

3.00 (3.09)

Head Turning Task
Panic-Fear
Change
Irritability
Change
Fatigue
Change
Hyperventilation
Change

.SO (2.07)
-.06
1.00 (1.41)
-.06
2.00 (2.44)
+.26
3.46, (2.53)
-1.73

4.60 (5.66)
-1.06
5.66 (4.46)
-2.06
4.60 (4.89)
-1.33
7.13 (5.39)
-5.26

-1.60
8.20 (5.65)

1.83

2.00

-.93
1.60 (2.50)

-2.40

-.26

11.264 (8.25)

2.73, (3.71)

-6.73

1.93

1.83

4.76**
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Table 3.6 Continued

Asthma (a)

Asthma & Panic (b)

Panic (c)

Control (d)

Straw Task
Fatigue
Change
Hyperventilation
Change
Bronchoconstriction
Change
Panic Symptoms
Change

2.13 (2.32)
+.13
3.06, (1.98)

4.86 (4.32)
-1.60
5.00 (3.56)

7.00 (5.43)

2.00 (2.39)

-1.20

-.66

10.33,d (8.38)

1.40, (3.26)

-5.80

-.60

-1.33

-3.13

8.20b (5.33)

13.93, (6.47)

-2.20

-8.80

-5.86

4.60 (4.17)

10.66 (6.84)

14.33 (13.81)

-2.33

-5.06

-6.93

5.93 (3.30)

10.25 (8.05)

.87

5.26**

3.17*

-3.53
3.40 (3.13)
-1.40

2.10

Table 3.6 Continued
~

Asthma (a)

Asthma & Panic (b)

~~

Panic (c)

Control (d)

4.66 (6.91)

.35 (.92)

Relaxation Task
Panic-Fear
Change
Irritability
Change
Fatigue
Change
Hyperventilation
Change

.33 (.89)
+.40
.73 (1.27)
+.33

1.13 (1.68)
+2.40
2.06 (2.52)
+1.53

+.86

+1 .oo

4.73 (6.50)

1.64 (3.27)

+.46

+.57
2.42 (2.56)

1.93 (2.49)

4.20 (3.83)

5.73 (5.50)

+.33

-.93

+.06

1.26 (1.38)

1.40 (1.68)

6.73 (7.31)

+.46

+.46

-2.20

.62

.61

.55

-1.oo
.42 (1.34)

2.00

+.42

01
01

Table 3.6 Continued

Asthma (a)

M

Measure

(SD)

Asthma & Panic (b)

M (D)

Panic (c)

M

(rn)

Control (d)

M

(SD)

F(37 5 6)

Relaxation Task
Bronchoconstriction
Change
Panic Symptoms
Change

2.80 (2.95)
+3.20

1.80 (2.04)
+.46

3.40 (5.67)
+1.73
4.13 (3.64)
+1.46

6.20 (1 1.30)

.64 (1.15)

+.86

+.78

9.06 (12.31)

4.10 (7.17)

-1.66

.77

.75

+.85

Note. Negative change scores reflect intensification of symptoms relative to baseline; positive change scores reflect decrease in
symptoms relative to baseline. Groups are significantly different from means subscripted.
Q<

.05.

** Q < .01.
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change in lung function. The Asthma only and Panic only groups were expected to
exhibit a decrease in lung function after these tasks. Following the straw task, it was
expected that the Asthma only and Asthma and Panic groups would both show an
increase in lung function. No change was expected for the Control group, and a decrease
was expected for the Panic only group.
The spirometric equipment calculates the degree to which the three exhalation
trials are consistent with each other, and selects the “best” exhalation (i.e., values as large
as possible, but also consistent with the other two exhalations) as the one to use for
interpretation. The accepted level of reliability is less than 0.5 L variation between the
three trials. If no two of the three trials are within 0.5 L of each other, additional
measurements are made (Hyatt, Scanlon, & Nakamura, 1997). Because some of the
participants were not able to provide spirometric values that were reliable even after four
or five exhalations, a number of readings were not included in analyses. The pattern of
unreliable spirometric performance is in and of itself interesting. The Asthma only
group’s percentage of unreliable measurements was low compared to that of the other
groups (12%), Asthma and Panic group 30%, Panic only group 29%, and the Control
group 16%. In order to use as much data as possible, ANCOVA was utilized with the
spirometric percent variance as a covariate. In addition, eliminating data that fell below
the 5% variance cutoff would have decreased the cell sizes for the Asthma and Panic and
Panic only groups in a disproportional manner.
An ANCOVA on baseline forced vital capacity (FVC) percent predicted data
using percent variance as a covariate revealed no significant group differences, F(3,55) =

.84, ns. A similar analysis on baseline forced expiratory volume at 1 second (FEV,)
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percent predicted data was also nonsignificant, F(3,55) = 1.24, ns. Because of the lack of
significant baseline differences between groups on any of these measures, change scores
were not calculated. Rather, each measurement was analyzed via ANCOVA with the
percent variance used as a covariate (see Table 3.7).
No significant differences were identified for any spirometric measure following
any task. ANCOVAs for FVC, F(3,55) = .90, ns, FEVl, F(3,53) = .91, ns, and an
ANOVA on the ratio of FEV1/FVC,F(3,55) = .89, ns, for the head turning task failed to
reach significance. Likewise, for the straw task, no significant differences were identified
via ANCOVAs on FVC, F(3,55) = 1.95, ns, FEV1, F(3,55) = 1.63, ns, or an ANOVA on
FEVl/FVC, F(3,56) = 130, ns. Relaxation task results were similar, with an ANCOVA
on FVC, F(3,54) = .60, ns, and FEVl, F(3,54) = 1.28, ns, resulting in nonsignificance.
Likewise, an ANOVA on relaxation FEVIEVC, F(3,55) = 1.38, ns, was not significant.
Hypothesis Four
After the relaxation and head turning tasks, individuals with Panic Disorder and
both Asthma and Panic were expected to report an increase in panic-related cognitions in
comparison to the Asthma only and Control groups. After the straw task, the Asthma
only and Asthma and Panic groups were expected to report a greater increase in panicrelated cognitions than the Panic only group, with the Control group reporting no
increase.
Total scores for the Panic Attack Cognitions Questionnaire (PACQ; Clum et al.,
1990) were compared at baseline (see Table 3.8). Results of an ANOVA on the PACQ
scores revealed a significant group effect, F(3,56) = 6.24, p < .001. Post hoc tests
indicated that women in the Panic only group reported significantly more panic related

1

Table 3.7
Means and Standard Deviations for Spirometry

Asthma (a)

Asthma & Panic (b) Panic (c)

Control (d)

Baseline

93.40 (9.27)

91.06 (10.91)

94.06 (14.58)

98.33 (16.64)

F(3,55) = .84

Head Turning

94.93 (7.90)

89.20 (16.98)

92.06 (13.64)

97.00 (17.79)

F(3,55) = .90

Straw

93.06 (10.61)

86.00 (12.29)

92.86 (11.64)

97.66 (17.22)

F(3,55) = 1.95

Relaxation

93.86 (10.39)

90.20 (10.21)

94.40 (14.84)

97.57 (17.24)

F(3,54) = .60

Forced Vital Capacity

Forced Expiratory Volume at 1 second
Baseline

97.00 (9.77)

90.33 (19.42)

92.93 (13.16)

100.26 (16.64)

F(3,55) = 1.24

Head Turning

99.14 (7.24)

88.86 (18.69)

90.46 (17.49)

97.46 (17.77)

F(3,53) = .91

Straw

95.93 (10.29)

86.86 (18.50)

86.86 (14.59)

96.80 (19.45)

F(3,55) = 1.63

Table 3.7 Continued

Asthma (a)

__

Asthma & Panic (b) Panic (c)

Control (d)

~

~

Forced Expiratory Volume at 1 second

95.66 (10.44)

87.73 (17.60)

89.40 (16.72)

98.57 (19.63)

F(3,54) = 1.28

Baseline

.92 (.05)

1.13 (.88)

.87 (.07)

.90 (.05)

F(3,56) = .38

Head Turning

.92 (.04)

.88 (.15)

.86 (.09)

.89 (.05)

F(3,55) = .89

Straw

.91 (.02)

.88 (.13)

.83 (.12)

.88 (.09)

F(3,56) = 1.80

Relaxation

.91 (.06)

.85 (.15)

.84 (.11)

.90 (.07)

F(3,55) =

Relaxation
FEV 1/FVC

1.38

Table 3.8
Means and Standard Deviations for Panic Attack Cognitions Questionnaire Scores
~~

Asthma (a)

Asthma & Panic (b) Panic (c)

Baseline

25.73, (1.27)

28.86 (4.06)

25.86,d (1.80)

26.26, (1.80)

F(3,56) = 6.24***

Head Turning

25.33 (7.57)

32.13 (5.12)

36.86 (12.27)

26.26 (1.16)

F(3,55) = 2.29

-3.20

-11.00

0.00

27.13 (3.75)

32.33 (5.89)

37.86 (17.04)

26.26 (0.96)

-1.40

-3.47

25.40 (0.73)

27.13 (2.32)

+.33

+1.73

Change
Straw
Change
Relaxation
Change

+.40

-.12
32.13 (10.34)
-6.27

Control (d)

F(3,55) = .93

0.00
25.42 (1.15)

F(3,55) = .24

+.84

Note. Negative change scores reflect intensification of symptoms relative to baseline; positive change scores reflect decrease in
symptoms relative to baseline. Groups are significantly different fiom means subscripted.
*** p < .001.
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thoughts than women in the Asthma only and Control groups. Interestingly, although the
PACQ mean for the Asthma and Panic group appeared to be higher than the Panic only
group mean, it was not significantly different at the .05 level. No significant baseline
differences were found for the Asthma and Panic group.
Change scores were calculated for each task in comparison to baseline. A
MANOVA on change scores revealed an overall significant Wilks’ lambda, F39,129) =
2.32, p < .01, power = .80, eta2 = .11. Oneway ANOVAs revealed no significant
differences on the straw F(3,55) = .93, ns, power = .24, eta2 = .04, or relaxation tasks l33,
55) = .24, ns,power = .09, eta2= .01. However, on the head turning task, a trend toward
significance was found, €33’55)

= 2.29,

< .08, power = .54, eta2 = .11. Although post

hoc tests did not identify any group differences for the head turning task, visual
inspection of the PACQ change scores for this task suggests that women in the Asthma
and Panic and Panic only groups reported more panic-related thoughts than women in the
Asthma only and Control groups.
Hvpothesis Five
Women in the Asthma only, Panic only, and Asthma and Panic groups were
expected to report more self-focus on bodily sensations than women in the Control group.
Analysis of the total scores on the Body Vigilance Scale (Schmidt et al., 1997; see Table
3.9) revealed significant group differences, F(3,56) = 10.08, p < .OOOl). On this measure,
women in the Asthma and Panic and Panic only groups reported more bodily self-focus
than women in the Asthma and Control groups.

Table 3.9
Means and Standard Deviations for Anxiety Sensitivity Measures

Asthma (a)

Asthma & Panic (b)

Panic (c)

Control (d)

Anxiety Sensitivity Index

16.86b,c(6.67)

33.06,d (1 1.39)

30.26,d (15.62)

15.53b,c (6.64)

10.55***

Body Vigilance Scale

15.54b,, (5.93)

23.63a:d (9.76)

23.53,d (6.95)

11.40b,, (6.36)

10.08***

Cardiovascular

26.001, (7.74)

39.934 (13.36)

35-53 (13.88)

25.60b (9.30)

5.87***

Respiratory

25.20b (9.25)

41.00,d (14.81)

37.93d (16.00)

23.60b,c (1 1.72)

6.66***

Gastrointestinal

26.93b (8.37)

39.33,d (12.65)

35.20 (14.98)

25.13b (1 1.65)

4.61**

Public anxiety

25.20b (7.08)

38.06,d (12.73)

34.86 (13.34)

26.60b (1 1.83)

4.44**

Measure

Anxiety Sensitivity Profile

Table 3.9 Continued
~~

Asthma (a)

Asthma & Panic (b)

Panic (c)

Control (d)

Anxiety Sensitivity Profile

Dissociative/Neurological

27.60b (8.97)

40.73,d (13.72)

36.60 (14.89)

28.00b (12.66)

3.89**

Cognitive Dyscontrol

25.53b (8.67)

40.20,d (12.41)

34.66d (13.41)

22.93b,, (10.80)

7.33***

Note: Groups are significantly different from means subscripted.

** Q < .01. *** Q < .001.

Hypothesis Six
Individuals in the Asthma only, Panic only, and Asthma and Panic groups were
expected to report more misinterpretation of bodily sensations than women in the Control
group. Because three participants failed to complete the Brief Body Sensations
Interpretation Questionnaire (BBSIQ; Clark et al., 1997), the Asthma and Panic group
totaled 13 and the Panic only group totaled 14 for the following analyses. A MANOVA
on the BBSIQ subscales revealed an overall significant group effect Wilks’ lambda,
F(18,136) = 2.37, p

< .003, power = .98, eta2 = .22 (see Table 3.10). Followup ANOVAs

indicated no significant group differences on measures of external explanation rankings
or neutral explanations for either the panic or external scenes, F(3,53) = .25, ns.and
F(3,53) = .32, ns, respectively. The panic explanations were rated higher than the neutral

explanations by the Panic only group in comparison to the Control group, F(3,53) = 3.81,

p < .01. No differences were found for this subscale for the Asthma only or Asthma and
Panic groups. The panic explanations were rated higher by women in the Asthma and
Panic and Panic only groups compared to women in the Asthma only and Control groups,
F(3,53) =

10.71, p < .0001. Finally, women in the Panic only group rated the external

explanations as more likely than the Asthma only group, €3333)

= 3.32, p

< .02. No

differences were found for the Control or Asthma and Panic groups on this subscale.
A MANOVA on Anxiety Sensitivity Profile (ASP; Taylor & Cox, 1998) subscale
scores (see Table 3.9) revealed a significant overall group effect, Wilks’ lambda F(3,56) =
1.73, p < .04,power = .92, effect size = .41. Followup oneway ANOVAs and post hoc
comparisons identified two patterns of significant differences. On the Cardiovascular,
F(3,56) = 5.87, Q < .001, Gastrointestinal, F(3,56) = 4.61, p < .006, Public Anxiety,

Table 3.10
Means and Standard Deviations for Brief Body Sensations Interpretation Questionnaire

Asthma (a)

Asthma & Panic (b) Panic (c)

Control (d)

Panic explanation rank

2.76 (.28)

2.48 (S1)

2.36d (.54)

2.81, (.28)

3.18**

External explanation rank

2.63 (S2)

2.48 (S9)

2.33 (S9)

2.58 (.43)

.86

Panic explanation rating

1.47b,c (1.17)

3-60,d (1.95)

3 . 0 0 ~(1.41)

.89b,c (1.21)

10.71***

External explanation rating

1.90, (1.07)

3.36 (2.01)

3.48,(1.62)

2.46 (1.47)

3.32*

Neutral explanations- panic scenes

5.7 1 (1.04)

5.65 (1.23)

5.98 (.78)

5.65 (1.12)

.32

Neutral explanations-external scenes

6.2 1 (.97)

6.09 (1.5 1)

6.05 (1.02)

6.04 (1.02)

.07

Note: Groups are significantly different from means subscripted.

* p. < .05. ** p. < .01. *** p. < .001.
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F(3,56) = 4.44, p

< .007, and DissociativelNeurologicalsubscales, F(3,56) = 3.89, p <

.01, the Asthma and Panic group scored significantly higher than the Asthma and Control
groups. No differences were identified on these subscales for the Panic only group. For
the Respiratory, F(3,56) = 6.66, p < .001, and Cognitive Dyscontrol, F(3,56) = 7.33, p <

.001, subscales, the Asthma and Panic group scored higher than the Asthma only and
Control groups. In addition, the Panic only group scored higher than the Control group
on the above subscales.
Hypothesis Seven
Women in the Panic only and Asthma and Panic groups were expected to report
more fear of anxiety sensations than the Asthma group. In turn, the Asthma only group
was expected to report a higher level than the Control group. Panic-fear levels were
expected to be higher for the Asthma and Panic group than the Asthma only group.
Significant differences between groups (see Table 3.9, Figure 3.3) were identified on the
Anxiety Sensitivity Index (ASI; Reiss et al., 1986), F(3, 56) = 10.55, p < .0001. Women
in the Asthma and Panic and Panic only groups scored higher than women in the Asthma
only and Control groups. However, women in the Asthma only group did not report
greater fear of anxiety sensations than women in the Control group. As discussed above,
women in the Asthma and Panic group scored higher than women in the Asthma only
group on four of six subscales of the ASC, including the Panic-Fear subscale.
Ancillary Analyses
Visual Analog Scales
Several women did not to complete one or more of the visual analog scales (VAS;
asthma attack similarity, panic attack similarity, control over sensations, stressfulness of
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task). As a result, cell sizes are not consistent for these measures. In cases where cell
sizes differ, the associated E test degrees of freedom have been listed along with means
and standard deviations in Table 3.1 1. Oneway ANOVAs on baseline VAS scores were
calculated. No significant group differences were identified for the panic VAS F(3,56) =
2.16,

or asthma VAS, F(3,46) = 2.12, ns. On the stress VAS, a trend approaching

significance was found, F(3,56) = 2.57, E < .06. Women in the Panic only group rated the
baseline as more stresshl than women in the Control group. No differences were
identified for the Asthma only or Asthma and Panic groups. On the control VAS, a
similar pattern was identified, with women in the Panic only group reporting that they had
less control over the sensations experienced at baseline than women in the Control group,
F(3,56) = 3.81, p < .01. Again, no significant differences were identified for the Asthma

only or Asthma and Panic groups.
In order to control for baseline VAS scores, change scores for each VAS from
baseline were calculated for each of the three tasks. A MANOVA on the VAS for each
task was conducted. For the panic VAS, Wilks’ lambda F(9,129) = 1.78, p < .07, power
--.

= .66, eta2 = .09, a

trend toward significance was identified. Post hoc tests, however,

revealed no significant group differences on the head turning F(3,55) = 2.27, a and
relaxation tasks F(3,55) = .29, ns, On the straw task, F(3,55) = 5.22, p < .003, women in
the Asthma and Panic group reported that the task was much more like a panic attack than
women in the Asthma only or Control groups. No differences were identified for the
Panic only group.
For the MANOVA on the asthma VAS, a group main effect was significant,
Wilks’ lambda, F(9,99) = 2.58, Q < .01, power = 3 4 , eta2 = .15. Followup ANOVAs

Table 3.1 1
Means and Standard Deviations for Visual Analog, Scales

Asthma (a)

Asthma & Panic (b) Panic (c)

Control (d)

Panic Visual Analog Scale
Baseline

2.13 (1.51)

1.67 (.62)

2.73 (1.79)

1.67 (1.11)

F(3,56) 2.16

Head Turning

2.40 (1.50)

3.20 (1.42)

3.73 (2.12)

2.47 (1.41)

l33,55) = 2.27

Straw

2.53b (1.19)

3.73a.d (1.03)

4.20 (1.78)

2.47b (1.25)

l33,55) =5.22**

Relaxation

1.47 (1.13)

1.33 (.62)

2.13 (1.85)

1.14 (.36)

F(3,55) = .29

Asthma Visual Analog Scale
Baseline

2.67 (1.50)

1.80 (1.21)

3.00 (2.14)

1.67 (1.30)

F(3,46) = 2.12

Head Turning

3.00 (1.56)

2.80 (1.15)

4.38 (1.77)

2.09 (1.22)

F(3,43) = 1.17

Straw

3.73b (1.58)

4.67,d (1.11)

5.14 (1.21)

3.00b (2.32)

F(3,43) = 4.80**

Relaxation

1.73 (1.44)

1.33 (.82)

2.00 (1.55)

1.09 (.30)

F(3,43) = 1.16

c

s

Table 3.1 1 Continued

Asthma (a)

Asthma & Panic (b) Panic (c)

Control (d)

Stress Visual Analog Scale
Baseline

1.93 (1.22)

2.07 (1.44)

2.47 (.83)

1.40 (.51)

F(3,56) = 2.57

Head Turning

2.47 (1.30)

3.40 (1.88)

3.93 (1.91)

2.33 (1.29)

F(3,55) = 1.53

Straw

2.87 (1.46)

3.80 (1.15)

4.20 (1.70)

2.80 (1.52)

F(3,55) = 1.24

Relaxation

1.67 (1.29)

1.73 (.88)

2.40 (1.84)

1S O (1.34)

€33,55)

= .28

Control Visual Analog Scale
Baseline

4.67 (1.72)

5.27 (1.39)

4.33d (1.84)

6.13, (1.25)

F(3,56) = 3.81**

Head Turning

4.27 (1.87)

3.73 (1.39)

3.07 (1.98)

4.60 (1.55)

€7(3,55)= 2.27

Straw

3.87 (1.60)

3.27 (1.03)

3.27 (1.75)

4.40 (1.87)

€7(3,55)= 2.25

Relaxation

4.93 (1.67)

5.53 (1.68)

5.13 (1.88)

5.64 (1.98)

F(3,55) = .22

Note: Groups are significantly different from means subscripted.

** p < .01.

L

0

P
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indicated no significant differences on the head turning, F(3,46) = 1.17, ns, or relaxation
tasks, F(3,43) = 1.16, ns. On the straw task, the ANOVA was significant, €33,43)
Q

= 4.80,

< .006. Post hoc tests revealed that the Asthma and Panic group rated the straw task as

more like an asthma attack than the Asthma only and Control groups. No differences
were identified for the Panic only group.

On the stress VAS, a MANOVA revealed no group effect, Wilks’ lambda F(9,
129) = 3 9 , ns, power = .34, eta2 = .04. Similarly, the analysis for the control VAS was
not significant, Wilks’ lambda F(9, 129) = 1.60, ns,power = .61, eta2 = .08. Hence, no
followup ANOVAs were calculated for these two measures.
Correlations between Questionnaire Measures
Correlations between several of the questionnaire measures (ASI, STAI-S, STAIT, BVS) were calculated (see Table 3.12). Significant positive correlations were found
between all four of these measures. Each measure was significantly correlated with each
other measure.
Additional correlational analyses were completed to examine relationships
between the AS1 and subscales of the ASP and ASC. For the AS1 and ASC correlations,
data from the Asthma only and Asthma and Panic groups was used, as the other two
groups did not complete the ASC (Tables 3.13 and 3.14). Interestingly, for women in the
Asthma only group, the AS1 was not significantly correlated with any of the ASP
subscales (Cardiovascular, Respiratory, Gastrointestinal, Public Anxiety, Dissociative/
Neurological, and Cognitive Dyscontrol), but for women in the Asthma and Panic group,
the AS1 was positively correlated with every subscale of the ASP. Subscales of the ASC
(Panic-Fear, Irritability, Fatigue, Hyperventilation, Bronchoconstriction) that were
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Table 3.13
Correlations between Asthma Symptom Checklist Subscales and Anxiety Sensitivity Measures for the Asthma Only Group

Anxiety

Panic-

Irritability

Fatigue

Hyperventilation

Bronchoconstriction

Sensitivity Fear
Inventory
Anxiety Sensitivity Inventory

.62*

.62*

.30

.60*

.46

Cardiovascular

.47

.50

.50

.28

.51*

.27

Respiratory

.39

.34

.45

.33

.51

.17

Gastrointestinal

.35

.57*

.58*

.39

.61*

.44

Public Anxiety

.32

.42

.48

.12

.37

.19

DissociativeiNeurological

.32

.50

.47

.34

.44

.34

Cognitive Dyscontrol

.25

.27

.46

.22

.36

.11

1

0

4

Table 3.14
Correlations between Asthma Symptom Checklist Subscales and Anxiety Sensitivity Measures for the Asthma and Panic Group

Anxiety

Panic-

Sensitivity

Fear

Irritability

Fatigue

Hyperventilation

Bronchoconstriction

Inventory
Anxiety Sensitivity Inventory

.go**

.32

.36

.06

.30

Cardiovascular

.74**

.61*

.45

.22

.16

-.07

Respiratory

.81**

.67**

.47

.35

.30

.03

Gastrointestinal

.90**

.72**

.30

.37

.02

.05

Public Anxiety

.82**

.82**

.36

.43

.05

.02

DissociativeNeurological

.93**

.74**

.38

.33

.08

.05

Cognitive Dyscontrol

.85**

.68**

.37

.3 1

.05

.09

* p < .05. ** p < .01

c

0
00

109
significantly correlated with the AS1 for the Asthma only group included the Panic-Fear,
Irritability, and Hyperventilation subscales. For the Asthma and Panic group, only the
Panic-Fear subscale correlated significantly with the ASI. In examining correlations
between ASC and ASP subscales, for women in the Asthma only group, the
Hyperventilation and Cardiovascular subscales were positively correlated. The
Gastrointestinal subscale was significantly correlated with the Panic-Fear, Irritability, and
Hyperventilation subscales. For women in the Asthma and Panic group, the only
subscale that was correlated with any subscale of the ASP was the Panic-Fear subscale.
This subscale was significantly positively correlated with all six ASP subscales (see
Table 3.14).
For the Panic only and Control groups, correlations between the AS1 and the
subscales of the ASP were calculated (see Table 3.15). For the Panic only group, the AS1
was significantly positively correlated at p < .O 1 for all six ASP subscales. For the
Control group however, no ASP subscale was significantly correlated with the ASI.
Exploratory Within-Sub-iect Analyses
The three experimental tasks in the present study were conceptualized as being
different with regard to the testing of three key theories. The hypotheses were phrased so
that between-groups variables were the primary variables of interest. For this reason,
when this study was in its design phase, repeated measures MANOVA was not
considered as an analysis tool. However, given that so few of the predicted relations
emerged, further exploratory analyses using repeated measures MANOVA were
conducted in order to explore within groups effects. Investigating changes in lung
function and the questionnaire measures for each group across tasks allows for the
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Table 3.15
Correlations between subscales of the Anxietv Sensitivity Profile and the Anxiety
Sensitivity Index

Panic

Control

Cardiovascular

.69**

SO

Respiratory

.67**

.3 1

Gastrointestinal

.71**

.32

Public Anxiety

.67**

.41

Dissociative/Neurological

.75* *

.37

Cognitive Dyscontrol

.70**

.30
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identification of tasks that might elicit more asthmdpanic related symptoms or changes in
lung function for a particular group. The questionnaire and spirometric data following
the tasks were re-analyzed with 4 (Group: Asthma only, Panic only, Asthma and Panic,
Control) x 3 (Task Change Score: Head Turning, Straw, Relaxation) MANOVAs. The
task change score represents the repeated measures and the change from baseline for each
dependent variable for each task. No significant Group main effects were found for any
of the post-task measures. To test within-groups differences across tasks, paired t-tests
were performed with alpha set at .05. A summary of the results is presented in Table

3.16.
Profile of Mood States. Although a significant Task main effect was found for
anxious mood, Wilks’ lambda F(2,54) = 35.94, p < .0001, eta2 = .57, power = 1.00, no
significant Group main effect was found, Wilks’ lambda F(3, 122) = 1.88, ns. However,
a significant Group x Task interaction was found, Wilks’ lambda F(6,108) = 3.37, p <

.004, eta2 = .15, power = .92. No significant Task simple main effect was found for the
Control group, F(2,54) = 1.93, ns. However, significant Task simple main effects were
found for the Asthma only, F(2,54) = 3.98, p <.024, Panic only, F(2,54) = 9.64, p < .0001,
and Asthma and Panic groups, F(2,54) = 32.00, p < .0001.
Post hoc t-tests indicated that participants in the Asthma only group reported more
anxious mood &om baseline to the straw task than from baseline to head turning task or
relaxation task (see Table 3.3). No significant differences were identified for the head
turning and relaxation tasks for the Panic only group. For the Panic only group, anxious
mood scores increased more from baseline to straw task and head turning task than from

Table 3.16
Summary of Within-Subjects Results
Measure

Asthma

Asthma & Panic

Panic

Control

ST>HT=RL

ST=HT>RL

ST = HT > RL

ns
-

ns

ST = HT > RL

ST=HT>RL

ns

ST > HT > RL

ST > HT > RL

ST>HT>RL

ST>HT>RL

FEV 1

ns

ns

ns

ns

FVC

ns

ns

ns

ns

FEVl/FVC

ns
-

HT > ST

ns

ns
-

Profile of Mood States - Anxiety
Subscale
Panic Attack Cognitions Questionnaire
Borg Category Scale

RL = HT, ST

Note. ST = straw task, HT = head turning task, RL = relaxation task.
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baseline to relaxation task. No differences were found between the straw and head
turning tasks for the Panic only group. For the Asthma and Panic group, participants
reported more anxious mood from baseline to head turning task and straw task than from
baseline to relaxation task. No significant differences were identified for the Asthma and
Panic group’s head turning and straw task anxious mood change scores.
Panic Attack Cognitions Questionnaire. For the PACQ, a significant Task main
effect, Wilks’ lambda F(2,54) = 19.19, p < .0001, eta2 = .4 1, power = 1.OO, and Group x
Task interaction, Wilks’ lambda F(6,108) = 3.01, p < .009, eta2 = .14, power = .89, was
found. No significant Group main effect was identified, F(3,55) = .79, p < .50, eta2 = .04,
power = .21. Breaking down the interaction, no significant simple main effect was found
for the Control group, F(2,54) = .34, ns, or the Asthma only group, F(2,54) = 1.10, ns.

For the Panic only group, a significant simple main effect for Task was found, F(2,54) =
14.55, p < .0001, as well as for the Asthma and Panic group, F(2,54) = 13.35, p < .0001
(see Table 3.8). Post hoc tests revealed that women in the Panic only and Asthma and
Panic groups reported more panic related cognitions from baseline to the head turning and
straw tasks relative to the relaxation task. No significant differences were identified
between change scores for the head turning and straw tasks for either group.
Born Catenow Scale. The BCS analyses resulted in a significant Task main
effect, Wilks’ lambda F(2,54) = 19.19, E < .OOO 1, eta2 = .4 1, power = 1.OO, and a
significant Group x Task interaction, Wilks’ lambda F(6,108) = 3.01, p < .009, eta2 = .14,
power = .89. No significant Group main effect was found, Wilks’ lambda F(3,55) = .79,

ns, eta2 = .04, power = .21. Breaking down the interaction, significant simple main
effects were found for the Control, Wilks’ lambda F(2,54) = 13.38, p < .0001, Panic only,
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Wilks’ lambda F(2,54) = 28.88, p < .0001, Asthma and Panic, Wilks’ lambda F(2,54) =
38.26, p < .0001, and Asthma only groups, Wilks’ lambdaF(2,54)

= 8.53, p

< .001. For

all four groups, post hoc tests revealed that the straw task produced greater reports of
dyspnea symptoms than the head turning task, and that the straw and head turning tasks
resulted in greater reports of dyspnea than the relaxation task (see Table 3.4).
Spirometric Measures. Percent predicted values for FEV 1 and FVC were utilized,
as well as the ratio of FEVl /FVC. For FEVI, no significant main effects or interactions
were identified for the change scores. For Task, Wilks’ lambda l?(2,53)

= 2.46, ns, eta2=

.08, power = .47, for Group, Wilks’ lambda F(3,54) = 1.49, ns, eta2= .07, power = .37,

and for Group x Task, Wilks’ lambda F(6,106) = .46, ns, eta2= .02, power = .18.
For FVC, a Task main effect was found, Wilks’ lambda F(2,54) = 3.21, p < .04,
eta 2= .lo, power = .59. No Group main effect, Wilks’ lambda €3335)

= .99, ns, eta2=

.05, power = .25, or Group x Task interaction was found, Wilks’ lambda F(6,lOS) = 93,

ns, eta2= .04, power = .35. In order to follow up the Task main effect, paired t-tests with
a more conservative p value of .01 were utilized to control for Type I errors. No
significant simple main effects were identified for Task, head turning vs. straw, i( 1,58) =
-2.25, ns, head turning vs. relaxation, i(1,57) = -35, ns, or straw vs. relaxation change
scores, I(
1,58) = 1.27, ns.
For the ratio of FEVl /FVC, a significant Task main effect was found, Wilks’

< .01, eta2= .14, power = .73. No significant Group main
lambda F(2,53) = 4 . 4 4 , ~
effect, Wilks’ lambda F(3,54) = 1.24, ns, eta2= .06, power = .37, or Group x Task
interaction was identified, Wilks’ lambda F(6,106) = 1.22, ns, eta2= .06, power = .46.
Again, following up the Task main effect, no significant simple main effects were found

116
1,57) = -2.5 1,
for head turning vs. straw, t( 1,58) = -2.35, ns, head turning vs. relaxation, I(

ns, or straw vs. relaxation change scores, I( 1,58) = -.29, ns.
Symptom Checklist Subscales. For the subscales of the SCL, no Group main
effect was identified, Wilks’ lambda F(3,55) = 2.09, ns, eta2 = .lo, power = .50. A
significant Task main effect Wilks’ lambda F(2,54) = 65.14, p < .0001, eta2 = .70, power
=

1.OO, and a significant Group x Task interaction was found, Wilks’ lambda F(6,108) =

4.20, p < .001, eta2 = .19, power = .97. See Table 3.6 for means, standard deviations, and
change scores for the subscales of the SCL.
Breaking down the interaction, no significant differences were found for the
Panic-Fear subscale for the Control group, Wilks’ lambda F(2,54) = .40, ns, or the
Asthma and Panic group, Wilks’ lambda F(2,54) = 1.03,m. However, for the Panic only
and Asthma and Panic groups, significant differences were found, Wilks’ lambda F(2,54)
=

12.77, p < .0001, Wilks’ lambda F(2,54) = 23.68, p < .0001. Post hoc tests revealed no

significant differences in Panic-Fear change scores between the straw and head turning
tasks for the Asthma only and Panic only groups. Women in both the Asthma only and
Panic only groups reported greater changes in Panic-Fear ratings for the head turning and
straw tasks than the relaxation task.
On the Irritability subscale, no significant differences were found for the Control
group, Wilks’ lambda F(2,54) = 2.28, ns, or the Asthma only group, Wilks’ lambda
F(2,54) = .37,

ns.

However, significant differences were identified for the Panic only

group, Wilks’ lambda F(2,54) = 13.36, p < .0001, as well as for the Asthma and Panic
group, Wilks’ lambda F(2,54) = 8.55, p < .001. Post hoc tests revealed no significant
differences in irritability ratings between the straw and head turning tasks for the Asthma
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and Panic group and Panic only groups. However, women in the Asthma and Panic
group reported greater irritability for the head turning and straw tasks from baseline than
the relaxation task. No significant difference was found for the Panic only group between
the head turning task and relaxation tasks although a significant difference emerged
between the straw task and relaxation task, with the straw task producing greater selfreports of irritability from baseline.
For the Bronchoconstriction subscale, significant differences for all four groups
were found, Control, Wilks’ lambda F(2,54) = 10.12, p < .0001, Panic only, Wilks’
lambda F(2,54) = 17.89, p < .0001, Asthma and Panic, Wilks’ lambda F(2,54) = 45.76, E
< .0001, Asthma only, Wilks’ lambda F(2,54) = 1 1 . 2 2 , <
~ .0001. Women in the Asthma

only, Panic only, and Asthma and Panic groups reported more bronchoconstriction after
the straw task than the head turning task, and women in these groups reported more
bronchoconstriction after the head turning task and the straw task compared to the
relaxation task. Participants in the control group reported more bronchoconstriction on
the straw task than the head turning and relaxation tasks. No significant difference was
found for the head turning and relaxation tasks for the Control group.
Analysis of the Fatigue subscale resulted in significance for the Panic only group,
Wilks’ lambda F(2,54) = 5.20, p < .009. No significant effect was found for the Control
group, Wilks’ lambda E(2,54) = .42, ns, Asthma and Panic group, Wilks’ lambda F(2,54)
= S9, p

< .55, or the Asthma only group, Wilks’ lambda F(2,54) = .06, p < .93. Post hoc

tests for the Panic only group revealed that these women reported more fatigue for the
head turning task than the relaxation task. No significant differences between the straw
and head turning or straw and relaxation task were found.
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The Hyperventilation subscale analyses revealed a significant effect for the Panic
only, Wilks’ lambda F(2,54) = 13.19, p < .OOO 1, Asthma only, Wilks’ lambda F(2,54) =
3.20, p < .04, and Asthma and Panic groups, Wilks’ lambda F(2,54) = 17.59, p < .0001.

No significant effect was found for the Control group, Wilks’ lambda F(2,54) = 2.88, ns,
Post hoc tests for the Asthma only and Panic only groups revealed no significant
difference between the head turning and straw tasks, but the head turning and straw tasks
produced greater reports of hyperventilation than the relaxation task. Women in the
Asthma and Panic group reported more hyperventilation for the head turning task than the
straw task. In addition, the head turning and straw tasks resulted in greater self-reports of
hyperventilation than the relaxation task.
Finally, for the Panic Specific subscale, no significant differences were identified
for the Control group, Wilks’ lambda F(2,54) = 2.22, ns. However, a significant effect
was found for the Panic only, Wilks’ lambda F(2,54) = 12.47, p < .0001, Asthma and
Panic, Wilks’ lambda F(2,54) = 18.60, p < .0001, and Asthma only groups, Wilks’
lambda F(2,54) = 3.39, p < .04. Post hoc testing revealed no differences between the
head turning and straw tasks for the Panic only, Asthma only, and Asthma and Panic
groups, but head turning and straw tasks resulted in increased reports of panic specific
symptoms compared to the relaxation task.
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Chapter 4
DISCUSSION
In this study, three theories that relate to the comorbidity of asthma and panic
disorder were tested. Women with or without asthma and with or without panic disorder
were assessed on both spirometric and self-report measures of their responses to three
tasks designed to test aspects of each theory.
Self-Report
State and Trait Anxiety
Previous research conducted by Dorhofer & Sigmon (in press), utilizing groups of
women with or without asthma, and with or without panic attacks, found differences in
state anxiety. In the Dorhofer & Sigmon (in press) study, women with both asthma and a
history of panic attacks reported significantly more state anxiety than controls. They
endorsed less state anxiety overall than women in the present study. The differences in
the means for the two studies may explain the apparent discrepancy in results. Both
controls gnJ

women with both asthma and panic disorder endorsed more state anxiety

than in the previous study. It is possible that anticipation of the experimental tasks in this
study contributed to increases in self-reports of state anxiety for participants compared to
participants in the previous study.
Differences in trait anxiety are consistent with previous research that found that
individuals with both asthma and panic disorder reported significantly higher levels of
trait anxiety than individuals with asthma only (van Peski-Oosterbaan et al., 1996). In
addition, using the Taylor Manifest Anxiety Scale (Taylor, 1953) to assess trait anxiety,
Can et al. (1996) found that individuals with both asthma and panic disorder reported
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more trait anxiety than individuals with asthma only or controls, and that individuals with
panic disorder reported more trait anxiety than individuals with asthma only. Thus,
converging lines of evidence suggest that having panic disorder with or without asthma
leads to greater reports of trait anxiety in general, in addition to having episodes of panic.
One possible sequelae regarding the effectiveness of cognitive-behavioral treatment for
panic disorder may lie in its ability to not only provide skills for coping with panic
attacks, but to lower levels of trait anxiety through cognitive restructuring as well.
Asthma Symptoms
It is unclear why women in the Asthma and Panic group would report more
irritability and fatigue but not more hyperventilation or bronchoconstriction symptoms
than women with asthma alone. Hyperventilation and bronchoconstriction are symptoms
that may be characteristic of a panic attack, as well as an asthma attack. It may be that
questionnaire instructions were specific enough to limit participants’ ratings to actual
asthma attack and not panic attack symptoms (“Please rate the following symptoms you
may experience when you are having an asthma attack.”). To date, no other published
study has compared respiratory symptoms for individuals who have asthma with or
without panic disorder. Future research should investigate more thoroughly and with a
more diverse sample the effects that having comorbid asthma and panic disorder may
have on self-reports of asthma symptoms.
Focus on Bodily Sensations
It was predicted that women in the Asthma only group would report more selffocusing than women in the Control group. However, this was not the case. It appears
that meeting diagnostic criteria for panic disorder is concomitant with increased focus on
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bodily sensations, but a diagnosis of asthma does not necessarily lead to greater reports of
bodily self-focus.
Previous research has utilized the Body Sensations Questionnaire (BSQ;
Chambless et al., 1984) as a measure of fear of specific bodily sensations in populations
with or without asthma and with or without panic disorder (Carr et al., 1994). The Carr et
al. (1 994) study found no significant differences in fear of bodily sensations between
individuals with or without asthma only. Participants with panic disorder (with or
without asthma) reported higher levels of fear or bodily sensations. These results parallel
current findings. However, no published research has specifically examined the amount
of focus on bodily sensations in a population with asthma. Future research should
develop measures that can assess the amount of focus on bodily sensations and fear of
bodily sensations that includes symptoms that are specific to asthma.
Anxiety Sensitivity
Extensive research has documented the role that anxiety sensitivity plays in the
development and maintenance of panic disorder (Maller & Reiss, 1992, Reiss, 1987;
Taylor et al., 1992), consistent with higher self-reports of anxiety sensitivity of women in
the two panic groups. Consistent with some previous research, no anxiety sensitivity
differences were identified between individuals with and without asthma. For example,
Carr et al. (1994) found no anxiety sensitivity differences between groups with asthma
alone and controls. However, it should be noted that the Carr et al. (1994) study had
uneven groupings and some groups had a small sample size. This limitation may have
prevented the identification of significant findings for the anxiety sensitivity construct.
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Although the present study’s lack of significant differences in anxiety sensitivity
level between the Asthma only and Control groups is consistent with some research, the
results are in sharp contrast to Dorhofer & Sigmon (in press). Dorhofer and Sigmon (in
press) did find clear differences between women with asthma only and controls. It is not
clear why these two studies, conducted with similar numbers of participants drawn from a
similar student population, have inconsistent results. It is possible that the criteria used to
determine group inclusion in the Dorhofer & Sigmon (in press) study may not have
adequately divided individuals with and without a history of panic attacks. The authors
used a time criterion, panic attacks within the last year. Women with a history of panic
attacks longer than 1 year previous to the study may have been included in the Asthma
only group. This inclusion may have led to a higher mean level of anxiety sensitivity for
the Asthma group. Further research in this area is necessary to provide additional
evidence as to whether or not individuals with asthma alone have higher levels of anxiety
sensitivity than individuals who do not have asthma. In addition, if high levels of anxiety
sensitivity are found for individuals with asthma only, the implications for the
development of panic disorder in this population will need to be thoroughly examined.
Interestingly, although it is logical to expect that women with both asthma and
panic disorder would score higher in comparison to women with asthma only on
measures of fear of respiratory, dissociative/ neurological, and cognitive dyscontrol
symptoms, these women also scored higher on scales that assess severity of fear of
gastrointestinal, public anxiety, and cardiovascular symptoms. In contrast, women with
panic disorder only scored higher on the respiratory and cognitive dyscontrol scales. It
may be that women with both asthma and panic disorder learn to fear a wider array of
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symptoms because they are vigilant about two different types of attacks- panic
asthma attacks. Anecdotally, women with asthma and panic disorder report that they
frequently have trouble identifying whether sensations are asthma or panic related. It may
be that these women fear any bodily sensation, regardless of the cause of the sensation.
Again, it is not known whether this fear arises as a consequence of having a chronic
illness, or if it is a separate phenomenon.
Future research should focus on helping individuals who have both asthma and
panic disorder identify the source of anxiety producing bodily sensations. This skill may
be crucial, because what an individual does to cope with the sensations will greatly differ
depending on the origin of the sensations. If the sensations are perceived as being
asthma-related, the individual may use a short-acting inhaler (i.e., albuterol) to treat the
symptoms. If the sensations are perceived as panic-related, the individual may use
cognitive, relaxation, or other techniques to address the sensations. Unfortunately,
because short-acting inhalers often cause anxiety symptoms, mistaking panic sensations
for asthma symptoms and treating oneself with an inhaler may actually lead to increased
anxiety. Treatment involving exposure to asthma or panic sensations, as currently
practiced in cognitive-behavioraltherapy for panic disorder, may also be beneficial to
reduce anxiety about these sensations.
Results are consistent with previous findings that panic-fear scale is positively
correlated with a diagnosis of panic disorder (Carret al., 1995). Given that panic-fear
levels are associated with a variety of negative outcomes for individuals with asthma, the
difference in women with or without panic disorder is an important one. Future research
should examine whether a diagnosis of panic disorder in individuals with asthma is linked

~~
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to higher numbers of visits to primary health care practitioners, increased numbers of
hospitalizations, and higher numbers of prescriptions. Overall health care costs may be
higher for individuals with both diagnoses. Furthermore, treatment of panic disorder in
individuals with asthma may be able to reduce numbers of visits, hospitalizations,
prescriptions, and overall health care costs.
Mood After Tasks
Previous research has identified correlational differences in mood that are related
to peak air flow measurements for individuals diagnosed with asthma (Hyland, 1990).
No consensus has been reached as to which specific emotions are associated with

decreases in peak air flow, but it is suspected that negative mood states are more likely to
be linked to reduced lung function (Steptoe & Holmes, 1985). Although individuals with
asthma have been found to exhibit greater physiological changes in response to stressful
activities than controls, controls also show some changes in oscillatory resistance that are
correlated with self-reports of intense emotions (Ritz, Steptoe, DeWilde, & Costa, 2000).
These findings were supported by the present study. For the sample as a whole, as
anxious mood increased, lung capacity decreased.
Although the combination of both asthma and panic disorder may lead to a similar
level of anxiety on a general basis, having both disorders did not result in greater selfreports of transitory anxious mood during this particular baseline situation. These results
differ from baseline anxiety mood scores for women in the Dorhofer & Sigmon (in press)
study, where the group with both asthma and a history of panic attacks reported
significantly higher baseline anxious mood than the Control group. Again, it may be that
differences in group assignment criteria led to the discrepant results between these two
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studies. Nevertheless, taking the results of both studies together, it appears that having
panic attacks or panic disorder with or without asthma leads to reports of higher baseline
anxious mood.
The present study is limited in its ability to more thoroughly examine correlations
between anxious mood and lung function for each group separately because of its small
sample size and problems with reliability of the lung function measures. In addition,
because of high correlations between several measures, multiple regressions predicting
lung function measures could not be conducted. Thus, only mood and lung function
correlations were calculated for the entire sample, and were not broken down by group.
To date, no published study has specifically examined how the relation between mood
and lung function may differ for individuals who have asthma with or without panic
disorder. It is important that future research investigate potential differences in the
correlation between anxious mood and lung function utilizing these two groups of
individuals.
Cognitive Theory
Several hypotheses addressed the role that cognitions may play in the relation
between asthma and panic disorder. An adaptation of Clark’s cognitive theory of panic to
asthma suggests that thoughts about bodily sensations may lead to a worsening of asthma
symptoms or a panic attack. Mislabeling non-asthma related sensations as asthma-related
has been found to be related to increases in rehospitalization (Dirks & Schraa, 1983), and
may be connected to other negative outcomes for individuals with asthma (e.g., overuse

of medications).
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Clark (1993) outlines three criteria that must be fulfilled in order for cognitive
mediation of panic attacks to be supported by research. These criteria were adapted to
the asthma literature for the purposes of the present study.
Criterion One
The adaptation of Criterion One stated that individuals with asthma fear and
misinterpret certain bodily sensations more than controls. Taking the results of the three
anxiety sensitivity questionnaire measures together, it appears that women who have
asthma without panic disorder do not tend to misinterpret bodily sensations more than
women without asthma. Therefore, Criterion One was not supported by the results of this
study as it pertains to individuals with asthma only. However, women with both panic
disorder and asthma misinterpret, fear, and focus on various types of bodily sensations
more than both women with asthma only and controls.
Future research should investigate the types of sensations that individuals with
both asthma and panic disorder fear, and how these sensations differ from those feared by
individuals with asthma or panic disorder only. As discussed above, research examining
how individuals with both asthma and panic disorder interpret and differentiate physical
symptoms is crucial. It will be important in the future to develop treatments to assist
individuals in learning how to discriminate between various types of bodily sensations,
and how to react to them in a more adaptive manner.
It should be noted that results for women with panic disorder were in the predicted
direction and support Clark’s (1993) original theory as it pertains to panic. Clark (1993)
predicted that individuals with panic disorder would interpret ambiguous internal
sensations as threatening. Women in the Panic only group reported more negative
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interpretations of bodily sensations than controls, more fear of respiratory and cognitive
dyscontrol symptoms, and focused more on bodily sensations than women without panic
disorder. These results clearly support Clark’s cognitive theory of panic disorder.
Criterion Two
Criterion Two stated that thoughts based on the misinterpretation of bodily
sensations accompany challenge induced asthma symptoms or attacks. Criterion Two
was not supported in relation to individuals with asthma only, but was supported as it
relates to individuals with panic disorder. In addition, increases in panic-related
cognitions for the Panic only and Asthma and Panic groups were significantly greater
than those produced by the relaxation task. This is consistent with previous research that
suggests that for individuals with panic disorder, experimentally induced bodily
sensations are accompanied by self-reports of increased fearful cognitions (e.g., Rachman
et al., 1988).
A number of reasons may have contributed to the lack of significant findings for
women with asthma only. It may be that participants were aware of the source of the
sensations (i.e., that the sensations were induced by the task, not an unknown internal
source) and were less likely to misinterpret them as being catastrophic in nature.
Sensations that are produced in the laboratory, with an experimenter in the room, might
not be as frightening as if they are experienced “out of the blue” and with no one else
nearby.
It is also possible that the tasks were not salient enough to produce sensations that
these women fear or are likely to misinterpret. Of the 60 women who participated in the
study, only two stopped the tasks before the 2 minute time period was completed. Both
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participants had been diagnosed with panic disorder (one in the Asthma and Panic group,
one in the Panic only group) and were unable to complete either the head turning or straw
task. Given that half the sample had been diagnosed with panic disorder, and therefore
the tasks should have been extremely aversive, it is surprising that nearly all women were
able to complete the tasks. However, not all individuals with panic disorder fear the same
sensations. During the exposure component of cognitive-behavior therapy for panic
disorder, tasks that are specific to sensations that an individual fears are selected as
exposure assignments (Barlow & Craske, 1994). It may be that the head turning and
straw tasks produced sensations that were simply not feared by women in this study.
Future research in this area could investigate tailoring tasks used for exposing participants
to the individual, rather than expecting that any single task will induce panic-related
cognitions and sensations in all participants.
Criterion Three
The third criterion stated that manipulations of cognitive variables have an
influence on whether or not an individual experiences asthma symptoms, increased air
flow resistance, or an asthma attack during a challenge task. This criterion was not
directly examined. However, as discussed in Chapter 1, previous research has supported
this hypothesis both for individuals with panic disorder and individuals with asthma only.
Manipulation of cognitions for individuals with panic disorder leads to increased
likelihood of panic symptoms or attacks during panic challenge tasks (e.g., Margraf,
1993; Salkovskis & Clark, 1990; van der Molen et al., 1986).
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Conclusions about Cognitive Theory
Overall, both of the criteria proposed by Clark (1993) that were extended to
asthma and tested in this study were not supported. It appears that women who have
asthma and no history of panic disorder do not interpret bodily sensations more negatively
than women who do not have asthma, nor do they focus more on bodily sensations, or
report more fear of these sensations than women without asthma. Women with asthma
did not report more catastrophic cognitions during the tasks than women without asthma.
It should be noted, however, that women with panic disorder (with or without asthma)
reported more fear of bodily sensations, more bodily self-focus, and at baseline, more
panic-related cognitions than the other groups. In addition, the head turning and straw
tasks produced greater increases in panic-related cognitions than the relaxation task for
the Panic only and Asthma and Panic groups. These results are consistent with previous
research and Clark’s (1993) original theory.
DyspnedSuffocation Fear Theory
In testing Ley’s (1989) dyspnedsuffocation fear theory, four aspects of the theory
were addressed. First, the relaxation task represented an attempt to replicate the findings
of Carr et al. (1992). In the Carr et al. (1992) study, individuals with asthma only and
individuals with panic disorder reported similar levels of dyspnea and similar levels of
psychopathology. The authors noted that variance in panic symptoms in individuals with
asthma is better accounted for by dyspnea scores compared to individuals with panic
disorder. In other words, panic symptoms in asthma may be due to dyspnea, but in panic
disorder, they are not due to dyspnea levels.
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It was predicted that women in the Asthma only, Panic only, and Asthma and
Panic groups would report similar levels of change in dyspnea scores fiom baseline to
afler the relaxation task. These levels were predicted to be significantly higher than those
reported by women in the Control group. All four groups reported similar levels of
dyspnea both at baseline and after the relaxation task. However, when within-subjects
differences were examined, the straw task produced the greatest increase in dyspnea
reports, followed by the head turning task for all four groups. The relaxation task
produced the smallest changes in dyspnea reports. These results suggest that the straw
task did produce increased dyspneic sensations, but that all groups, including the Control
group, reported similar levels of dyspnea after the tasks.
A number of differences between the Carr et al. (1992) study and the present study
may have led to the discrepant between-groups results for the relaxation task. In the
previous study, participants recruited from the community included both males and
females with an average age of 45. Furthermore, in the Carr et al. (1992) study,
participants were seated in a reclining chair with the lights off for the relaxation task. In
the present study, participants sat upright in the same chair that was used for the other
tasks, and lights remained on during the relaxation task. It is possible that sample and
methodological differences contributed to the lack of significant findings for the
relaxation task in the present study.
Women in the three experimental groups were expected to report significantly
greater dyspnea levels after the head turning task in comparison to controls. Although
between-group differences were not found for the head turning task, it is clear that the
task itself did produce an increase in dyspnea reports relative to baseline for all groups.
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Due to their unfamiliarity with the sensation, women in the Control group were
expected to report more dyspnea during the straw task than women in the other three
groups. However, no significant group differences were identified. Within-subjects
analyses revealed that for all four groups, the straw task produced the greatest increase in
dyspnea relative to the other two tasks.
There are several possible reasons that may have contributed to the lack of
between-groups differences in the present study. It may be that individuals who have not
experienced dyspnea on a regular basis (as individuals with asthma or panic disorder
might) pay less attention to the sensation of dyspnea. As noted above, women in both of
the panic disorder groups focus more on bodily sensations and might therefore be
expected to notice more subtle changes in dyspnea level in comparison to controls.
Again, examination of dyspnea change scores for the straw task shows that all four
groups reported an increase in dyspnea during the straw task in comparison to the other
two tasks. The task itself may have been strong enough to produce uniform changes in
perceived dyspnea. Future research should use more than one task specifically designed
to induce dyspneic sensations and compare self-reports across these tasks, rather than
relying on one task that appears to produce similar changes in all participants.
A fourth hypothesis testing the dyspnedsuffocation fear theory suggested that
differences would be identified in panic sensation levels after each task. The head turning
and relaxation tasks did not produce changes in panic symptoms. After the straw task,
women in the Panic only group reported more hyperventilation symptoms than women in
the Asthma only and Control groups, and women in the Asthma and Panic group reported
more bronchoconstriction than women in the Asthma only group. These results may
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appear to conflict with the findings discussed above, where no group differences in
dyspnea levels were identified. However, examination of the measures used may explain
the differences. The Borg scale is a 0- I0 Likert scale that asks individuals to rate the
amount of difficulty breathing that they experienced during the task. The
hyperventilation and bronchoconstriction subscales of the ASC ask about much more
specific symptoms (i.e., “shallow breathing,” “tingly in spots,” “chest tightening,”
“mucous congestion”). When asked to rate difficulty breathing in general, participants
may tend to minimize their symptoms, or not think of symptoms like “shallow breathing,”
as constituting “difficulty breathing”. When participants are asked specifically about
ways their breathing may be impaired, this may elicit increased self-reports of
hyperventilation and bronchoconstriction.
These results suggest that it is important for future research to use more specific
measures of breathing difficulty and dyspnea than the Borg scale. Respiratory symptoms
such as perceived hyperventilation and bronchoconstriction are hypothesized to play an
important role in the onset of panic attacks (Ley, 1989). Therefore, it is particularly
important to use measures of specific respiratory symptoms rather than a global rating of
breathing difficulty when studying individuals with both asthma and panic disorder.
When within-subjects differences were examined for the Bronchoconstriction
subscale, it was evident that the straw task produced the greatest increase, followed by the
head turning task, and lastly the relaxation task. These findings applied to the Asthma
only, Panic only, and Asthma and Panic groups. Women in the Control group exhibited a
slightly different pattern, with the straw task producing the largest increase in selfreported bronchoconstriction in comparison to the head turning and relaxation tasks,
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which were not significantly different from each other. These results are very similar to
those for the dyspnea self-reports. Furthermore, examination of within-subjects
differences on sensations specific to panic, the Asthma only, Panic only, and Asthma and
Panic groups reported equivalent levels of change from baseline for the head turning and
straw tasks. The levels of change reported for both the head turning and straw task were
equivalent for these groups. This finding indicates that the head turning and straw tasks
did indeed produce changes in panic sensation levels, but that these changes did not
necessarily differ across groups.
Overall, the between-groups hypotheses related to the dyspnedsuffocation theory
were generally not supported in this study. Dyspnea levels did not differ for any of the
groups at baseline or after any of the tasks. Self-reports of asthma-related and panic
sensations were greater for women in the Panic only group at baseline. No significant
differences between groups were identified for the head turning or relaxation tasks on
bodily sensations measures. After the straw task, however, women with panic disorder
only reported more hyperventilation symptoms than women in the Asthma only and
Control groups. In addition, women in the Asthma and Panic group reported more
bronchoconstriction during the straw task than women with asthma only. Therefore, the
hypothesis put forth by Carr et al. (1 992) that suggested that the high rate of concordance

of panic disorder in individuals who have respiratory disorders may be due to the
experience of dyspnea was not supported by the results of the present study.
Arguments by Ley (1 992a; 1992b) regarding using individuals who meet DSM
criteria for panic disorder also apply to the present study. Ley notes that his theory
applies to individuals who experience hyperventilatory panic attacks only. The use of
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DSM-IV criteria rather than Ley’s criteria for hyperventilatory panic attacks in selecting
participants in the present study may account for the lack of significant group differences.
Selection of participants who have hyperventilatory panic attacks for studies similar to the
present study might lead to results that would be more in line with the tenets of dyspned
suffocation fear theory.
Carr’s Hypothesis
Carr et al. (1 996) conducted an experiment that involved having individuals with
asthma, panic disorder, or both disorders engage in baseline and stressful tasks. The
authors found that at baseline, individuals with asthma had more difficulty breathing than
individuals with both asthma and panic disorder. Furthermore, a nonsignificant trend was
identified that suggested that individuals with both asthma and panic disorder
experienced improved lung function after a stressful task. Thus, Carr (1 998) concluded
that it is possible that having both asthma and panic disorder may actually improve lung
function and in some cases may serve as a protective function for individuals with
asthma.
The present study attempted to replicate the findings of Carr et al. (1996) by
measuring lung function after each task. However, no between-groups differences after
any of the tasks were identified for the spirometry measures. Similarly, when withinsubjects analyses were conducted, no differences in FEVl change scores were found for
any of the groups. For FVC however, the Asthma and Panic group’s change scores for
the relaxation task were greater than for the straw task. There were no significant
differences for the straw and head turning tasks nor for the head turning and relaxation
tasks. These results indicate that women in the Asthma and Panic group experienced a
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decrease in lung function after the straw task in comparison to the relaxation task. This
finding directly contradicts Carr’s hypothesis that having both asthma and panic disorder
serves as a protective factor.
For the ratio of FEVl/FVC, no within-subjects differences were found for the
Asthma only, Asthma and Panic, and Control groups. However, women in the Panic only
group experienced decreased lung function during the head turning task compared to the
straw task. There were no significant differences between the head turning and relaxation
tasks nor for the straw and relaxation tasks for this group. This finding suggests that for
the Panic group, the straw task produced greater lung obstruction than did the head
turning task.
It must be noted that the problems with the reliability of the spirometry readings
led to the need for different analyses than were originally proposed. Because many of the
participants’ spirometric efforts produced readings that were less reliable than would be
ideal, the variability readings for the spirometry measurements were used as covariates
rather than excluding measurements that did not fall within the cutoff for reliability.
Future research should utilize much larger samples than was possible in the present study,
and ensure as much as possible that spirometry efforts are consistent. Furthermore, the
type of lung function measurement equipment used in these two studies was not the same.
Carr et al. (1996) used forced oscillation pneumography, whereas the present study
utilized spirometry. This difference in equipment may have led to disparate findings.
Spirometry involves 3 separate blasts of air after the task and is effort-dependent. Forced
oscillation pneumography can continuously monitor breathing via a mouthpiece, and is
not effort-dependent. It is possible that use of forced oscillation pneumography might
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have identified brief alterations in lung function during the tasks, and it would have
eliminated the problems with participant effort that the spirometry caused.
Interestingly, there have been no published studies to date that clearly confirm
Carr’s hypothesis that having both asthma and panic disorder may lead to better lung
function. Dorhofer & Sigmon (in press) measured participants’ lung function after they
listened to neutral and asthma-related audiotaped scenes. In that study, peak air flow
measurements were taken with a simple plastic device. The authors found a nonsignificant trend that suggested that having both asthma and panic attacks might protect
against a drop in peak flow experienced by individuals with asthma only. It is also
possible that Carr’s original finding was an anomaly that is not replicable in further
research. However, studies that replicate these findings are needed before a definitive
statement is made regarding the possible beneficial effects of panic attacks or panic
disorder on the lung function of individuals diagnosed with asthma.
Study Limitations
Numerous limitations to the present study are noteworthy. The small sample size
of 60 participants across four groups may have led to a lack of significant findings for
some analyses. Comparisons between subsets of individuals within each group were not
possible because of the small sample size. Although several reasons led to the use of
women only in this study, the lack of men in this sample limits the generalizability of
study results. Future research should make a point of comparing groups of men and
women who suffer from both asthma and panic disorder.
The use of primarily Caucasian undergraduates as experimental participants raises
various concerns in and of itself. It is unclear how generalizable these results are to other
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populations such as males, middle-aged individuals, the elderly, or minority groups.
Research has indicated that changes in the prevalence of both asthma and panic disorder
occur with age (Dodge & Burrows, 1980; Pearlman & Bierman, 1988). In particular,
following women as they go through menopause and documenting how their asthma
and/or panic disorder symptoms change will be important for future research to
investigate.
One serious limitation is that for some individuals with asthma, simply taking a
deep breath before exhaling into a spirometer can cause short-lived lung function
decreases (Gayrard et al., 1975; Gayrard et al., 1979; Orehek et al., 1975). Unfortunately,
spirometry is the most widely used, least expensive, and least intrusive of a number of
measures of lung function. Until alternative ways of measuring lung function become
more affordable and less intrusive, the use of spirometry is likely to continue.
The tasks that were used in the present study may not have been salient enough to
lead to increases in anxiety for the majority of the participants. It is also possible that the
tasks were either too long or too short to produce an anxiety experience that would lead to
group differences. For example, if the tasks were too short, the threshold for anxiety may
not have been reached. If the tasks were too long, participants may have habituated to the
sensations. Anecdotally, several participants mentioned that the straw task bothered them
when they first began the task, but after a few seconds they relaxed and became less
anxious as they became used to the sensations. Using a smaller straw (a coffee stirrer
rather than a drinking straw) may also lead to an increase in sensations and anxiety during
this task. In addition, standardizing the speed at which participants turn their heads
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during the other experimental task could ensure that the task was more consistent
between participants.
Future Directions
It is only within the last 10 years that interest has emerged in researching the
effects of comorbidity of asthma and panic disorder. Therefore, there are numerous areas
that future research can and should address. Many of these have been discussed above,
but deserve additional attention here.
First, the relation between the anxiety sensitivity construct and the onset and
maintenance of panic disorder in individuals with and without asthma needs to be
examined more thoroughly. Conflicting findings have been reported regarding whether
or not individuals with asthma only report higher levels of anxiety sensitivity than
controls. Further study is required with a more demographically diverse sample than the
present study used to help shed light on this issue. If individuals with asthma only do
indeed report higher levels of anxiety sensitivity, longitudinal studies could examine the
rates with which high anxiety sensitivity individuals with asthma develop panic disorder.
The onset and course of panic disorder in individuals with asthma has not been
investigated to date. Longitudinal studies will be able to address this issue as well.
Treatment for individuals with comorbid asthma and panic disorder represents
another important area for future research. The results of the present study suggest that
using panic challenge tasks with these individuals will not be detrimental to lung function
in the short term. However, it remains unknown how effective and safe behavioral
treatments are for use with individuals with asthma over the long term.
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In general, the results of the present study indicate that having asthma and panic
disorder leads to increases in trait anxiety, self-focus on bodily sensations, fear of bodily
sensations, and anxiety sensitivity (on one of two measures of anxiety sensitivity) in
comparison to controls or individuals with asthma only. Cognitive theory was supported
for individuals in both panic groups. Finally, the head turning and straw tasks were
successful in producing increases in anxious mood, increases in panic and asthma
sensations, self-reported dyspnea, and panic related cognitions in comparison to the
relaxation task.
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APPENDIX A
Power Analysis
Power analyses were calculated based on statistics presented in Carr et al. (1996):
F(3,109) = 20.77
k=4
k*n = 109

w 2= Jk - 1)(F - 1)
(k-l)(F- 1 ) + h
w 2= (4 - 1)(20.77 - 1)
(4 - 1)(20.77 - 1) + 109
w 2= .352

a=
cD=

n7w2
1-w2
n’.352
.648

cD= .737 n’
Substituting 15 participants per cell in for n’, @ = 2.85. Looking these values up on
charts from Pearson and Hartley (195 l), a power value of .94 is obtained.
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APPENDIX B
Asthma and Anxiety
Informed Consent Form I

I have been asked to participate in this study because I am at least 18 years old and
responded to media recruitment efforts for a study on asthma and anxiety. The purpose of
this study is to gain more information about the relation between psychological events
and physical health. My participation in this study will help further the understanding of
the psychological processes involved in asthma and anxiety disorders. First, I will
undergo a psychological assessment to see if I qualify for the experiment. This
assessment will involve completion of a diagnostic interview (e.g., Do you currently have
times when you feel a sudden rush of intense fear or discomfort?). If I qualify, I will
participate in an experimental session. During this session, I will complete some
questionnaires. If a question makes me feel uncomfortable, I don’t have to answer it. I
will be asked to respond to various questions assessing:

0

0

How I feel about various bodily sensations (e.g., “It scares me when I feel
faint”, “Your heart is pounding”)
Symptoms of asthma that I may experience (e.g., “Coughing,” “Chest
congestion”)
My mood (e.g., “I do not feel sad,” “I am worried”)
My interpretations of everyday situations

In addition to the interview and questionnaires, I will complete three tasks. In one
task, I will briefly turn my head fiom side to side. In another task, I will breathe through
a straw for a short period of time. A third task involves relaxing. Between these tasks, I
will complete some questionnaires and have my lung function measured. Lung function
will be assessed by a spirometer. I will be asked to take a deep breath and then forcefully
exhale into a device that measures how well my lungs are working.

I understand that 1 will be paid for my participation in this study. If I qualify, I
will receive $10 for the interview and experimental session, which will require a
maximum of 2 hours.
The risks associated with this project are minimal. However, if I experience any
distress associated with completing questionnaires or the experimental session, I may
speak with a licensed psychologist (Dr. Sandy Sigmon, 207-58 1-2052). I may also
contact Dr. Sigmon long-distance by calling her collect. If I want more information about
this study, I may contact the experimenter, Diana Dorhofer, at 58 1-2031 (30 1 Little Hall,
University of Maine, Orono, ME 04469). If I live long-distance from the University and
have a question for Diana, I may call Dr. Sigmon collect and leave a message for her. At
any point in the study, I may request a referral for treatment. I may terminate my
participation at any point without penalty. If I desire, a summary of the results of this
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project will be made available to me at the end of the study. If I wish to receive a
summary of the results, I may indicate so at the bottom of this form.
My responses will remain anonymous and all of the information I provide will be
stored in a locked laboratory. My participation in this study is strictly voluntary and I
may withdraw at any time without penalty.

I acknowledge that I have received a copy of this consent form.
Participant’s signature:
Printed name:

Date:
Phone:

Please indicate if you would like a summary of the results of this study:

If yes, please write your permanent mailing address below:
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Asthma and Anxiety
Informed Consent Form I1
I have been asked to participate in this study because I am at least 18 years old and
responded to media recruitment efforts for a study on asthma and anxiety. The purpose of
this study is to gain more information about the relation between psychological events
and physical health. My participation in this study will help further the understanding of
the psychological processes involved in asthma and anxiety disorders. First, I will
undergo a psychological assessment to see if I qualify for the experiment. This
assessment will involve completion of a diagnostic interview (e.g., Do you currently have
times when you feel a sudden rush of intense fear or discomfort?). If I qualify, I will
participate in an experimental session. During this session, I will complete some
questionnaires. If a question makes me feel uncomfortable, I don’t have to answer it. I
will be asked to respond to various questions assessing:
How I feel about various bodily sensations (e.g., “It scares me when I feel
faint”, “Your heart is pounding”)
Symptoms of asthma that I may experience (e.g., “Coughing,” “Chest
congestion”)
My mood (e.g., “I do not feel sad,” “I am worried”)
My interpretations of everyday situations
In addition to the interview and questionnaires, I will complete three tasks. In one
task, I will briefly turn my head from side to side. In another task, I will breathe through
a straw for a short period of time. A third task involves relaxing. Between these tasks, I
will complete some questionnaires and have my lung function measured. Lung f i c t i o n
will be assessed by a spirometer. I will be asked to take a deep breath and then forcefully
exhale into a device that measures how well my lungs are working.
I understand that I will receive experimental credit for my participation in this
study. If 1 qualify, I will receive 2 credits for the interview and experimental session,
which will require a maximum of 2 hours. If I do not qualifl, I will receive 1 credit for
the interview portion of the study.
The risks associated with this project are minimal. However, if I experience any
distress associated with completing questionnaires or the experimental session, I may
speak with a licensed psychologist (Dr. Sandy Sigmon, 207-58 1-2052). I may also
contact Dr. Sigmon long-distance by calling her collect. If I want more information about
this study, I may contact the experimenter, Diana Dorhofer, at 581-203 1 (301 Little Hall,
University of Maine, Orono, ME 04469). If I live long-distance from the University and
have a question for Diana, I may call Dr. Sigmon collect and leave a message for her. At
any point in the study, I may request a referral for treatment. I may terminate my
participation at any point without penalty. If I desire, a summary of the results of this
project will be made available to me at the end of the study. If I wish to receive a
summary of the results, I may indicate so at the bottom of this form.
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My responses will remain anonymous and all of the information I provide will be
stored in a locked laboratory. My participation in this study is strictly voluntary and I
may withdraw at any time without penalty.
I acknowledge that I have received a copy of this consent form.
Participant’s signature:
Printed name:

Date:
Phone:

Please indicate if you would like a summary of the results of this study:

If yes, please write your permanent mailing address below:

APPENDIX C
Physician Release of Information
Physician name:
Physician address:

have participated in an experiment at the University of
I,
Maine that examines psychological factors that may influence asthma symptoms. This
experiment requires that participants have been diagnosed with asthma. Please complete
the following questions and return this form in the enclosed self-addressed stamped
envelope. I give permission for you to release information regarding my diagnosis of
asthma only to Diana Dorhofer, the primary experimenter for this study.

Participant signature

Date

Print name

Please complete the following questions:
Has

been diagnosed with asthma?

YES

NO

At approximately what age was she diagnosed?
What medications have you prescribed for her for her asthma symptoms (please include
dosage information)?

Please rate the severity of her asthma:
Severe
Is her asthma: Well-controlled
Not controlled well

Mild

Moderate

Moderately well-controlled

Thank you for completing this information. Please return this form in the enclosed
envelope. If you have any questions, please contact Diana Dorhofer (207-581-203l), 301
Little Hall, Orono, ME 04469.
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APPENDIX D
Anxiety Sensitivity Index
Respond to each item by indicating the number of the phrase which best
represents the extent to which you agree with the item. If any of the items addresses
something that is not part of your experience (i.e., "it scares me when I feel shaky'' for
someone who has never trembled or had the 'khakes"), answer on the basis of how you
think you might feel if you had such an experience. Otherwise, answer all items on the
basis of your own experience. Be careful to make only one choice for each item and
please answer all items.

0 = Very little
1 = A little
2 = Some
3 = Much
4 = Very much
1.
2.
3.
4.
5.
6.
- 7.
8.
9.

It is important to me not to appear nervous
When I cannot keep my mind on a task, I worry that I might be going crazy
It scares me when I feel "shaky" (trembling)
It scares me when I feel faint
It is important to me to stay in control of my emotions
It scares me when my heart beats rapidly
It embarrasses me when my stomach growls
It scares me when I am nauseous
When I notice that my heart is beating rapidly, I worry that I might have a
heart attack
10. It scares me when I am short of breath
1 1. When my stomach is upset, I worry that I might be seriously ill
12. It scares me when I am unable to keep my mind on a task
13. Other people notice when I feel shaky
14. Unusual body sensations scare me
15. When I am nervous, I worry that I might be mentally ill
- 16. It scares me when I am nervous
__
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APPENDIX E
Anxiety Sensitivity Profile
Instructions: It is very important that you read these instructions carefully so that you will be
able to answer the questions that follow. The purpose of this questionnaire is to measure
your level of fear of anxiety-related sensations. There are many anxiety-related sensations,
including the following: palpitations (pounding heart or accelerated heart rate), sweating,
trembling, shortness of breath, chest pain or discomfort, nausea, dizziness, feelings of
unreality, chills, and hot flashes. People differ in their fears of these sensations: some
people have little or no fear, others have mild or moderately severe fears, while others have
very strong fears.
Anxiety sensations are feared if a person believes that these sensations have bad
consequences. For example, people are frightened of palpitations if they believe these
sensations could lead to a heart attack. People are frightened of dizziness if they believe
that this sensation could mean that they are going crazy. People are frightened of publicly
observable anxiety reactions (e.g., blushing or trembling) if they believe these reactions
could cause others to ridicule or reject them.
We would like you to do two things for each of the items on the following pages:
1. Imagine that you are experiencing the sensation. Try to imagine this as vividly as
possible.
2. Using the scale provided, rate the likelihood that if YOU experienced the sensation, it
would lead to something bad happening to you, such as dying, going crazy, losing control,
or being ridiculed or rejected by others. There are no right or wrong answers, and all
responses will remain anonymous. Please note: We are not assessing whether or not you
experience these sensations as a result of being anxious. We want to assess whether you
believe that anxiety-related sensations would lead to something bad happening to you.
Practice item:
Imagine that you’re experiencing the following sensation. What is the likelihood
that this sensation would LEAD to something BAD happening to YOU? Circle the number
that best indicates your choice:

0. Your legs feel unsteady

Not at all
likely
1
2

Somewhat
likely

3

4

5

Extremely
likely
6
7

Before you answer the following questions, please place a check mark here if you fully
understand the instructions you have read:
If you don’t understand the instructions, please ask for clarification.
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What is the likelihood that this sensation would LEAD to something BAD happening to
YOU?
1 = Not at all likely
2
3 = Somewhat likely
4
5 = Extremely likely
1. Your heart is pounding
2. Your thoughts seem slower than usual
3. You feel like you can’t take a deep breath
4. Your stomach is making loud noises
5. You have tingling sensations in your hands
6. You have pain in your chest
7. Your thoughts seem jumbled
8. Your heart is beating so loud that you can hear it
9. You feel like you’re in a fog
10. Hot flushes sweep over you
11. You have diarrhea
12. You are “jumpy” or easily startled
13. You keep getting distracted by unwanted thoughts
14. Your heart beats rapidly
15. You feel like you’re suffocating
16. You have a knot in your stomach
17. You feel numb all over
18. Thoughts seem to race through your mind
19. You feel out of breath even though you haven’t been exerting yourself
20. Your heart pounds in your ears
2 1. You feel like something is stuck in your throat
22. Your body feels strange or different in some way
23. Your face sweats even though you’re not hot
24. Your voice quavers (trembles or sounds shaky)
25. You can’t keep your mind on a task
26. You have difficulty swallowing
27. Your stomach aches
28. You have burning sensations in your chest (heartburn)
29. Familiar surroundings seem strange or unreal to you
30. You feel like you’re choking
3 1. You feel your heartbeat pulsing in your neck
32. You are constipated
33. You feel faint or lightheaded
34. Your heart starts beating slower
35. You shiver even though you’re not cold
36. You have trouble thinking clearly
37. You feel that there’s a lump in your throat
38. You feel like you’re about to vomit

1 = Not at all likely
2
3 = Somewhat likely
4
5 = Extremely likely
39. You’re awake but you feel like you’re in a daze
40. Your stomach is upset
4 1. You have trouble remembering things
42. Your heart beats erratically
43. You have tingling sensations in your lips
44. Your mind goes blank
45. Your throat feels tight
46. You feel “spacey” or spaced out
47. You feel like you’re not getting enough air
48. Your face blushes red
49. You feel bloated (gassy)
50. You feel sick in your stomach (nausea)
5 1. Your heart skips a beat
52. Your face feels numb
53. The muscles in your face twitch
54. You are easily distracted
56. You have difficulty concentrating
57. You have to urinate more frequently than usual
58. Your hands are trembling
59. You feel like you can’t breathe properly
60. You feel like things are spinning around you
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APPENDIX F
Asthma Symptom Checklist
Please rate the following symptoms you may experience when you are having an asthma
attack.
1= Never
2= Rarely
3= Sometimes
4= Frequently
5= Always
1. Shallow breathing
2. Choking
3. Pins & needles feeling
4. Anxious
5. Edgy
6. Coughing
7. Itchy throat
8. worn out
9. Frustrated with things
10. Worried about myself
11. Worried about attack
12. Dizzy
13. Itchy lungs
14. Nauseated
15. No energy
16. Tingly in spots
17. Scared
18. Short tempered

Worried
20. Headache
21. Afraid of dying
22. Itchy skin
23. Panicky
24. Short of breath
25. Chest filling up
26. Chest congestion
27. Mucous congestion
28. Cranky
29. Numb
30. Fatigued
3 1. Irritable
32. Rapid breathing
33. Chest tightening
34. Frightened
35. Weak
36. Hard to breathe
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APPENDIX G
Body Vigilance Scale
Instructions: This measure is designed to index how sensitive you are to internal
bodily sensations such as heart palpitations or dizziness. Fill it out according to how you
have felt for the past week.
1. I am the kind of person who pays close attention to internal bodily sensations.

_________ 1_________2________ 3________4________ 5________ 6________ 7________ 8________ 9________ 10

0
Not at all
like me

Moderately
like me

Extremely
like me

2. I am very sensitive to changes in my internal body sensations.

_________ 1_________ 2________ 3________ 4________ 5________ 6________7________ 8________ 9________ 10

0
Not at all
like me

Moderately
like me

Extremely
like me

3. On average, how much time do you spend each day “scanning” your body for
sensations (e.g., sweating, heart palpitations, dizziness)?
0_______ 10
No time

________ 20_______ 30_______40_______ 50_______ 60_______ 70_______ 80_______90_______ 100
Half of the
time

All of the
time

4. Rate how much attention you pay to each of the following sensations using this scale:

1.
2.
3.
4.
5.
6.
7.
8.
9.

Heart palpitations
Chest paiddiscomfort
Numbness
Tingling
Short of breathkmothering
Faintness
Vision changes
Feelings of unreality
Feeling detached from self

10. Dizziness
11. Hot flash
12. Sweatinglclammy hands
13. Stomach upset
14. Nausea
15. Chokindthroat closing
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APPENDIX H
Borg Category Scale
Please rate the amount of difficulty breathing that you experienced during the task
you just completed.

0 Nothing at all
0.5 Very, very slight (just noticeable)
1 Very slight
2 Slight
3
4
5 Moderate
6 Somewhat severe
7 Severe
8 Very severe
9 Very, very severe (almost maximal)
10 Maximal
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APPENDIX I
Brief Body Sensations Interpretation Questionnaire
Here are some outline descriptions of situations in which it is not quite clear what
is happening. Read each one, and then answer the question below it very briefly. Write
down the first thing that comes into your mind without thinking too long about it. Please
write what you think is happening before you turn over the page. Be as specific as
possible.
When you have done that, turn the page over and you will see three possible
explanations for the situation. Arrange these in the order in which they would most likely
come to your mind if you found yourself in a similar situation. So the one that you would
consider most likely to be true should come first, and the one that you would consider
least likely to be true should come third. Do not think too long before deciding. We want
your first impressions, and do not worry if none of them fits with what you actually did
think.
la.

You have visitors over for a meal and they leave sooner than you expected.
Why?

1b.

a) They did not wish to outstay their welcome.
b) They had another pressing engagement to go to.
c) They did not enjoy the visit and were bored with your company.

2nd

1St

2a.

3rd

You feel short of breath.
Why?

2b.

a) You are developing the flu.
b) You are about to suffocate or stop breathing.
c) You are physically “out of shape.”

3a.

Your vision has become slightly blurred.
Why?
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3b.

a) You have strained your eyes slightly.
b) You need to get glasses or change your existing glasses.
c) This is a sign of a serious illness.

4a.

You go into a shop and the clerk ignores you.
Why?

4b.

a) They are bored with their job, and this makes them rude.
b) They are concentrating very hard on something else.
c) They find you irritating and resent your presence.

5a.

You feel lightheaded and weak.
Why?

5b.

a) You are about to faint.
b) You need to get something to eat.
c) You didn't get enough sleep last night.

6a.

You smell smoke.
Why?

6b.

a) Your house is on fire.
b) Some food is burning.
c) Someone is smoking a cigarette.

7a.

A friend suggests that you change the way that you're doing a job in your own
house.
Why?

7b.

a) They are trying to be helpful.
b) They think you're incompetent.
c) They have done the job more often and know an easier way.

8a.

Your chest feels uncomfortable and tight.
Why?

8b.

a) You have indigestion.
b) You have a sore muscle.
c) Something is wrong with your heart.

9a.

You wake with a start in the middle of the night, thinking you heard a noise, but
all is quiet.
What woke you up?

9b.

a) You were woken by a dream.
b) A burglar broke into your house.
c) A door or window rattled in the wind.

2nd

1st
1Oa.

3rd

You are introduced to someone at a party who fails to reply to a question you ask
them.
Why?

1Ob.

a) They did not hear the question.
b) They think you are uninteresting and boring.
c) They were preoccupied with something else at the time.

11a.

You notice your heart is beating quickly and pounding.
Why?

174

11b.

a) Because you have been physically active.
b) Because there is something wrong with your heart.
c) Because you are feeling excited.

1St
12a.

2nd

3‘d

You suddenly feel confused and are having difficulty thinking straight.
Why?

12b.

a) You are going out of your mind.
b) You are coming down with a cold.
c) You’ve been working too hard and need a rest.

1st
13a.

2nd

3‘d

A letter marked “URGENT” arrives.

What is in the letter?
13b.

a) It is an advertisement designed to attract your attention.
b) You forgot to pay a bill.
c) News that someone you know has died or is seriously ill.

1st
14a.

2nd

3rd

You notice that your heart is pounding, you feel breathless, dizzy and unreal.
Why?

14b.

1st

a) You have been overdoing it and are overtired.
b) Something you ate disagreed with you.
c) You are dangerously ill or are going mad.
2”d

3rd
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Now that you have answered the preceding questions we would be grateful if you
would answer one more question about each of the ambiguous situations. Please return to
the start of the booklet and then rate the extent to which you think each of the three
explanations would be likely to be true if you found yourself in that situation.
Use the scale below for your ratings. Put a number between 0 and 8 next to
of the three explanations in the text. Do not worry if your ratings appear to be different
from your previous answers, and please do not change any of your original answers.

_________ 1_________ 2_________ 3_________4_________ 5 _________ 6_________ 7_________ 8

0
Not at all
likely

A little

Moderately

very

Extremely
likely
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APPENDIX J
General History
AGE
HEIGHT
WEIGHT
DATE
TIME
At what age were you diagnosed with asthma?
Have you been diagnosed with any other chronic illness? (e.g., diabetes, high blood
pressure, etc.)
-Yes
no
If yes, what illness?
~

What medications do you take, at what dosages, and how often? Please include birth
control pills.
Do you take these medications as prescribed
more frequently
Describe increase or decrease

or

less frequently

How often do you have asthma attacks?
Once per day or more
Once per week or more
Once per month
Once per year
Less than once every couple of years
How often do you have asthma symptoms (e.g., wheezing, coughing, tightness of chest,
mucus, etc.)?
Once per day or more
Once per week or more
Once per month
Once per year
Less than once every couple of years
When was your last asthma attack?
Is your asthma

exercise induced,

allergy induced, or

If allergy induced, list things that trigger symptoms or an attack

both?
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During what months do you usually have asthma symptoms?
All months
February
March
January
May
June
July
September
October
November
~

~

Do you use a peak flow meter at home? Y
If yes, how often do you use it?
If yes, what is your usual peak flow?

April
August
December

N

What sport(s) or other types of exercise do you regularly engage in, if any?

How often and for how long?
Do you smoke? Y
N
If yes, how many cigarettes per day?
Do you live with someone who smokes? Y
N
If yes, how many hours per day are you exposed to household smoke?

APPENDIX K
Panic Attack Cognitions Questionnaire
Instructions: Using the scale below, rate each one of the following thoughts
according to the degree to which you thought it during and after the task you
just completed. Remember to rate each thought twice, once for during and
once for after the task.
1 =Not at all
2 = Some, but not much
3 = Quite a lot
4 = Totally dominated your thoughts
During
1. I am going to die.
2. I am going insane.
3. I am losing control.
4. This will never end.
5. I am really scared.
6. I am having a heart attack.
7. I am going to pass out.
8. I don’t know what people will think.
9. I won’t be able to get out of here.
10. I don’t understand what is happening to me.
1 1. People will think I am crazy.
12. I will always be this way.
13. I am going to throw up.
14. I must have a brain tumor.
15. I will choke to death.
16. I am going to act foolish.
17. I am going blind.
18. I will hurt someone.
19. I am going to have a stroke.
20. I am going to scream.
21. I am going to babble or talk funny.
22. I will be paralyzed by fear.
23. Something is really physically wrong with me.
24. I will not be able to breathe.
25. Something terrible will happen.
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APPENDIX L
Profile of Mood States
Instructions: Below is a list of words that describe feelings that people have.
Please read each one carefully. Then select one of the numbered descriptors that best
describes how you feel right now. Place that number on the small line to the left of each
word. Do not skip any items, and print your numbers clearly.

0 = Not at all
1 = A little
2 = Moderately
3 = Quite a bit
4 = Extremely
1. Tense
__ 2. Unhappy
- 3. Sorry for things done
__ 4. Shaky
__ 5. Sad
__ 6. Onedge
- 7. Blue
8. Panicky
- 9. Hopeless
10. Relaxed
11. Unworthy
12. Uneasy

13.
- 14.
- 15.
16.
17.
18.
19.
20.
- 21.
22.
- 23.
24.

Restless
Discouraged
Nervous
Lonely
Miserable
Anxious
Gloomy
Desperate
Helpless
Worthless
Terrified
Guilty

180
APPENDIX M
State-Trait Anxiety Inventory- State
Instructions: A number of statements which people have used to describe
themselves are given below. Read each statement and then, using the scale below, place
the number that indicates how you feel right now, that is, at this moment, in the blank
before the number. There are no right or wrong answers. Do not spend too much time on
any one statement but give the answer which seems to describe your present feelings best.

1 =Not at all
2 = Somewhat
3 = Moderately so
4 = Very much so
1. I feel calm
2. I feel secure
3. Iamtense
4. I feel strained
- 5. I feel at ease
6. I feel upset
7. I am presently worrying over possible misfortunes
8. I am satisfied
9. I feel frightened
10. I feel comfortable
11. I feel self-confident
12. I feel nervous
13. Iamjittery
14. I feel indecisive
15. I am relaxed
16. I feel content
17. I am worried
18. I feel confused
19. I feel steady
20. I feel pleasant
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State-Trait Anxiety Inventory- Trait
Instructions: A number of statements which people have used to describe
themselves are given below. Read each statement and then, using the scale below, place
the number that indicates how you generally feel in the blank before the number. There
are no right or wrong answers. Do not spend too much time on any one statement, but
give the answer which seems to describe how you generally feel.

1 = Almost never
2 = Sometimes
3 = Often
4 = Almost always
- 21. I feel pleasant
- 22. I feel nervous and restless

23.
24.
25.
26.
27.
28.
29,
__ 30.
31.
32.
- 33.
34.
35.
36.
37.
38.
__ 39.
__ 40.

I feel satisfied with myself
I wish I could be as happy as others seem to be
I feel like a failure
I feel rested
I am "calm, cool, and collected"
I feel that difficulties are piling up so that I cannot overcome them
I worry too much over something that really doesn't matter
Iamhappy
I have disturbing thoughts
I lack self-confidence
I feel secure
I make decisions easily
I feel inadequate
I am content
Some unimportant thought runs through my mind and bothers me
I take disappointments so keenly that I can't put them out of my mind
I am a steady person
I get in a state of tension or turmoil as I think over my recent concerns and
interests
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APPENDIX N
Symptom Checklist
Below is a list of symptoms that people experience. Please rate each item by writing
the number in each slot that best describes how you felt during the task you just completed.
0 = None
1 =Mild
2 = Moderate
3 = Severe
4 = Very severe
1. Shallow breathing
2. Choking
3. Pins & needles feeling
4. Anxious
5. Edgy
6. Coughing
7. Itchy throat
8. worn out
9. Frustrated with things
10. Worried about myself
11. Worried about attack
12. Dizzy
13. Itchy lungs
14. Nauseated
15. No energy
16. Tingly in spots
17. Scared
18. Short tempered
19. Racindpounding heart
20. Sweating
21. Hot flashes or chills
22. Fear of going crazy or
losing control
23. Hearing difficulties (ringing,
difficulty hearing)
24. Desire to escape or run out
25. Feelings of embarrassment

26. Worried
27. Headache
28. Afraid of dying
29. Itchy skin
30. Panicky
3 1. Short of breath
32. Chest filling up
33. Chest congestion
34. Mucous congesfion
35. Cranky
36. Numb
37. Fatigued
38. Irritable
39. Rapid breathmg
40. Chest tightening
4 1. Frightened
42. Weak
43. Hard to breathe
44. Trembling or shaking
45. Chest paiddiscomfort
46. Feeling that things aren’t real
47. Visual difficulties (blurred,
tunnel vision)
48. Difficulty concentrating
49. Difficulty keeping calm
50. Dry mouth
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APPENDIX 0
Visual Analog Panic Scale
Please rate the similarity of the sensations you experienced during the task to
those of a panic attack.

_____________ 2_____________ 3 _____________4_____________ 5 _____________ 6______________ 7

1

Not at all
similar

Moderately
similar

Extremely
similar

APPENDIX P
Visual Analog Stress Scale
Please rate the level of stress you felt during the task.

_____________ 2_____________3 _____________4_____________ 5 _____________ 6________-_____
7

1
Not at all
stressed

Moderately
stressed

Extremely
stressed

185
APPENDIX Q
Visual Analog Asthma Scale
Please rate the similarity of the sensations you experienced during the task to
those of an asthma attack.
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APPENDIX R
Visual Analog Control Scale
Please rate how much you believed you had control over the sensations you
experienced during the task.
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